Category: Health

  • MIL-OSI: OptimizeRx Corporation Appoints CEO Steve Silvestro to Board of Directors

    Source: GlobeNewswire (MIL-OSI)

    WALTHAM, Mass., June 24, 2025 (GLOBE NEWSWIRE) — OptimizeRx Corp. (the “Company”) (Nasdaq: OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, today announced the appointment of Steve Silvestro, currently serving as the Company’s Chief Executive Officer, to its Board of Directors, effective as of June 20, 2025.

    Mr. Silvestro joined the Company in 2019 and has been the Company’s CEO since March 2025, after serving as the interim CEO from January 2025. The appointment of Mr. Silvestro, with his knowledge of the Company and expertise in the industry, will enhance overall leadership and greatly contribute to the Company’s ability to execute its value creation plans and support key initiatives to deliver on its customer and shareholder roadmap.

    “The Board of Directors has been impressed with Steve’s leadership and the meaningful progress the Company has made since he stepped into the CEO role,” said Lynn Vos, Chairperson of OptimizeRx’s Board of Directors. “The initiatives he and the leadership team have executed have significantly strengthened OptimizeRx’s position with customers and laid a solid foundation for sustained long-term shareholder value creation. We’re pleased to welcome Steve to the Board and look forward to his continued contributions as we work together to refine and advance the Company’s strategic direction.”

    “It’s truly an honor to have the trust of such an experienced Board and be able to lead a team that is focused on operational excellence and customer delight,” added Steve Silvestro. “I am excited with the direction OptimizeRx is headed and believe we’re firmly positioned for a strong 2025 and are building a solid foundation for continued growth and execution in 2026 and beyond. I’m excited to join the Company’s Board and look forward to continuing to partner with our team, strategic partners, and customers as we continue to drive the Company’s growth. Our focus will remain on delivering exceptional customer experiences, deepening our value proposition with pharmaceutical partners, accelerating our shift toward a recurring revenue model, and progressing toward Rule of 40 performance.”

    About Stephen L. Silvestro

    Steve Silvestro was appointed Chief Executive Officer in March 2025. He joined the Company as Chief Commercial Officer in April 2019 and has since served as President from October 2023 until his appointment as interim CEO in January 2025. Prior to joining the Company, Mr. Silvestro was with CCH® Tagetik, a Wolters Kluwer company that provides corporate performance management software solutions for planning, consolidation and reporting, as its Vice President and General Manager from January 2018 until April 2019. From April 2017 to January 2018, Mr. Silvestro was with Prognos Health, Inc., a healthcare data and analytics company, as its Chief Commercial Officer and, before that, from September 2007 to April 2017, he was with Decision Resources Group, a multi-national corporation that provides high value global data solutions, analytics and consulting services to pharmaceutical, biotech, medical device, healthcare provider and payer, and managed care companies, in various capacities with him last serving as Executive Vice President, Head of Global Sales.

    About OptimizeRx

    OptimizeRx is a leading healthcare technology company that’s redefining how life science brands connect with patients and healthcare providers. Our platform combines innovative AI-driven tools like the Dynamic Audience Activation Platform (DAAP) and Micro-Neighborhood Targeting (MNT) to deliver timely, relevant, and hyper-local engagement. By bridging the gap between HCP and DTC strategies, we empower brands to create synchronized marketing solutions that drive faster treatment decisions and improved patient outcomes.

    Our commitment to privacy-safe, patient-centric technology ensures that every interaction is designed to make a meaningful impact, delivering life-changing therapies to the right patients at the right time. Headquartered in Waltham, Massachusetts, OptimizeRx partners with some of the world’s leading pharmaceutical and life sciences companies to transform the healthcare landscape and create a healthier future for all.

    Important Cautions Regarding Forward-Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as “anticipates”, “believes”, “estimates”, “expects”, “forecasts”, “intends”, “plans”, “projects”, “targets”, “designed”, “could”, “may”, “should”, “will” or other similar words and expressions are intended to identify these forward-looking statements. All statements in this press release that reflect the Company’s expectations, assumptions, projections, beliefs or opinions about the future, other than statements of historical fact, are forward-looking statements, including, without limitation, statements relating to OptimizeRx’s commitment to appointing directors who have perspectives, insights, experiences, and skills that expand the depth and breadth of the Board, executing the Company’s value creation plans, supporting key initiatives, advancing the Company’s strategic direction, delivering exceptional customer experiences, deepening the Company’s value proposition with pharmaceutical partners, accelerating the Company’s shift towards a recurring revenue model, progressing towards a Rule of 40 performance, and other statements relating to future performance, plans, and expectations. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. These forward-looking statements are based upon the Company’s current expectations and involve assumptions regarding the Company’s business, the economy, and other future conditions that may never materialize or may prove to be incorrect. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of various risks and uncertainties including, but not limited to, the Company’s ability to identify and appoint a new independent director, the effect of government regulation, seasonal trends, dependence on a concentrated group of customers, cybersecurity incidents that could disrupt operations, the ability to keep pace with growing and evolving technology, the ability to maintain contracts with electronic prescription platforms and electronic health records networks, competition, and other factors discussed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024, and in other filings the Company has made and may make with the SEC in the future. One should not place undue reliance on these forward-looking statements, which speak only as of the date on which they were made. The Company undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made, except as may be required by law.

    OptimizeRx Contact 

    Andy D’Silva, SVP Corporate Finance   
    adsilva@optimizerx.com
      
    Investor Relations Contact
    Steven Halper
    LifeSci Advisors, LLC
    shalper@lifesciadvisors.com

    The MIL Network

  • MIL-OSI: Xtract One Selected to Support San Mateo Medical Center in Keeping Patients and Staff Secure

    Source: GlobeNewswire (MIL-OSI)

    TORONTO, June 24, 2025 (GLOBE NEWSWIRE) — Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”) today announced its SmartGateway has been selected by San Mateo Medical Center, located in San Mateo, CA, to strengthen the facility’s security and provide AI-powered weapon detection. Xtract One’s leading technology-driven threat detection and security solutions are designed to enhance safety for patients, visitors, and staff at the medical center, starting with the main campus with plans to later expand to all satellite clinics.

    This deployment comes at a critical time for healthcare facilities, following California’s recent Assembly Bill (AB) 2975. With hospitals now being required to implement weapons detection screening policies at key entrances as a minimum, San Mateo Medical Center demonstrates its forward-thinking and proactive stance in deploying Xtract One’s cutting-edge technology designed to help elevate safety while enhancing the overall individual experience.

    “With violent incidents being five times more frequent in healthcare facilities than in other industries, we recognize the unique challenge hospitals face in ensuring a safe environment,” said Peter Evans, CEO of Xtract One. “Our SmartGateway has shown proven efficacy in on-site, real-world testing and we are confident that its deployment at San Mateo Medical Center will provide enhanced security that identifies potential threats of all kinds, including firearms and edged weapons, and minimizes disruptions to patients, staff, and visitors. We’re looking forward to working with San Mateo Medical Center and to showcasing how well SmartGateway supports healthcare facilities’ needs.”

    “Our goal is to create a safe and welcoming environment for everyone who enters our facility so that we can focus on what truly matters–our patients’ well-being” said Robet Blake, COO of San Mateo Medical Center. “Deploying Xtract One’s technology at our main campus reinforces that commitment. After extensive testing of various systems, we found SmartGateway’s innovative technology to be the most effective for our facility’s needs, allowing us to stay ahead of potential threats in order to maintain a secure and welcoming campus for everyone.”

    SmartGateway’s breakthrough innovation provides fast, discreet, and reliable individual screening, utilizing AI-powered sensors that unobtrusively scan guests for weapons and other prohibited items as they walk through. This technology replaces traditional metal detectors, reducing the need to empty pockets, optimizing patron experience by reducing time spent in security lines, and providing critical security insights to maximize screening outcomes. SmartGateway is designed to enable seamless passage through checkpoints and promote uninterrupted flow of movement.

    To learn more, visit www.xtractone.com.

    About Xtract One
    Xtract One Technologies is a leading technology-driven provider of threat detection and security solutions leveraging AI to deliver seamless and secure experiences. The Company makes unobtrusive weapons and threat detection systems that are designed to assist facility operators in prioritizing and delivering improved “Walk-right-In” experiences while enhancing safety. Xtract One’s innovative portfolio of AI-powered Gateway solutions excels at allowing facilities to discreetly screen and identify weapons and other threats at points of entry and exit without disrupting the flow of traffic. With solutions built to serve the unique market needs for schools, hospitals, arenas, stadiums, manufacturing, distribution, and other customers, Xtract One is recognized as a market leader delivering the highest security in combination with the best individual experience. For more information, visit www.xtractone.com or connect on Facebook, X, and LinkedIn.

    About San Mateo Medical Center
    San Mateo Medical Center is a public hospital and clinic system fully accredited by The Joint Commission. We operate outpatient clinics throughout the county and an acute-care hospital in San Mateo. Our mission is to “partner with our community to provide excellent healthcare for patients, including those experiencing social, environmental, or economic challenges.” As part of San Mateo County Health, the medical center serves the healthcare needs of all residents of San Mateo County, with an emphasis on education and prevention.

    About Threat Detection and Security Solutions
    Xtract One solutions, when properly configured, deployed, and utilized, are designed to help enhance safety and reduce threats. Given the wide range of potential threats in today’s world, no threat detection system is 100% effective. Xtract One solutions should be utilized as one element in a multilayered approach to physical security.

    Forward Looking Statements
    This news release contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”. Forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward looking statements. Such risks and uncertainties include, but are not limited to, the risks detailed from time to time in the continuous disclosure filings made by the Company with securities regulations. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. Although the Company has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. The Company has no obligation to update any forward looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.

    For further information, please contact:
    Xtract One Inquiries: info@xtractone.com, http://www.xtractone.com   
    Investor Relations: Chris Witty, Darrow Associates, cwitty@darrowir.com, 646-438-9385
    Media Contact: Kristen Aikey, JMG Public Relations, kristen@jmgpr.com, 212-206-1645

    The MIL Network

  • MIL-OSI: Xtract One Selected to Support San Mateo Medical Center in Keeping Patients and Staff Secure

    Source: GlobeNewswire (MIL-OSI)

    TORONTO, June 24, 2025 (GLOBE NEWSWIRE) — Xtract One Technologies (TSX: XTRA)(OTCQX: XTRAF)(FRA: 0PL) (“Xtract One” or the “Company”) today announced its SmartGateway has been selected by San Mateo Medical Center, located in San Mateo, CA, to strengthen the facility’s security and provide AI-powered weapon detection. Xtract One’s leading technology-driven threat detection and security solutions are designed to enhance safety for patients, visitors, and staff at the medical center, starting with the main campus with plans to later expand to all satellite clinics.

    This deployment comes at a critical time for healthcare facilities, following California’s recent Assembly Bill (AB) 2975. With hospitals now being required to implement weapons detection screening policies at key entrances as a minimum, San Mateo Medical Center demonstrates its forward-thinking and proactive stance in deploying Xtract One’s cutting-edge technology designed to help elevate safety while enhancing the overall individual experience.

    “With violent incidents being five times more frequent in healthcare facilities than in other industries, we recognize the unique challenge hospitals face in ensuring a safe environment,” said Peter Evans, CEO of Xtract One. “Our SmartGateway has shown proven efficacy in on-site, real-world testing and we are confident that its deployment at San Mateo Medical Center will provide enhanced security that identifies potential threats of all kinds, including firearms and edged weapons, and minimizes disruptions to patients, staff, and visitors. We’re looking forward to working with San Mateo Medical Center and to showcasing how well SmartGateway supports healthcare facilities’ needs.”

    “Our goal is to create a safe and welcoming environment for everyone who enters our facility so that we can focus on what truly matters–our patients’ well-being” said Robet Blake, COO of San Mateo Medical Center. “Deploying Xtract One’s technology at our main campus reinforces that commitment. After extensive testing of various systems, we found SmartGateway’s innovative technology to be the most effective for our facility’s needs, allowing us to stay ahead of potential threats in order to maintain a secure and welcoming campus for everyone.”

    SmartGateway’s breakthrough innovation provides fast, discreet, and reliable individual screening, utilizing AI-powered sensors that unobtrusively scan guests for weapons and other prohibited items as they walk through. This technology replaces traditional metal detectors, reducing the need to empty pockets, optimizing patron experience by reducing time spent in security lines, and providing critical security insights to maximize screening outcomes. SmartGateway is designed to enable seamless passage through checkpoints and promote uninterrupted flow of movement.

    To learn more, visit www.xtractone.com.

    About Xtract One
    Xtract One Technologies is a leading technology-driven provider of threat detection and security solutions leveraging AI to deliver seamless and secure experiences. The Company makes unobtrusive weapons and threat detection systems that are designed to assist facility operators in prioritizing and delivering improved “Walk-right-In” experiences while enhancing safety. Xtract One’s innovative portfolio of AI-powered Gateway solutions excels at allowing facilities to discreetly screen and identify weapons and other threats at points of entry and exit without disrupting the flow of traffic. With solutions built to serve the unique market needs for schools, hospitals, arenas, stadiums, manufacturing, distribution, and other customers, Xtract One is recognized as a market leader delivering the highest security in combination with the best individual experience. For more information, visit www.xtractone.com or connect on Facebook, X, and LinkedIn.

    About San Mateo Medical Center
    San Mateo Medical Center is a public hospital and clinic system fully accredited by The Joint Commission. We operate outpatient clinics throughout the county and an acute-care hospital in San Mateo. Our mission is to “partner with our community to provide excellent healthcare for patients, including those experiencing social, environmental, or economic challenges.” As part of San Mateo County Health, the medical center serves the healthcare needs of all residents of San Mateo County, with an emphasis on education and prevention.

    About Threat Detection and Security Solutions
    Xtract One solutions, when properly configured, deployed, and utilized, are designed to help enhance safety and reduce threats. Given the wide range of potential threats in today’s world, no threat detection system is 100% effective. Xtract One solutions should be utilized as one element in a multilayered approach to physical security.

    Forward Looking Statements
    This news release contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”. Forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward looking statements. Such risks and uncertainties include, but are not limited to, the risks detailed from time to time in the continuous disclosure filings made by the Company with securities regulations. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. Although the Company has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. The Company has no obligation to update any forward looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.

    For further information, please contact:
    Xtract One Inquiries: info@xtractone.com, http://www.xtractone.com   
    Investor Relations: Chris Witty, Darrow Associates, cwitty@darrowir.com, 646-438-9385
    Media Contact: Kristen Aikey, JMG Public Relations, kristen@jmgpr.com, 212-206-1645

    The MIL Network

  • MIL-OSI: Royalty Pharma and Revolution Medicines Enter Into Funding Agreements for Up to $2 Billion

    Source: GlobeNewswire (MIL-OSI)

    • Up to $1.25 billion ($250 million upfront) of synthetic royalty funding and up to $750 million in secured debt
    • Innovative partnership enables Revolution Medicines to retain control over pipeline development and global commercialization of daraxonrasib
    • Highlights Royalty Pharma’s unique ability to provide capital at scale to help leading companies achieve their strategic goals
    • Daraxonrasib, in Phase 3 development for pancreatic cancer and non-small cell lung cancer, would be the first targeted therapy to inhibit all major forms of RAS, one of the most common drivers of human cancers

    NEW YORK, June 24, 2025 (GLOBE NEWSWIRE) — Royalty Pharma plc (Nasdaq: RPRX) today announced a $2 billion funding arrangement with Revolution Medicines, consisting of a synthetic royalty of up to $1.25 billion on daraxonrasib and a senior secured loan of up to $750 million. These funds will support Revolution Medicines’ plans for global development and commercialization of daraxonrasib and its pipeline programs for patients with RAS-addicted cancers.

    “We are excited to announce today a groundbreaking partnership that provides Revolution Medicines with up to $2 billion of long-term capital through a customized funding solution that facilitates the expansive development and global commercialization of its leading RAS(ON) inhibitor portfolio,” said Pablo Legorreta, founder and Chief Executive Officer of Royalty Pharma. “This partnership exemplifies a new funding paradigm for highly innovative biotech companies. In contrast to a conventional pharma partnership, this large scale and flexible funding agreement enables Revolution Medicines to retain control of the clinical development of daraxonrasib, as well as the ability to capture significant value creation that would result from the successful clinical development and commercialization of its pipeline.”

    “Today’s announcement represents a major boost to our bold vision on behalf of patients with RAS-addicted cancers,” said Mark A. Goldsmith M.D., Ph.D., Chief Executive Officer and Chairman of Revolution Medicines. “This funding agreement significantly increases the financial resources we can deploy while preserving optionality as we scale our operations to create the industry-leading global targeted medicines franchise for patients with RAS-addicted cancers based on our highly differentiated RAS(ON) inhibitor portfolio.”

    Daraxonrasib, a RAS(ON) multi-selective inhibitor, is a potential practice-changing medicine in Phase 3 development for RAS mutant pancreatic canceri and non-small cell lung cancer (NSCLC). RAS is one of the most commonly mutated genes in human cancer. There are currently no approved targeted therapies that broadly target RAS for these cancers. In the United States, approximately 56,000 patients are diagnosed with RAS-driven pancreatic cancer annually, while approximately 60,000 patients are diagnosed with RAS-driven NSCLC annually. Revolution Medicines expects Phase 3 results for daraxonrasib in pancreatic cancer in 2026 and the Phase 3 NSCLC study is currently enrolling patients.   

    Royalty Terms

    Royalty Pharma will provide up to $1.25 billion in exchange for a synthetic royalty on annual worldwide net sales of daraxonrasib (and zoldonrasib if approved in an overlapping daraxonrasib indication). Details on the terms of the royalty agreement are shown in the table below.

    Royalty terms Tranche 1 Tranche 2 Tranche 3(1) Tranche 4(1) Tranche 5(1) Total
    Amount $250m $250m Up to $250m Up to $250m Up to $250m $1.25 bn
    Timing Immediate Positive data
    (RASolute 302)
    FDA approval in 2L pancreatic cancer Sales milestone achievement Positive Phase 3 data in 1L pancreatic cancer
    Draw Required Required Revolution Medicines option Revolution Medicines option Revolution Medicines option
    Annual sales: Royalty tiers: Royalty tiers: Royalty tiers: Royalty tiers: Royalty tiers: Royalty tiers:
    $0-2 bn
    $2-$4 bn
    $4-$8 bn
    2.55%(2)
    1.50%
    0.60%
    2.00%(2)
    1.00%
    0.40%
    1.50%
    0.80%
    0.40%
    1.00%
    0.75%
    0.50%
    0.75%
    0.50%
    0.50%
    7.80%(2)
    4.55%
    2.40%

    FDA: Food and Drug Administration; 1L: first-line; 2L: second-line
    1 Royalty rates will be adjusted pro-rata depending on draw amount.
    2 The royalty rate on annual sales of $0-2 billion may increase from 2030 to 2041 in the event that sales in the immediate prior year are below an agreed-upon threshold

    Term Loan

    Royalty Pharma will provide a senior secured term loan of up to $750 million at SOFR plus 5.75% (3.5% SOFR floor) which matures six years after the first tranche of $250 million is drawn. The first tranche must be drawn following U.S. Food and Drug Administration approval of daraxonrasib for metastatic pancreatic cancer. The two additional $250 million tranches are available at Revolution Medicines’ option based on the achievement of certain annual net sales milestones for daraxonrasib. Royalty Pharma retains the flexibility to syndicate all or a portion of this loan with other investors.

    Advisors

    Goodwin Procter and Maiwald acted as legal advisors to Royalty Pharma. Latham & Watkins acted as legal advisor and TD Securities acted as financial advisor to Revolution Medicines.

    About Royalty Pharma

    Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry’s leading therapies. Royalty Pharma funds innovation in the biopharmaceutical industry both directly and indirectly – directly when it partners with companies to co-fund late-stage clinical trials and new product launches in exchange for future royalties, and indirectly when it acquires existing royalties from the original innovators. Royalty Pharma’s current portfolio includes royalties on more than 35 commercial products, including Vertex’s Trikafta, GSK’s Trelegy, Roche’s Evrysdi, Johnson & Johnson’s Tremfya, Biogen’s Tysabri and Spinraza, AbbVie and Johnson & Johnson’s Imbruvica, Astellas and Pfizer’s Xtandi, Novartis’ Promacta, Pfizer’s Nurtec ODT and Gilead’s Trodelvy, and 15 development-stage product candidates.

    Forward-Looking Statements

    The information set forth herein does not purport to be complete or to contain all of the information you may desire. Statements contained herein are made as of the date of this document unless stated otherwise, and neither the delivery of this document at any time, nor any sale of securities, shall under any circumstances create an implication that the information contained herein is correct as of any time after such date or that information will be updated or revised to reflect information that subsequently becomes available or changes occurring after the date hereof. This document contains statements that constitute “forward-looking statements” as that term is defined in the United States Private Securities Litigation Reform Act of 1995, including statements that express the company’s opinions, expectations, beliefs, plans, objectives, assumptions or projections regarding future events or future results, in contrast with statements that reflect historical facts. Examples include discussion of Royalty Pharma’s strategies, financing plans, growth opportunities, market growth, and plans for capital deployment. In some cases, you can identify such forward-looking statements by terminology such as “may,” “might,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “target,” “forecast,” “guidance,” “goal,” “predicts,” “project,” “potential” or “continue,” the negative of these terms or similar expressions. Forward-looking statements are based on management’s current beliefs and assumptions and on information currently available to the company. However, these forward-looking statements are not a guarantee of Royalty Pharma’s performance, and you should not place undue reliance on such statements. Forward-looking statements are subject to many risks, uncertainties and other variable circumstances, and other factors. Such risks and uncertainties may cause the statements to be inaccurate and readers are cautioned not to place undue reliance on such statements. Many of these risks are outside of Royalty Pharma’s control and could cause its actual results to differ materially from those it thought would occur. The forward-looking statements included in this document are made only as of the date hereof. Royalty Pharma does not undertake, and specifically declines, any obligation to update any such statements or to publicly announce the results of any revisions to any such statements to reflect future events or developments, except as required by law. For further information, please reference Royalty Pharma’s reports and documents filed with the U.S. Securities and Exchange Commission (“SEC”) by visiting EDGAR on the SEC’s website at www.sec.gov.

    Royalty Pharma Investor Relations and Communications

    +1 (212) 883-6637
    ir@royaltypharma.com

    _______________________
    i Pancreatic adenocarcinoma (PDAC)

    The MIL Network

  • MIL-OSI: KIF18A Inhibitor Clinical Trials FDA Approved KIF18A Targeting Therapies Market Report

    Source: GlobeNewswire (MIL-OSI)

    Delhi, June 24, 2025 (GLOBE NEWSWIRE) — Global KIF18A Targeting Therapies Market Trends, Clinical Trials, Technology Platforms & Future Outlook 2025 Report Highlights & Findings:

    • First KIF18A Targeting Therapy Commercial Availability Expected By 2030
    • Highest Phase Of Development: Phase-I/II
    • KIF18A Targeting Therapies In Clinical Trials:  > 10 Therapies
    • KIF18A Targeting Therapies Clinical Trials Insight By Company, Country, Indication & Phase
    • KIF18A Targeting Therapies Market Development Trends Insight
    • KIF18A Therapies Technology Platforms Insight

    Download Report: https://www.kuickresearch.com/report-kif18a-targeting-inhibitor-kif18a-inhibitor-clinical-trials-kif18a-targeting-therapy

    The global oncology landscape is witnessing rapid progress in precision medicine, and one of the most lead nominees in emerging targets is Kinesin Family Member 18A (KIF18A). It is a mitotic motor protein that is essential for chromosome alignment during mitosis, which facilitates proper segregation of chromosomes. Its perturbation leads to genomic instability, which is a distinguishing feature of cancer. Extrapolations of KIF18A have also been seen in various cancers such as ovarian and breast cancer, with an association with prognosis, drug resistance, and the potential to metastasize. As a crucial protein involved in mitosis and overexpression in cancer, KIF18A is now a promising therapeutic target.

    Targeting KIF18A interferes with mitotic mechanisms in chromosomally unstable (CIN-positive) cancer cells, causing selective death of cancer cells. In contrast to conventional chemotherapies, which indiscriminately impact all proliferating cells, KIF18A inhibitors provide a more selective and less toxic option by taking advantage of cancer cells’ vulnerability to proper mitosis. The major approach is small molecule inhibitors that disrupt KIF18A’s motor activity, hindering it from modulating microtubule dynamics at the kinetochore. It leads to mitotic arrest and failure of chromosome alignment, ultimately triggering apoptosis in cancer cells.

    Clinical development is progressing well. Volastra Therapeutics, a forerunner in this arena, is developing two KIF18A-targeting molecules: Sovilnesib (AMG650), acquired from Amgen and underway in Phase I trials for platinum-resistant high-grade serous ovarian cancer, and VLS-1488, an in-house oral inhibitor in Phase I/II. Both molecules displayed favorable safety profiles and early anti-tumor effects, with particular efficacy in high-chromosomal-instability tumors. Volastra’s pipeline demonstrates the therapeutic potential of inhibiting KIF18A to treat difficult-to-treat cancers.

    Accent Therapeutics is also advancing with ATX-295, an oral KIF18A inhibitor in initial clinical testing for solid tumors such as triple-negative breast and high-grade serous ovarian cancers. Their biomarker strategy makes use of genomic instability markers such as whole-genome doubling to better optimize patient selection and optimize therapy outcomes.

    AI based drug discovery is providing additional impetus to this area. Insilico Medicine has utilized proprietary platforms such as Chemistry42 and PandaOmics to discover ISM9682, a new macrocyclic KIF18A inhibitor with high preclinical efficacy. The AI platforms facilitate rapid optimization of candidates with increased specificity and pharmacological profiles, highlighting the growing use of sophisticated computational approaches in drug discovery.

    Aside from clinical advancement, the market opportunity for KIF18A inhibitors is also robust. As precision oncology gains more attention, the therapies are well poised to capture the opportunity of targeted therapies, particularly in diseases that are refractory to current treatments. Various companies, including Nvidia-funded Iambic Therapeutics, Aurigene Oncology, Simcere Zaiming Pharmaceutical, and Amgen, are developing promising product candidates in preclinical phases.

    Overall, the KIF18A-targeted therapy market is changing very quickly, powered by strong scientific justification, initial clinical success, and novel development approaches. As additional preclinical and clinical information becomes available, the market has significant potential for strong growth, powered by partnerships, application of artificial intelligence and machine learning tactics, and the overall dedication to creating targeted and individualized cancer therapeutics.

    The MIL Network

  • MIL-OSI Africa: Expanding access to sexual and reproductive health services in Ethiopia


    Download logo

    To address gaps in sexual and reproductive healthcare access, widened by the COVID-19 pandemic and ongoing humanitarian crises, Ethiopia is reinforcing its health system, making these vital services more accessible for women and adolescents in remote and crisis-affected areas.

    A key part of this effort is promoting self-care, by giving people the knowledge and tools to manage their own sexual and reproductive health through safe, simple and affordable practices for family planning, HIV prevention, cervical cancer prevention, nutrition, and maternal, adolescent and youth health. Practical examples range from access to contraceptives, pregnancy tests, and HIV self-test kits, all supported by educational guidance. This also includes self-management of medical abortion in line with national legislation, which permits the procedure under certain conditions.  

    With support from World Health Organization (WHO), health authorities have developed the National Self-Care Intervention Guideline, focusing on interventions for women, adolescent and child health. They have also integrated self-care and expanded sexual and reproductive health services into key national policy guidelines, including those related to family planning, safe abortion care, teenage pregnancy reduction, and sexual and reproductive health responses in humanitarian settings.

    Across the country, health workers are being trained to teach people how to promote these self-care tools. This started with a workshop for 38 public health officials from the Ministry of Health, Regional Health Bureaus and other institutions in June 2024. The initiative was then expanded to the sub-national level, equipping 67 health providers and managers with skills, in October 2024.  

    “The recommendations and action plan we developed will help us integrate self-care into our existing health services effectively,” said Daniel Nadew, Maternal Child Health desk team lead from Addis Ababa City Health Bureau.

    Following the scaling up self-care training, at Kolfe Health Centre in Addis Ababa, one of the pilot facilities, the introduction of self-care services contributed to a significant increase in access to services. In 2024, as part of the family planning service delivery, more than 800 women received over-the-counter combined oral contraceptives, compared with 280 in 2022.

    Additionally, 84 women were trained to self-administer a safe and effective injectable contraceptive, known as DMPA, and more than 1000 adolescents were provided condoms after training on correct use.

    Moreover, 50 women received self-management of medical abortion services, which included comprehensive training on how and when to use the medication, the correct dose, side effects, possible complications, and guidance on when to get medical help.

    “The self-care training has significantly improved my knowledge and skills in providing comprehensive family planning and abortion care. The practical sessions were particularly helpful, and I feel more confident in my ability to support women in my community,” said Fatima Belay*, a health worker from Addis Ababa.

    Belay * also highlighted the benefits of self-administered injectable contraceptives: “I appreciate the ease and convenience of the self-administering contraceptive, which I am able to use at home, at my usual workplace, or wherever I am.”

    Amid the humanitarian crises in the northern region of Amhara, WHO and the Ethiopian Public Health Institute trained 30 healthcare providers from 13 health facilities in conflict-affected districts on self-care intervention guidelines.

    Following the training, nine facilities provided onsite selfcare orientation for their staff which resulted in over 100 women and adolescents being educated on selfcare for family planning, antenatal care, pregnancy danger signs, nutrition, and safe abortion.  

    Gish Abay Health Centre empowered 120 adolescents with skills for correct condom use and provided safe abortion care for 35 adolescent girls. Tilili Health Centre broadened the scope of self-care to include HIV self-testing, breast self-examination, pregnancy self-testing, and condom and emergency contraceptive use.

    “These interventions significantly benefited the community and contributed to the efforts towards reducing preventable maternal and perinatal deaths. It will enable us to reach every mother, newborn, child, and adolescent in our community who are critically in need of health services,” said Nadew.

    “Ethiopia’s commitment for self-care integration is empowering individuals, especially women and adolescents, with the knowledge and tools for proactive health management, offering considerable community convenience and cost savings,” said Dr Owen Kaluwa, WHO Representative in Ethiopia. “WHO is proud to support this effort, which significantly improves health outcomes by expanding access to critical sexual and reproductive health services, particularly crucial in conflict-affected areas.”

    Distributed by APO Group on behalf of World Health Organization (WHO) – Ethiopia.

    MIL OSI Africa

  • AI 171 plane crash: 259 victims identified, DNA result awaited for one passenger

    Source: Government of India

    Source: Government of India (4)

    Authorities in Gujarat on Tuesday confirmed that 259 of the 260 bodies recovered from the site of the June 12 Air India plane crash in Ahmedabad have been identified. The ill-fated flight, a Boeing 787-8 Dreamliner en route to London’s Gatwick Airport, crashed moments after takeoff, resulting in the deaths of 241 of the 242 individuals on board.
     
    Rakesh Joshi, Superintendent of Ahmedabad Civil Hospital, said the identified victims include 240 passengers and 19 non-passengers. “DNA test result of one passenger is still awaited,” he added. The current death toll is slightly lower than the initial estimate of 270, but officials have maintained caution in declaring a final figure. “The crash site is still being cleared. Unless we are certain that no additional victims are going to be found, we cannot confirm the final death toll,” Joshi said.
     
    Of the 256 bodies handed over to families, 253 were identified through DNA matching while six were recognised through facial identification. All 52 British nationals on board have been identified, with 49 bodies repatriated to the United Kingdom and the remaining three prepared for transport.
     
    The Air India aircraft crashed into a hostel complex of the BJ Medical College in the Meghani Nagar area of Ahmedabad shortly after departure from Sardar Vallabhbhai Patel International Airport. Only one passenger survived. Among those who perished was former Gujarat Chief Minister Vijay Rupani.
     
    In a statement issued on Sunday, Air India CEO and Managing Director Campbell Wilson reaffirmed the safety of the airline’s Boeing 787 fleet. “We have completed additional precautionary checks on our operating Boeing 787 fleet as requested by the DGCA. The aircraft have been deemed safe and meet the required standards,” Wilson said.
     
    (ANI)
  • MIL-OSI United Kingdom: UK partnership brings new 250-bed Islamabad hospital closer to opening

    Source: United Kingdom – Executive Government & Departments

    World news story

    UK partnership brings new 250-bed Islamabad hospital closer to opening

    The first NHS Trust partnership with a Pakistani hospital will focus on sharing clinical best practices and staff development.

    London’s Imperial College Healthcare NHS Trust will provide specialist knowledge and advice on hospital planning, staffing and training to Novacare. In turn, affiliate fees from services will be reinvested back into Imperial’s NHS services.

    The hospital is designed to offer comprehensive care across 28 clinical specialties, including cardiology, oncology, orthopaedics, neurology, and maternal health. It is set to open in 2026 and will feature advanced infrastructure such as smart building management systems, AI-optimised vertical transportation, and infection control and fall prevention technologies.

    British High Commissioner, Jane Marriott CMG OBE, said:

    “This agreement is bringing the UK’s world leading healthcare expertise to Pakistan, and in turn support the UK’s NHS. Through sharing the NHS’s cutting edge clinical best practices, and through helping to develop staff, this agreement will directly help to save lives.”

    This partnership strengthens the UK’s global healthcare leadership by exporting NHS clinical standards and expertise. It includes opportunities for Novacare clinicians to observe multidisciplinary team meetings, receive second opinions from UK specialists, and undergo training aligned with NHS protocols. Complex cases may also be referred to Imperial’s private facilities in London, enhancing revenue for UK healthcare institutions.

    Her Excellency visited the construction of the hospital with the UK Trade Envoy to Pakistan, Mohammad Yasin MP, who is on a 3-day visit to Pakistan. Following a tour of the site, she met with:

    • Johannes Kedzierski, CEO, Novacare
    • Faraz Minai, Director, Novacare and CEO, Andalus Holdings
    • Ghalib Hafiz, Director, Novacare and Partner, Andalus Holdings
    • Mustafa Hassan, Director, Novacare
    • Qaiser Rafiq, Project Director, Novacare

    The Novacare Islamabad site, based in DHA Phase V, will be a 15-minute journey from the Blue Zone by the time the hospital opens.

    For updates on the British High Commission, please follow our social media channels:

    Updates to this page

    Published 24 June 2025

    MIL OSI United Kingdom

  • MIL-OSI Africa: Africa launches second phase of phytosanitary programme to fight crop pests

    Source: South Africa News Agency

    The Department of Agriculture, in collaboration with the United Nations Food and Agriculture Organisation (FAO) and the International Plant Protection Convention (IPPC), has unveiled the second phase of the Africa Phytosanitary Programme (APP).

    APP is an initiative of the IPPC and FAO, which aims to strengthen the resilience of Africa’s phytosanitary systems against plant pests of regulatory, economic, and environmental significance, using cutting-edge digital tools.

    Held in White River, Mpumalanga on Monday, the launch brought together over 50 phytosanitary specialists from nine countries, including Algeria, Cape Verde, Chad, the Republic of Congo, Liberia, Malawi, Senegal, South Africa, and Tunisia.

    The countries will take part in a weeklong Train-the-Trainer (ToT) workshop in advanced pest surveillance techniques, including the use of customised digital tools and applications for monitoring, detecting, and reporting major pests of economic, regulatory, and environmental importance in Africa.

    The participants will be equipped with state-of-the-art tablets for geospatial pest surveillance, use field survey protocols developed by technical experts, and undertake practical sessions using the pest survey tools.

    Delivering remarks on behalf of Agriculture Minister John Steenhuisen, Jan Hendrik Venter, Director of Plant Health at the Department of Agriculture, emphasised Africa’s potential to become a global leader in high-quality plant product trade.

    “Africa stands at a turning point. With immense biodiversity, rising agricultural productivity, and growing opportunities under the African Continental Free Trade Area (AfCFTA), we are well-positioned to become a global leader in the trade of high-quality plant products.

    “But this vision can only be achieved if we ensure that the movement of plants and plant products is safe, traceable, and fully compliant with international phytosanitary standards,” Venter said.

    Venter added that well-trained, well-equipped plant health officials across the continent, are the best line of defence in maintaining pest-free or low-prevalence status, “an essential condition for accessing these lucrative markets.”

    The first and pilot phase of APP started in 2023, engaging phytosanitary specialists from Cameroon, Democratic Republic of Congo, Egypt, Guinea-Bissau, Kenya, Mali, Morocco, Sierra Leone, Uganda, Zambia, and Zimbabwe.

    Phase 2 builds on achievements made in the pilot phase and aims to train plant health officers, who upon their return to their countries will teach their peers in the national plant protection organisations (NPPOs) and other government stakeholders on the use of the APP suite of digital tools.

    “We are building a critical mass of phytosanitary inspectors, technicians and officers across Africa, by equipping plant health officers with the tools and skills to prevent and address major plant pest threats, that ultimately jeopardise food security, agricultural trade, economic growth and the environment,” FAO Deputy Director General and IPPC Officer-in-Charge, Beth Bechdol said in her video message.

    Funded through generous contributions from the European Union and the United Kingdom of Great Britain and Northern Ireland, APP phase two builds on support from the United States Department of Agriculture (USDA), Animal and Plant Health Inspection Service (APHIS) which funded phase one in 2023.

    FAO and the IPPC are working to replicate and scale up the benefits from APP to more African countries and other regions.

    Mitigating the pest problem in Africa

    Globally, plant pests are responsible for destroying about 40 percent of crop yields, resulting in economic losses of approximately USD 220 billion.

    In Africa, the impacts of climate change are exacerbating the problem, with invasive pests such as, fruit flies, false codling moth, maize lethal necrosis disease, citrus greening and fall armyworm – causing major damages.

    According to the Centre for Agriculture and Bioscience International (CABI) data, fall armyworm alone is estimated to cause the highest yield loss in Africa – USD 9.4 billion annually.

    The African Union’s Plant Health Strategy for Africa highlights that limited technical capability remains a key barrier to achieving sustainable agriculture on the continent.

    Through APP, FAO, the IPPC and partners aim to strengthen plant health systems and build national phytosanitary capacity across Africa. – SAnews.gov.za

    MIL OSI Africa

  • MIL-OSI Asia-Pac: Transitional registration to conclude

    Source: Hong Kong Information Services

    Secretary for Health Prof Lo Chung-mau today welcomed the completion of the evaluation and approval procedures for all proprietary Chinese medicines (pCms) with transitional registration by the Chinese Medicine Council of Hong Kong (CMCHK).

     

    The CMCHK announced today that the evaluation and approval process for converting the transitional registrations of pCm to formal registrations has been completed.

     

    The Department of Health explained that the transitional registration system for pCm will conclude on June 30 and by then, all pCms sold in Hong Kong must have valid formal registrations.

     

    Prof Lo noted that this marks an important milestone for the regulation of Chinese medicine (CM) in Hong Kong, ensuring the public’s access to quality and safe pCms, while also supporting Hong Kong’s development as a bridgehead for the internationalisation of CM.

     

    He pointed out that Hong Kong-registered pCms will become a key component in CM development as well as health and medical innovation.

     

    “With Hong Kong’s robust regulatory system for pCms, its brand effect can attract more high-quality pCms from the Mainland and overseas to register in the city, thereby assisting the industry in further expanding into global markets and accelerating the internationalisation of CM.”

     

    To assist holders of transitionally registered pCms in obtaining formal registration as early as possible, the Health Bureau has previously provided funding to the industry through the Chinese Medicine Development Fund.

     

    Under the Proprietary Chinese Medicine Registration Support Scheme, subsidies were granted to holders of transitionally registered pCms to engage professional consultants for advice on formal registration matters and to conduct necessary laboratory tests.

     

    Moving forward, the Government said it will continue to collaborate with the CM industry to jointly promote the innovation and development of CM.

     

    In addition, the Health Bureau will release the Chinese Medicine Development Blueprint by the end of this year, which will include more strategies to comprehensively enhance the development of CM in Hong Kong.

    MIL OSI Asia Pacific News

  • MIL-OSI United Kingdom: Be Proud Awards: Manchester champions recognised for endearing community spirit

    Source: City of Manchester

    The best of Manchester shone brightly as the city saw the return of the annual Be Proud Awards.

    Held at the prestigious Hilton Manchester, the evening was a touching tribute and reminder of the selflessness, resilience and community spirit that makes everyone in the city proud to be Mancunian.

    The awards bring together people from all backgrounds and all walks of life, those who go above and beyond to support their neighbours, protect the environment, inspire young leaders and give back to those who need additional support.  But they all unite under one common ambition, and that is to simply pour back into their communities.

    The coveted awards are split into ten categories including creating safer neighbourhoods, increasing skills and employment and supporting health and wellbeing. Norma Bowerbank, from Moston, won the top Pride of Manchester award for her endearing work in advocating for men’s mental health care. 

    Norma is the proud founder of Directions for Men, a charity that fosters wellness through peer-supported group sessions, encouraging connection among individuals with shared experiences and backgrounds.

    The organisation also champions physical and mental wellbeing by hosting activities like walking football, boules, and group walks, reinforcing its commitment to holistic health. Beyond her charity work, Norma serves as a devoted primary school governor, actively participating in her church community, and mentors young children in reading.

    She also volunteers at her local police station, offering support to crime victims, and lends a hand at the Royal Voluntary Service café as just a few of her many selfless contributions to her community.   

    Councillor Lee-Ann Igbon, Executive Member for Vibrant Neighbourhoods, said: “The Be Proud Awards are a truly special celebration of what keeps Manchester thriving and that’s the people who make up communities. This is a moment to honour the everyday heroes who give back selflessly, strengthen our connections and embody the spirit of pride that defines this city.  

    “I want to say huge congratulations to our winners and finalists; the recognition is very much deserved. Manchester thrives because of its vibrant neighbourhoods, and these awards shine a light on those who make them extraordinary.”

     
    The Be Proud Awards 2025 winners are:  

    Pride of Manchester – Sponsored by Manchester Evening News 

    Norma  Bowerbank  – Directions for Men  

    Supporting Health and Wellbeing

    Norma Bowerbank – Directions for Men 

    Neighbourhood Action on Climate Change

    Easy Come Easy Grow  

    Supporting those affected by Poverty

    Gemma Reid – The Chatterbox Project 

    Increasing Skills Education and Employability

    Kenny Umeh – Oasis Centre

    Making our Neighbourhoods Safer

    MASH Outreach Volunteers

    Supporting Health and Wellbeing

    Norma Bowerbank – Directions for Men

    Promoting Equality and Diversity

    North Manchester Community Partnership 

    Making Our Neighbourhoods Cleaner and Greener

    Sustainable Northmoor through Urban Greening (SNUG) 

    Creative Communities

    REEL MCR

    Businesses Supporting the Community 

    Sharon Waldron – Pull Up Bar Cafe 

    MIL OSI United Kingdom

  • MIL-OSI Russia: China Creates New Healthcare Blueprint for the World

    Translation. Region: Russian Federal

    Source: People’s Republic of China in Russian – People’s Republic of China in Russian –

    Source: People’s Republic of China – State Council News

    CHENGDU, June 24 (Xinhua) — How to ensure access to advanced medical services in remote and underdeveloped areas? Can customized medical solutions meet unique needs? With such questions in mind, China is accelerating technological development, creating a new healthcare scheme that benefits the world.

    Jotham Kimondo, a 35-year-old doctoral student from Tanzania, studies at the University of Electronic Science and Technology of China in Chengdu, capital of southwest China’s Sichuan Province.

    Under the guidance of Professor Wu Zhe of Chengdu Tianfu Jincheng Advanced Medical Equipment Research Institute, J. Kimondo is engaged in the development of ultrasonic medical devices.

    As a teacher in Tanzania, J. Kimondo is keen to bring ultrasound equipment design and manufacturing to China to help his country.

    “My research involves innovative design of ultrasound medical devices to monitor pathological changes in human tissues – an important indicator of disease. Women in Tanzania still rely on traditional methods, such as palpation, to examine their breasts. This approach is highly dependent on the individual experience of doctors and is not always accurate. Some women refuse examinations altogether,” explained J. Kimondo.

    He added that many diseases still affect Tanzanians: “I want to improve healthcare in Tanzania, to help people stay healthy. Joint development of innovative ultrasound equipment will be very useful for early screening of breast diseases and other diseases, especially when these devices become more accessible and cheaper for promotion in African countries.”

    There are more than 53 advanced medical companies registered in the Tianfu Jincheng Future Medicine Laboratory City, which are exploring cutting-edge innovation and integrative medicine.

    Recently, at the Remote Ultrasound Center of Tianfu Jincheng Institute, a doctor held an online consultation with a colleague from the Second People’s Hospital of Chengdu East New Area, giving instructions on how to use a portable ultrasound device on a patient’s carotid artery.

    Ultrasound data was displayed in real time on a shared screen, allowing doctors to directly discuss pathologies and make professional diagnoses.

    “Traditional expensive ultrasound machines cost millions. In western China, rural residents often have to travel to county hospitals for checkups,” Wu Zhe explained.

    “Our goal is to ensure widespread use of portable ultrasound devices in rural areas for early diagnosis and monitoring of chronic diseases. Our portable equipment is much cheaper and easier to use in grassroots health care facilities,” he added.

    The portable, smartphone-sized device has already been used in more than 10 medical institutions in eastern Chengdu, providing free carotid artery and thyroid examinations to more than 2,000 residents.

    With China’s growing capabilities in industrial design, manufacturing and medical research, innovation in medical equipment development is rapidly advancing. Growing recognition of Chinese medical devices in overseas markets is increasing international orders, spurring Chinese companies to enter the global market.

    At the Future Medicine Laboratory City, employees of Chengdu Seamaty Technology Co., Ltd. pack reagents for biochemical testing. This batch is being prepared for shipment from Chengdu to destinations around the world.

    This “small giant” company, which develops diagnostic equipment for rapid analysis, already supplies products to more than 150 countries and regions around the world.

    At its quality control center, hundreds of fully automated biochemistry analyzers undergo pre-shipment inspection.

    “This batch of equipment will be shipped to Europe. Last year, the company’s sales were 320 million yuan (about $44.6 million), and in the first five months of this year, our international business grew 59 percent year on year,” said Deputy General Manager Wang Bin, noting that the increase in overseas orders reflects the growing recognition of Chinese medical devices in global markets.

    Innovative technologies such as 3D printing, organs-on-a-chip, nanorobots and neural interfaces are advancing medical device research and application in China, shaping the medical landscape of the future.

    At Chengdu Tianqi Additive Intelligent Manufacturing, 3D printing is used to create personalized medical solutions. Using computer-aided design/computer-aided manufacturing (CAD/CAM) and layer-by-layer printing, virtual designs are transformed into the intended physical products.

    In a modern workshop, dozens of industrial printers work in an orderly manner, and a laser engraver with an accuracy of 0.01 mm creates patterns in titanium powder.

    Customized titanium plates for maxillofacial surgery are printed in a matter of hours. This seemingly ordinary industrial scene reflects China’s significant progress in high-precision, intelligent manufacturing of medical devices.

    Compared to manual plate bending in the past, 3D printing provides more accurate, convenient and safer production of customized products.

    “We are currently working on a custom order for a patient in Singapore. Engineers upload the patient’s data into the system, and AI algorithms help designers create personalized models for facial reconstruction, which are then printed entirely on metal 3D printers,” said Gao Bancui, marketing director at Chengdu Tianqi Additive Intelligent Manufacturing.

    He added that in the future, the company will focus on serving countries in the Middle East, Africa and Southeast Asia to meet the individual medical needs of more countries along the Belt and Road Initiative. -0-

    MIL OSI Russia News

  • MIL-OSI China: China races to turn quantum computing into industrial solutions

    Source: People’s Republic of China – State Council News

    Wang Jianwei (C), a professor at Peking University, tests an integrated photonic quantum chip with doctoral students Jia Xinyu (L) and Zhai Chonghao in a laboratory of Peking University in Beijing, capital of China, Feb. 18, 2025. (Xinhua)

    In a significant stride toward practical quantum computing, a Chinese startup has successfully deployed its superconducting quantum processor to improve the accuracy of breast cancer screenings, showcasing the technology’s potential to revolutionize medical diagnostics.

    The breakthrough came from Origin Quantum, a Hefei-based startup, which harnessed the parallel processing power of its “Origin Wukong” quantum computer to analyze medical images with unprecedented speed.

    This pioneering work is indicative of China’s growing capability in translating quantum computing advancement into practical solutions. In an ambitious drive, the nation seeks to foster an industrial ecosystem of the future amid the global quantum computing race.

    The Chinese government work report early this year called for the establishment of a growth mechanism for investment in future industries, including quantum technology, bio-manufacturing, embodied intelligence and 6G.

    The national policy guideline spurred a swift market response with entities transforming frontier, lab-based research into operational technologies with tangible impact.

    By tapping into the unique strengths of quantum technology, Origin Quantum’s innovative approach in processing medical imaging data, developed in collaboration with Bengbu Medical University, resulted in a dramatic reduction of misdiagnosis and missed cases.

    “The system enhances mammogram screening accuracy on current noisy intermediate-scale quantum computers, enabling high-precision and rapid classification of both healthy images and lesion malignancy,” said Xie Zongyu, a physician from the university’s First Affiliated Hospital.

    “Our ultimate goal is to establish a quantum intelligent diagnostic system,” Xie added.

    REAL-WORLD USES

    In March, a team of Chinese scientists unveiled Zuchongzhi 3.0, a 105-qubit superconducting quantum processor prototype with speed gains in the quadrillions over leading supercomputers for one specific task, showcasing capabilities that surpass those of classical supercomputers.

    However, lab advances like this remain niche demonstrations with minimal real-world impact. Over the coming five years, global quantum scientists are aiming to pinpoint a handful of practical quantum applications — like quantum chemistry and drug discovery, now largely bolstered by supercomputers and AI algorithms.

    A growing number of Chinese tech companies, including Origin Quantum, are gearing up to make their mark in this field.

    “Computational chemistry can partly predict interactions between drug molecules and target proteins. But classical computers have difficulty in accurately predicting complex large molecules,” said Guo Guoping, chief scientist of Origin Quantum that launched the molecular docking software QDock.

    “In theory, quantum computers can screen potential compounds and simulate complex reactions to break the computational bottleneck in drug discovery,” Guo added.

    AceMapAI, a Suzhou-based biotech company, is working with partners including Tencent Quantum Lab to explore the potential of quantum computing in drug molecular dynamics simulation, and drug screening and optimization.

    Zhao Xuejiao, deputy director of Anhui Quantum Computing Engineering Research Center, said that the complex computational problems in China’s biopharmaceutical industry will provide a broad application scope for quantum computing.

    A Shanghai-based startup is also experimenting with applying quantum algorithms to the massive computations in smart cities.

    TuringQ introduced this month a quantum-inspired solution for Autonomous Valet Parking (AVP) that significantly reduces parking wait time and enhances efficiency.

    AVP is capable of autonomously navigating routes and parking accurately.

    The firm’s solution has already been deployed in a large commercial parking lot.

    The algorithm cuts the average customer search time from 19.8 minutes under traditional manual scheduling to about 5.5 minutes when the parking space vacancy rate is only 5 percent.

    The application of quantum algorithms in the financial sector has become a significant area. Beijing Quantum firm QBoson, the Postal Savings Bank of China and China Mobile jointly designed a quantum algorithm-based bank teller scheduling solution.

    QBoson’s quantum computer conducted a full search of the extremely large solution space and found the global optimum within milliseconds.

    “Quantum computing companies design algorithms based on feedback from those with computational bottlenecks before testing them on quantum machines,” said Dou Mengan, vice president of Origin Quantum. “This model creates a sustainable industrial ecosystem.”

    ENTREPRENEURIAL ZEAL

    On a road in Hefei, Anhui Province, which is dubbed “Quantum Avenue,” dozens of quantum tech firms, including Origin Quantum, cluster along this compact stretch. In Shanghai and Beijing, the number of companies investing in this track is also on the rise.

    CCID Consulting’s research shows that China’s quantum computing firms increased from 93 in 2023 to 153 in 2024, a rise of nearly 40 percent.

    The country’s quantum computing industry scale will keep rising swiftly to 11.56 billion yuan (1.61 billion U.S. dollars) by 2025, maintaining an annual growth rate of over 30 percent, according to CCID Consulting.

    In 2023 and 2024, the total R&D expenditure in quantum computing exceeded 100 percent of the total revenue, indicating that companies in the sector have entered a period of active development.

    China’s quantum engineers are exploring multiple technological routes: Origin Quantum focuses on superconducting, TuringQ and QBoson on photonic quantum computing, and Hyqubit from Beijing on ion traps.

    Now, in early development of quantum computing, the front-runners and best technical approaches have not yet been consolidated, meaning “any country that is able to deploy quantum tech first will have a first-mover advantage,” according to a report published by the Mercator Institute for China Studies last December.

    China has built a full industrial chain ecosystem in quantum computing, covering quantum chip design and production, quantum computer manufacturing, quantum algorithm development and industry solutions, said Zhao.

    Cutting-edge attempts also include integrating quantum computing with generative AI. In April, Origin Quantum successfully fine-tuned a billion-parameter AI model on its quantum computer Origin Wukong, marking the first real-world application of quantum computing in large-model tasks.

    “In the past five years, the surge of generative AI has brought about many disruptive changes in computing models,” said Sun Xiaoming, a researcher at the Institute of Computing Technology under the Chinese Academy of Sciences.

    “In the next five years, quantum computing is likely to move from labs to applications, and the integration of AI and quantum computing is expected to become a trend,” added Sun. 

    MIL OSI China News

  • MIL-OSI: NUCLIDIUM Presents Positive Phase 1 Results of its Novel PET Imaging Agent 61Cu-NuriPro™ at SNMMI 2025 Annual Meeting

    Source: GlobeNewswire (MIL-OSI)

    • 61Cu-NuriPro™ detected more lesions up to 4 hours post-administration in 50% of patients, not visualized by 18F-piflufolastat PET1,2
    • Dosimetry data highlight favorable tumor-to-background ratio with 61Cu-NuriPro™
    • 61Cu-NuriPro™’s 3.3 hours half-life allows for greater distribution range and later imaging after administration
    • Data presented on Monday, June 23 by Principal Investigator Dr. Gary Ulaner, MD, PhD at the SNMMI 2025 Annual Meeting in New Orleans

    Basel, Switzerland, June 24, 2025NUCLIDIUM AG a clinical-stage radiopharmaceutical company developing copper-based theranostics, today announced positive data from the Phase 1 clinical trial evaluating the company’s novel PET imaging agent, 61Cu-NuriProTM (61Cu-NODAGA-PSMA I&T) in patients with metastatic prostate cancer. These data were presented on June 23 at the Society of Nuclear Medicine & Molecular Imaging (SNMMI) 2025 Annual Meeting in New Orleans by Dr. Gary Ulaner, MD, PhD, Director of Molecular Imaging and Therapy at Hoag Family Cancer Institute and Principal Investigator for the trial. Dr. Ulaner highlighted 61Cu-NuriPro’s favorable safety, dosimetry profile and imaging characteristics in Prostate Specific Membrane Antigen (PSMA)-positive prostate cancer patients.

    The Phase 1 trial conducted at Hoag Molecular Imaging and Therapy Clinic evaluated the safety, dosimetry and preliminary diagnostic efficacy of 61Cu-NuriProTM in patients with metastatic prostate cancer, and was compared to 18F-piflufolastat. 61Cu-NuriPro™ demonstrated a safety profile comparable to clinically established PSMA tracers with a favorable imaging performance. Notably, 61Cu-NuriPro PET visualized additional lesions in 50% of the patients which were not seen on the 18F-piflufolastat PET, with favorable tumor-to-background ratios. The number of detected lesions on the 61Cu-NuriPro PET increased up to 4 hours after administration, highlighting the diagnostic benefits of 61Cu’s 3.3-hour half-life and high positron yield.

    “Accurate and reliable imaging remains essential in the management of prostate cancer. The Phase 1 results from 61Cu-NuriPro™ demonstrate not only a solid safety profile but also good imaging quality compared to standard-of-care,” said Dr. Gary Ulaner, MD, PhD, Director of Molecular Imaging and Therapy at Hoag Memorial Hospital Presbyterian and Principal Investigator of the trial. “These early data suggest strong potential for improving diagnostic performance and patient outcomes.”

    Leila Jaafar, PhD, CEO and Co-Founder of NUCLIDIUM added “These results further validate our first-in-class copper theranostics platform and the clinical promise of 61Cu-NuriPro™ as a potential best-in-class diagnostic. We are dedicated to rapidly advancing our portfolio of copper-based theranostic agents for a broader range of cancers, with a focus on safety, sustainability, and scalability.”

    61Cu-NuriProTM (61Cu-NODAGA-PSMA I&T) is the diagnostic component of NUCLIDIUM’s PSMA-targeted NuriProTM program2,3,4,5,6. The company’s second diagnostic, 61Cu-TraceNET™, targeting SSTR-positive tumors, is in a Phase 1/2a clinical trial in broncho-pulmonary, and gastroenterohepatic neuroendocrine tumors (BP- and GEP-NETs). The agent will be developed further for imaging in a subset of metastatic breast cancer patients. Clinical trials of two corresponding therapeutics, 67Cu-NuriPro™ and 67Cu-TraceNET™, are expected to start enrollment in early 2026.

    About NUCLIDIUM
    Nuclidium AG is a clinical-stage biotechnology company pioneering the development of next-generation copper-based radiopharmaceuticals for the diagnosis and treatment of cancer. Leveraging copper isotopes — Copper-61 for diagnostics and Copper-67 for therapeutics — Nuclidium is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics. With operations in Switzerland and Germany, the company combines innovative chemistry, deep clinical expertise, and strategic manufacturing capabilities to deliver scalable, accessible, and clinically superior theranostic solutions to patients worldwide. Nuclidium is committed to expanding the reach and efficacy of radiotheranostics, including addressing critical unmet medical needs in oncology and women’s health.

    For more information, please contact:

    NUCLIDIUM
    Leila Jaafar, CEO
    Email: info@nuclidium.com

    Investor/Media Contact NUCLIDIUM
    Trophic Communications
    Stephanie May
    Email: nuclidium@trophic.eu
    Phone: +49 171 1855682

    1 European Medicines Agency. Pylclari – International non-proprietary name: piflufolastat (18F), Assessment report-EMA/CHMP/279917/2023, https://www.ema.europa.eu/en/documents/assessment-report/pylclari-epar-public-assessment-report_en.pdf, accessed 20 June 2025

    2 FDA Approves Pluvicto/Locametz for Metastatic Castration-Resistant Prostate Cancer. J Nucl Med. May 2022;63(5):13n.

    3 Keam SJ. Piflufolastat F 18: Diagnostic First Approval. Mol Diagn Ther. Sep 2021;25(5):647-656. doi:10.1007/s40291-021-00548-0

    4 Heo YA, Jadvar H, Calais J, et al. Flotufolastat F 18: Diagnostic First Approval Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging. Mol Diagn Ther. Jul 13; Jan 2023;63(1):59-68. doi:10.1007/s40291-023-00665-y10.2967/jnumed.121.263262

    5 Hennrich U, Eder M. [(68)Ga]Ga-PSMA-11: The First FDA-Approved (68)Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer. Pharmaceuticals (Basel). Jul 23 2021;14(8)doi:10.3390/ph14080713

    6 Basaco Bernabeu T, Fani M, et al. 61Cu-PSMA–Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging. JNM. Sep 2024, 65 (9) 1427-1434. doi: https://doi.org/10.2967/jnumed.123.267126

    The MIL Network

  • MIL-OSI: NUCLIDIUM Presents Positive Phase 1 Results of its Novel PET Imaging Agent 61Cu-NuriPro™ at SNMMI 2025 Annual Meeting

    Source: GlobeNewswire (MIL-OSI)

    • 61Cu-NuriPro™ detected more lesions up to 4 hours post-administration in 50% of patients, not visualized by 18F-piflufolastat PET1,2
    • Dosimetry data highlight favorable tumor-to-background ratio with 61Cu-NuriPro™
    • 61Cu-NuriPro™’s 3.3 hours half-life allows for greater distribution range and later imaging after administration
    • Data presented on Monday, June 23 by Principal Investigator Dr. Gary Ulaner, MD, PhD at the SNMMI 2025 Annual Meeting in New Orleans

    Basel, Switzerland, June 24, 2025NUCLIDIUM AG a clinical-stage radiopharmaceutical company developing copper-based theranostics, today announced positive data from the Phase 1 clinical trial evaluating the company’s novel PET imaging agent, 61Cu-NuriProTM (61Cu-NODAGA-PSMA I&T) in patients with metastatic prostate cancer. These data were presented on June 23 at the Society of Nuclear Medicine & Molecular Imaging (SNMMI) 2025 Annual Meeting in New Orleans by Dr. Gary Ulaner, MD, PhD, Director of Molecular Imaging and Therapy at Hoag Family Cancer Institute and Principal Investigator for the trial. Dr. Ulaner highlighted 61Cu-NuriPro’s favorable safety, dosimetry profile and imaging characteristics in Prostate Specific Membrane Antigen (PSMA)-positive prostate cancer patients.

    The Phase 1 trial conducted at Hoag Molecular Imaging and Therapy Clinic evaluated the safety, dosimetry and preliminary diagnostic efficacy of 61Cu-NuriProTM in patients with metastatic prostate cancer, and was compared to 18F-piflufolastat. 61Cu-NuriPro™ demonstrated a safety profile comparable to clinically established PSMA tracers with a favorable imaging performance. Notably, 61Cu-NuriPro PET visualized additional lesions in 50% of the patients which were not seen on the 18F-piflufolastat PET, with favorable tumor-to-background ratios. The number of detected lesions on the 61Cu-NuriPro PET increased up to 4 hours after administration, highlighting the diagnostic benefits of 61Cu’s 3.3-hour half-life and high positron yield.

    “Accurate and reliable imaging remains essential in the management of prostate cancer. The Phase 1 results from 61Cu-NuriPro™ demonstrate not only a solid safety profile but also good imaging quality compared to standard-of-care,” said Dr. Gary Ulaner, MD, PhD, Director of Molecular Imaging and Therapy at Hoag Memorial Hospital Presbyterian and Principal Investigator of the trial. “These early data suggest strong potential for improving diagnostic performance and patient outcomes.”

    Leila Jaafar, PhD, CEO and Co-Founder of NUCLIDIUM added “These results further validate our first-in-class copper theranostics platform and the clinical promise of 61Cu-NuriPro™ as a potential best-in-class diagnostic. We are dedicated to rapidly advancing our portfolio of copper-based theranostic agents for a broader range of cancers, with a focus on safety, sustainability, and scalability.”

    61Cu-NuriProTM (61Cu-NODAGA-PSMA I&T) is the diagnostic component of NUCLIDIUM’s PSMA-targeted NuriProTM program2,3,4,5,6. The company’s second diagnostic, 61Cu-TraceNET™, targeting SSTR-positive tumors, is in a Phase 1/2a clinical trial in broncho-pulmonary, and gastroenterohepatic neuroendocrine tumors (BP- and GEP-NETs). The agent will be developed further for imaging in a subset of metastatic breast cancer patients. Clinical trials of two corresponding therapeutics, 67Cu-NuriPro™ and 67Cu-TraceNET™, are expected to start enrollment in early 2026.

    About NUCLIDIUM
    Nuclidium AG is a clinical-stage biotechnology company pioneering the development of next-generation copper-based radiopharmaceuticals for the diagnosis and treatment of cancer. Leveraging copper isotopes — Copper-61 for diagnostics and Copper-67 for therapeutics — Nuclidium is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics. With operations in Switzerland and Germany, the company combines innovative chemistry, deep clinical expertise, and strategic manufacturing capabilities to deliver scalable, accessible, and clinically superior theranostic solutions to patients worldwide. Nuclidium is committed to expanding the reach and efficacy of radiotheranostics, including addressing critical unmet medical needs in oncology and women’s health.

    For more information, please contact:

    NUCLIDIUM
    Leila Jaafar, CEO
    Email: info@nuclidium.com

    Investor/Media Contact NUCLIDIUM
    Trophic Communications
    Stephanie May
    Email: nuclidium@trophic.eu
    Phone: +49 171 1855682

    1 European Medicines Agency. Pylclari – International non-proprietary name: piflufolastat (18F), Assessment report-EMA/CHMP/279917/2023, https://www.ema.europa.eu/en/documents/assessment-report/pylclari-epar-public-assessment-report_en.pdf, accessed 20 June 2025

    2 FDA Approves Pluvicto/Locametz for Metastatic Castration-Resistant Prostate Cancer. J Nucl Med. May 2022;63(5):13n.

    3 Keam SJ. Piflufolastat F 18: Diagnostic First Approval. Mol Diagn Ther. Sep 2021;25(5):647-656. doi:10.1007/s40291-021-00548-0

    4 Heo YA, Jadvar H, Calais J, et al. Flotufolastat F 18: Diagnostic First Approval Appropriate Use Criteria for Prostate-Specific Membrane Antigen PET Imaging. Mol Diagn Ther. Jul 13; Jan 2023;63(1):59-68. doi:10.1007/s40291-023-00665-y10.2967/jnumed.121.263262

    5 Hennrich U, Eder M. [(68)Ga]Ga-PSMA-11: The First FDA-Approved (68)Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer. Pharmaceuticals (Basel). Jul 23 2021;14(8)doi:10.3390/ph14080713

    6 Basaco Bernabeu T, Fani M, et al. 61Cu-PSMA–Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging. JNM. Sep 2024, 65 (9) 1427-1434. doi: https://doi.org/10.2967/jnumed.123.267126

    The MIL Network

  • MIL-OSI Asia-Pac: Secretary for Health welcomes conclusion of transitional registration system for proprietary Chinese medicines

    Source: Hong Kong Government special administrative region

    Secretary for Health welcomes conclusion of transitional registration system for proprietary Chinese medicines

    The following is issued on behalf of the Chinese Medicine Council of Hong Kong (CMCHK):

    The CMCHK announced today (June 24) that the evaluation and approval process for converting the transitional registrations of proprietary Chinese medicines (pCm) to formal registrations has been completed. The transitional registration system for pCm will come to an end on June 30. By then, all pCms sold in Hong Kong must have valid formal registrations, marking a new chapter in the regulatory regime of Chinese medicine in Hong Kong.

    According to the Chinese Medicine Ordinance (Cap. 549), all pCms must be registered with the Chinese Medicines Board (CMB) under the CMCHK before they can be sold, imported or possessed in Hong Kong. The registration of pCm must comply with the stringent requirements of the CMB in respect of safety, quality and efficacy. Taking into account the actual situation of the trade, the Government implemented a transitional measure in the past. PCms manufactured or sold in Hong Kong as of March 1, 1999, and meeting the eligibility criteria for transitional registration, were allowed to continue to be sold during the application period for “Certificate of registration of pCm” (HKC) with a “Notice of confirmation of transitional registration of pCm” (HKP).

    During the implementation of the transitional registration arrangement, the CMB processed a total of 14 172 cases of HKP applications and approved 9 150 for issuance of HKP. Among these cases, 6 174 cases were successfully issued with HKC, while the remaining 2 976 cases were not issued with HKCs due to reasons such as the applicants’ failure to submit the required information, withdrawal of applications by the applicants, or revocation of the HKPs, among others.

    In view of the time taken by the trade to adapt to the registration requirements and the impact of the pandemic, the CMB extended the deadline for submission of registration information on a number of occasions. In February 2024, the CMB made a final decision that all applications for HKC from HKP must be completed by June 30, 2025. After that, HKP will be revoked for overdue cases, and the products concerned will not be allowed to be sold, imported, or possessed in Hong Kong.

    Members of the public who need to verify the information of pCms can visit the CMCHK’s website.

    The Chairman of the CMCHK, Mrs Jeanie Hu, said, “I would like to express my heartfelt gratitude to the CMB for its efforts over the years and the full co-operation of the trade in accomplishing this historic task. The successful completion of the transitional registration for pCm signifies that all pCms currently sold in Hong Kong have strictly complied with the three core registration requirements – namely, safety, quality and efficacy – and fully met the requirements of the Ordinance in respect of packaging and labelling. This further enhances the protection of public health. The full implementation of the pCm registration system has not only raised public confidence in the regulatory system for Chinese medicines in Hong Kong, but also promoted the sustainable development of the local Chinese medicine industry, further consolidating Hong Kong’s strategic position as an important hub for the internationalisation of Chinese medicines.”

    Ends/Tuesday, June 24, 2025
    Issued at HKT 15:30

    MIL OSI Asia Pacific News

  • MIL-OSI NGOs: MSF remains ready to resume medical activities in Libya

    Source: Médecins Sans Frontières –

    • MSF was forced to suspend activities in Libya on 27 March 2025 after the Internal Security Agency (ISA) of Libya closed our premises.
    • We are concerned for our former patients, including the migrants and refugees we were treating for tuberculosis.
    • We are willing to resume our activities in Libya should the safety of our staff and patients be guaranteed.

    Two and a half months after the forced suspension of our activities by the Libyan authorities, following a wave of repression that affected ten humanitarian organisations present in the west of the country, Médecins Sans Frontières (MSF) reaffirms our willingness to resume medical services and support to the Libyan authorities. We also remain concerned about the health of our former patients and the interruption of access to healthcare for people in Libya.

    On 27 March 2025, MSF was forced to suspend our medical activities in the country, following the closure of our premises by the Internal Security Agency (ISA) of Libya and the interrogation of several of our team members. All MSF staff were released, but after the crackdown, we were forced to evacuate our international employees from Libya and to terminate the contracts of our Libyan staff.

    Since mid-March, the ISA began summoning and interrogating the staff of international non-governmental organisations providing care to migrants and refugees in Libya.

    “MSF is ready to resume the medical projects that were underway for tuberculosis, mental health and maternal health, for any patient in need of care, and in collaboration with the relevant Libyan authorities,” says Steven Purbrick, MSF head of mission for Libya. “Provided that the safety of our staff and patients is guaranteed, MSF calls for its suspension to be lifted.”

    MSF had received no formal notification of the basis for the ISA actions and regrets this intimidatory crackdown which compromises access to medical care. We are deeply concerned with the consequences for patients’ health. We had treated migrants and refugees who are subjected to abuse and violence, with severe health consequences and acute medical needs. MSF’s referral mechanism to UNHCR or IOM to evacuate migrants and refugee patients identified as medical priority cases has now come to a halt.

    Before the suspension of activities, MSF was treating a cohort of more than 300 Libyan, migrant and refugee patients, mostly for tuberculosis, antenatal care and psychological support, especially for survivors of violence. Some patients were in a critical situation. MSF managed to refer most of them to other facilities, such as the National Center for Disease Control, but also lost contact with several of them.

    “Two of our tuberculosis patients died in Misrata immediately after our suspension. We hear that a further four other patients have since passed away in the same facility,” says Carla Peruzzo, medical coordinator for MSF in Libya. “We are very concerned about patients with chronic diseases like diabetic patients in need of insulin and people in need of dialysis, with kidney chronic disease.” 

    MSF was supporting the only public centre for tuberculosis patients in Libya. The tuberculosis unit was implemented by MSF within the Misrata Chest hospital in 2020.

    Medications destined for donation to public hospitals were locked inside MSF’s premises, which we will now be obliged to destroy due to the loss of temperature control.

    “The medical needs met by MSF are not always covered in Libya’s public health system, which faces structural challenges, such as understaffing and shortages of medication supply,” says Peruzzo. “A breakdown in tuberculosis treatment can lead to the development of a drug-resistant form of the disease, rapid deterioration in the patient’s state of health and even death.”

    Over the years MSF had successfully developed a technical collaboration with the National Tuberculosis Program to reinforce capacities to detect cases in specialised facilities, review national guidelines of the central laboratory in Tripoli and support the department of health education. We are ready to continue our planned support to the National Tuberculosis Program and the rest of our medical activities in Libya.

    MSF had been working in eastern and western Libya since 2011, providing essential healthcare, tuberculosis diagnosis and care, mental health support, and maternal health consultations.

    In 2023, MSF provided emergency medical support following the flooding in Derna, supporting two healthcare centres and providing medical consultations to almost 5,000 people. MSF also provided mental health services after the disaster.

    In 2024, MSF conducted over 15,000 medical consultations, 3,000 mental health consultations, and 2,000 consultations for tuberculosis.  

    MIL OSI NGO

  • MIL-OSI Europe: Text adopted – Welfare of dogs and cats and their traceability – P10_TA(2025)0135 – Thursday, 19 June 2025 – Strasbourg

    Source: European Parliament

    Text proposed by the Commission   Amendment Amendment 1
    Proposal for a regulation
    Recital 1 (1)  Live animals, including cats and dogs are covered by Annex I to the Treaty on the Functioning of the European Union and form part of the common agricultural policy of the Union. There is a market for these animals in the Union, including substantial cross-border trade. Many Member States are signatories to the European Convention for the Protection of Pet Animals. There is a wide range of evidence of sub-optimal functioning of the internal market for dogs and cats in the Union as well as of illegal trade in these animals within the Union and at import into the Union. Therefore, it is necessary to establish minimum requirements for the welfare of dogs and cats bred and kept in establishments, as well as strengthened requirements regarding the traceability of dogs and cats supplied in the Union. (1)  Live animals, including cats and dogs are covered by Annex I to the Treaty on the Functioning of the European Union, form part of the common agricultural policy of the Union and their welfare should be protected. There is a market for these animals in the Union, including substantial cross-border trade. Many Member States are signatories to the European Convention for the Protection of Pet Animals. There is a wide range of evidence of sub-optimal functioning of the internal market for dogs and cats in the Union as well as of illegal trade in these animals within the Union and at import into the Union. Therefore, considering the findings on animals, which recognise their capacity for emotions, pain and social interactions, it is necessary to establish minimum requirements for the welfare of dogs and cats that are bred and kept in establishments, as well as strengthened requirements regarding the traceability of dogs and cats placed on the Union market. Amendment 2
    Proposal for a regulation
    Recital 2 (2)  The absence of Union welfare provisions on breeding, keeping and placing on the market of dogs and cats, as well as divergent national rules where they exist, have very often led to those animals being born, bred and sold or adopted at no cost, in circumstances detrimental to their welfare. Competition between commercial breeders of dogs and cats in different Member States is not conducted on a level playing field because animal welfare conditions are one of the main elements of the competitiveness of these operators and they differ considerably between Member States. As a consequence, competition is distorted, especially for high standards breeders and keepers, which are unable to monetise their investments into animal welfare when they trade cross border because they are confronted with operators that profit from sub-standard animal welfare conditions to exert competition and drive prices and standards down. (2)  Dogs and cats, with its own unique biological and behavioural needs, are traded and kept as pets in the Union. The absence of Union welfare provisions on breeding, keeping and placing on the market of dogs and cats, as well as divergent national rules where they exist, have sometimes led to those animals being born, bred and sold or adopted at no cost, in circumstances which could have serious detrimental consequences to their welfare. Competition between commercial breeders of dogs and cats in different Member States is not conducted on a level playing field because animal welfare conditions are one of the main elements of the competitiveness of these operators and they differ considerably between Member States. As a consequence, competition is distorted, especially for high standards breeders and keepers, which are unable to monetise their investments into animal welfare when they trade cross border because they are confronted with operators that profit from sub-standard animal welfare conditions to exert competition and drive prices and standards down. Amendment 3
    Proposal for a regulation
    Recital 3 (3)  Also, consumers are insufficiently protected as they are often confronted, when acquiring a dog or a cat, with the negative consequences of the poor welfare conditions in which the animals have been bred and kept in the establishments, such as health problems, behavioural problems or genetic defects of the dog or cat purchased or acquired. (3)  Also, consumers are insufficiently protected as they are often confronted, when acquiring a dog or a cat, with the negative consequences of the poor welfare conditions in which the animals have been bred and kept in the establishments, such as health problems, behavioural problems or genetic defects of the dog or cat purchased or acquired. To support informed consumer choices and promote compliance with Union rules, it is essential to inform the public and raise awareness of the difference between responsible and non-compliant or unlawful breeding practices. Amendments 280 and 307
    Proposal for a regulation
    Recital 3 a (new) (3a)   While several Member States have already introduced positive lists at national level to regulate the private ownership of animals, the absence of a common Union framework of welfare provisions on breeding, keeping and placing on the market of pet animal species other than dogs and cats, as well as divergent national rules, leads to inconsistencies, gaps in enforcement, confusion for consumers and, often, to serious animal welfare consequences for species that are unsuitable to be kept as pets, as well as risks to biodiversity, human health and safety and nature conservation. Amendment 308
    Proposal for a regulation
    Recital 3 b (new) (3b)   There have been previous calls to establish a science-based Union-wide list of animals that have been assessed as being suitable to be kept as pets, under appropriate welfare conditions, without causing harm to populations in the wild, and therefore to European biodiversity, or to human health and safety. In doing so, it is essential to ensure an assessment of the impact on animals, including their welfare, behaviour, dietary needs, and veterinary care, in order to avoid situations that could cause unnecessary suffering, inappropriate living conditions, or endangerment of species. Amendment 4
    Proposal for a regulation
    Recital 4 a (new) (4a)  Cooperation between Member States should be enhanced in order to identify illegal breeding establishments, dismantle associated networks, and ensure effective enforcement of applicable rules. Strengthening cross-border collaboration, information exchange and coordinated inspections is essential to address the transnational nature of certain illegal activities and to protect animal welfare and consumer interests across the Union. Amendment 5
    Proposal for a regulation
    Recital 4 b (new) (4b)  The number of companion animals in the Union has increased significantly over recent years, reflecting the strong attachment of Union citizens to the welfare of dogs and cats. In light of developments in animal welfare science, the Union and its Member States should be encouraged to promote a legal approach that reflects not only the status of animals as property, but also the ethical responsibility of humans towards their welfare and protection. Amendment 6
    Proposal for a regulation
    Recital 6 (6)  Illegal trade of dogs and cats has developed in part due to lack of traceability of these animals to the original litter. In turn, illegal trade practices are associated with suffering of dogs and cats subject to uncontrolled breeding practices. It is not possible to ensure that operators abide by the same standards of animal welfare, and to ensure uniform conditions of competition in the internal market in relation to the supplying of dogs and cats without reliable means to trace the animals to their origin. It is therefore crucial to ensure the traceability of dogs and cats by a system that identifies and registers dogs and cats before their first supplying in the Union as well as each time there is a change of ownership of the animals. (6)  Illegal trade of dogs and cats has developed in part due to lack of traceability of these animals to the original litter and to consumers’ enthusiasm for these animals, facilitated by the development of online purchasing. In turn, illegal trade practices are associated with suffering of dogs and cats subject to uncontrolled breeding practices. It is not possible to ensure that operators abide by the same standards of animal welfare, and to ensure uniform conditions of competition in the internal market in relation to the placing on the market of dogs and cats without reliable means to trace the animals to their origin. It is therefore crucial to ensure the traceability of dogs and cats by a system that identifies and registers dogs and cats before their first placing on the Union market as well as each time there is a change of ownership of the animals. Amendment 309
    Proposal for a regulation
    Recital 6 a (new) (6a)   This Regulation introduces mandatory registration, reinforced controls on online sales, and enhanced traceability of dogs and cats, with transition periods of up to 10 years in order to allow the relevant authorities to prepare. It further stresses the importance of Union-wide standards for responsible breeding to prevent detrimental health and welfare impacts on dogs and cats. This Regulation addresses these issues by establishing clear welfare requirements and ensuring that breeding practices uphold the highest standards. Amendment 7
    Proposal for a regulation
    Recital 7 (7)  Illegal trade in cats and dogs from outside the EU has been increasing. Current EU rules on the movements of dogs and cats into the EU, such as the provisions of Regulation 576/2013 and of the Animal Health Law, do not contain sufficient tools to prevent this illegal trade. This means that additional rules to fight illegal trade in dogs and cats are required. Existing animal health rules require that, both for commercial and non-commercial movement of dogs and cats entering into the Union, the animals must be identified with a microchip. To reinforce these traceability provisions, the owners of dogs and cats entering into the Union should ensure their registration in one of the Member States’ databases at the place of destination. This will provide for greater control on the movements of those animals. (7)  Illegal trade in cats and dogs from outside the EU has been increasing. Current EU rules on the movements of dogs and cats into the EU, such as the provisions of Regulation 576/2013 and of the Animal Health Law, do not contain sufficient tools to prevent this illegal trade. This means that additional rules to fight illegal trade in dogs and cats are required. Existing animal health rules require that, both for commercial and non-commercial movement of dogs and cats entering into the Union, the animals must be identified with a microchip. To reinforce these traceability provisions, the owners or persons responsible for dogs and cats entering into the Union should ensure their registration in one of the Member States’ databases at the place of destination. This will provide for greater control on the movements of those animals. Amendment 8
    Proposal for a regulation
    Recital 8 (8)  The traceability provisions of this proposal also contribute to the protection of public health via better animal welfare, better animal health, and better controls on the possible transmission of animal diseases (some of which being of zoonotic nature), this following a One Health approach. (8)  The traceability provisions of this proposal also contribute to the protection of public health via better animal welfare, better animal health, and better controls on the possible transmission of animal diseases (some of which being of zoonotic nature, some of which transmitting to wildlife, this following a One Health approach. Amendment 9
    Proposal for a regulation
    Recital 8 a (new) (8a)  Regulation (EU) 2016/429 of the European Parliament and of the Council regulates transmissible animal diseases for the purpose of avoiding the spread of such diseases in the Union. The health of animals is one of the five domains of animal welfare, and thus addressed in this Regulation. However, this Regulation does not address the diseases listed in Regulation (EU) 2016/429, but rather the state of health of dogs and cats as shaped by non-communicable diseases (for example injuries) or non-listed diseases (for example certain parasites). The rules laid down in this Regulation are therefore complementary to Regulation (EU) 2016/429 and do not duplicate or overlap with the rules laid down in that Regulation. Amendment 10
    Proposal for a regulation
    Recital 10 (10)  Regulation (EU) 2016/429 requires the identification of dogs and cats with a transponder but only if they are subject to movements between Member States entered into the Union. The identification required by that Regulation is not fully harmonised as it does not include precise standards regarding transponders. Furthermore, that Regulation does not require Member States to keep databases of dogs and cats. Therefore, Member States should be required to establish and maintain databases of dogs and cats supplied in the Union market to ensure the traceability of these animals. It is also necessary to ensure the interoperability of these databases. This will facilitate finding information on dogs and cats across the Union, as well as enable competent authorities to carry out official controls to ensure compliance with animal welfare rules. (10)  Regulation (EU) 2016/429 requires the identification of dogs and cats with a transponder but only if they are subject to movements between Member States entered into the Union. The identification required by that Regulation is not fully harmonised as it does not include precise standards regarding transponders. Furthermore, that Regulation does not require Member States to keep databases of dogs and cats. Therefore, Member States should be required to establish and maintain databases of dogs and cats placed on the Union market to ensure the traceability of these animals. It is also necessary to ensure the interoperability of these databases. This will facilitate finding information on dogs and cats across the Union, as well as enable competent authorities to carry out official controls to ensure compliance with animal welfare rules. Amendment 11
    Proposal for a regulation
    Recital 11 (11)  The supplying of dogs and cats, whether for profit or at no cost, has an impact on the internal market. Therefore, to prevent fraud, traceability of all animals traded in the Union market should be ensured and the keeping of animals in breeding establishments, pet shops or animal shelters should be subject to detailed rules. (11)  The placing on the market of dogs and cats, whether for profit or at no cost, has an impact on the internal market. Therefore, to prevent fraud, traceability of all animals traded in the Union market should be ensured and the keeping of animals in breeding and selling establishments, pet foster homes or animal shelters should be subject to detailed rules. The military, police or customs that breed or keep dogs for their own services’ use are not in such situation as they do not carry out their breeding or keeping activities for the market. Amendment 12
    Proposal for a regulation
    Recital 11 a (new) (11a)  The occasional supply of puppies and kittens by their owners who keep dogs or cats for personal or familial enjoyment and companionship and without any commercial intent or purpose, does not have a significant impact on the internal market and it is therefore justified to exclude such supply activities from the scope of application of this Regulation. Amendment 13
    Proposal for a regulation
    Recital 13 (13)  Directive 2010/63/EU of the European Parliament and of the Council4 regulates the keeping, breeding and supply of animals kept for scientific purposes including dogs and cats. Dogs and cats intended for scientific purposes should therefore be excluded from the scope of application of this Regulation. (13)  Directive 2010/63/EU of the European Parliament and of the Council4 regulates the keeping, breeding and supply of animals kept for scientific purposes including dogs and cats. Regulation (EU) 2019/6 of the European Parliament and of the Council regulates clinical trials for veterinary medicinal products involving the use of animals, including dogs and cats. Dogs and cats intended or used for scientific purposes as well as dogs and cats used in clinical trials required for the marketing authorisation of veterinary medicinal products should therefore be excluded from the scope of application of this Regulation. __________________ __________________ 4 Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes (OJ L 276, 20.10.2010, p. 33). 4 Directive 2010/63/EU of the European Parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes (OJ L 276, 20.10.2010, p. 33). Amendment 14
    Proposal for a regulation
    Recital 14 (14)  A large number of dogs and cats will be covered by detailed welfare rules for the first time, which will allow them to benefit from better living conditions. However, considering the practical difficulties in certain cases to determine whether dogs and cats are kept as pets or for placing on the market or supply, this Regulation should exempt from certain obligations pet owners who keep a number of dogs and cats and produce a number of litters below a certain threshold. Otherwise, those pet owners would be subject to the relevant requirements of this Regulation, which would not be proportionate. (14)  A large number of dogs and cats will be covered by detailed welfare rules for the first time, which will allow them to benefit from better living conditions. However, considering the practical difficulties in certain cases to determine whether dogs and cats are kept as pets or used for agricultural purposes, such as herding, guarding livestock, farm protection, or for placing on the market or supply, this Regulation should exempt pet owners who keep a number of dogs and cats and produce a number of litters below a certain threshold. Otherwise, those pet owners would be subject to the relevant requirements of this Regulation, which would not be proportionate. Stray cats that roam freely and that keep rodent populations in check, have long been part of this rural balance and serve a functional and symbiotic role on agricultural holdings. Rural and remote areas, where access to veterinary services and compliance infrastructure may be limited, as well as the need to avoid imposing a disproportionate burden on farmers and small-scale breeders, should be duly taken into account. Amendment 15
    Proposal for a regulation
    Recital 17 (17)  Moreover, in the Union market different types of operators carrying out different types of activities supply dogs and cats. Aside from commercial breeders there are pet shops where dogs and cats, that are typically born and bred in other establishments, are kept for sale. The protection of these animals may be suboptimal, and there are no common welfare standards that need to be observed in these establishments. Given that pet shops are commercial operators that place on the market dogs and cats, it is therefore necessary to apply the requirements of this Regulation to these establishments. (17)  Moreover, in the Union market different types of operators carrying out different types of activities place dogs and cats on the market. Aside from commercial breeders there are selling establishments where dogs and cats, that are typically born and bred in other establishments, are kept for sale. The protection of these animals may be suboptimal, and there are no common welfare standards that need to be observed in these establishments. Given that selling establishments are commercial operators that place on the market dogs and cats, it is therefore necessary to apply the requirements of this Regulation to these establishments. Amendment 16
    Proposal for a regulation
    Recital 19 (19)  Despite the differences in the activities carried out by commercial breeders and pet shops, on the one hand, and animal shelters, on the other, they all supply dogs and cats in the Union market and there is a certain amount of overlap, especially at the level of the demand. When looking for a dog or cat, consumers make choices between buying an animal from a breeder (either directly or through a pet shop or intermediary), or adopting one from a shelter. The acquisition of dogs or cats directly from pet owners is marginal. One important factor in the choice of a dog or a cat is the possible behavioural or other problems that the animal may exhibit because of having been kept in poor welfare conditions and which may reduce their suitability to be kept as a pet animal, irrespective of whether the animal has been kept in a commercial breeding establishment, in a pet shop or in a shelter. Moreover, given that trade is also conducted by intermediaries and mostly online, consumers may not be aware before they acquire a dog or a cat of whether the animal originates from a shelter, a breeder or a pet shop. There is evidence that the number of animals supplied to the Union market by shelters is significant, in particular for cats. There is also evidence that animals are supplied from shelters in some Member States to prospective pet owners in other Member States, in particular for dogs. In order to ensure the achievement of the objective of this Regulation to ensure the smooth functioning of the internal market in dogs and cats, and the rational development of the sector while ensuring a high level of animal welfare, it is necessary to apply some of the requirements of this Regulation to shelters that keep a certain minimum number of animals, irrespective of whether they sell animals against payment or only supply animals for free or upon reimbursement of reasonable costs. However, for reasons of proportionality and given that the activities of shelters differ from those of other operators and may fulfil a public interest function, only some of the requirements of this Regulation should apply to shelters, concerning, in particular the number and competence of animal caretakers, housing, feeding and watering, behavioural needs and painful practices, and advisory visits by a veterinarian. (19)  Despite the differences in the activities carried out by commercial breeders and selling establishments, on the one hand, and animal shelters, on the other, they all place dogs and cats in the Union market and there is a certain amount of overlap, especially at the level of the demand. When looking for a dog or cat, consumers make choices between buying an animal from a breeder (either directly or through a selling establishment or intermediary), or adopting one from a shelter. The acquisition of dogs or cats directly from pet owners is marginal. One important factor in the choice of a dog or a cat is the possible behavioural or other problems that the animal may exhibit because of having been kept in poor welfare conditions and which may reduce their suitability to be kept as a pet animal, irrespective of whether the animal has been kept in a commercial breeding establishment, in a selling establishment or in a shelter. Moreover, given that trade is also conducted by intermediaries and mostly online, consumers may not be aware before they acquire a dog or a cat of whether the animal originates from a shelter, a breeder or a selling establishment. Providing such information could assist buyers in making informed and responsible choices. There is evidence that the number of animals placed on the Union market by shelters is significant, in particular for cats. There is also evidence that animals are placed on the market from shelters in some Member States to prospective pet owners in other Member States, in particular for dogs. In order to ensure the achievement of the objective of this Regulation to ensure the smooth functioning of the internal market in dogs and cats, and the rational development of the sector while ensuring a high level of animal welfare, it is necessary to apply some of the requirements of this Regulation to shelters that keep a certain minimum number of animals, irrespective of whether they place dogs or cats on the Union market against payment, for free or upon reimbursement of reasonable costs. However, for reasons of proportionality and given that the activities of shelters differ from those of other operators and may fulfil a public interest function, only some of the requirements of this Regulation should apply to shelters, concerning, in particular the number and competence of animal caretakers, housing, feeding and watering, behavioural needs and painful practices, and advisory visits by a veterinarian. Amendment 17
    Proposal for a regulation
    Recital 19 a (new) (19a)  Member States have observed the increasing use of foster homes by operators responsible for unwanted, abandoned, stray, lost or confiscated dogs or cats . Given that the number of dogs and cats kept in foster homes may impact the market of dogs and cats, foster homes should be covered by this Regulation. In such cases, the operators placing the dogs or cats in foster homes should be responsible for ensuring that the requirements of this Regulation are met in those foster homes. This could be achieved inter alia through the establishment of a contractual relationship between the operator and the foster family. Amendment 18
    Proposal for a regulation
    Recital 20 (20)  In addition, given the significant numbers of animals supplied in the Union by shelters, and the need to ensure the achievement of the objectives of this Regulation regarding traceability and prevention of illegal trade, shelters should also be subject to the requirements of this Regulation concerning identification and registration of dogs and cats, regardless of whether or not their activity can be considered economic in nature. (20)  In addition, given the significant numbers of animals placed on market in the Union by shelters, and the need to ensure the achievement of the objectives of this Regulation regarding traceability and prevention of illegal trade, shelters should also be subject to the requirements of this Regulation concerning identification and registration of dogs and cats, regardless of whether or not their activity can be considered economic in nature. Operators responsible for shelters should be encouraged to take appropriate measures to prevent reproduction of the dogs or cats kept in shelters. Amendment 19
    Proposal for a regulation
    Recital 23 (23)  In order to ensure proper enforcement of this Regulation, it is essential that competent authorities are able to identify the establishments subject to their official controls. It is therefore necessary that operators keeping dogs and cats in establishments notify their activities to the competent authorities. (23)  In order to ensure proper enforcement of this Regulation, it is essential that competent authorities are able to identify the establishments subject to their official controls. It is therefore necessary that operators keeping dogs and cats in establishments notify their activities to the competent authorities and that the competent authorities keep an updated register of these establishments. In order to minimise the administrative burden for operators, competent authorities should be able, for that purpose, to use information or data collected in the register of dogs and cats establishments under Regulation (EU) 2016/429. Amendment 278
    Proposal for a regulation
    Recital 24 (24)  Well trained and skilled staff are essential for improving the welfare conditions of animals. Competencies in animal welfare require knowledge of the basic behavioural patterns and needs of the species concerned. Animal caretakers should have the competencies in animal welfare relevant to their tasks and the animals they handle, in order to avoid inflicting pain, distress and suffering on dogs and cats. (24)  The distress and suffering of dogs and cats during training activities by untrained or poorly educated handlers can have detrimental effects on the behavioural patterns of dogs and cats, with possible risks to human health and safety and the environment. Therefore, well trained and skilled staff are essential for improving the welfare conditions of animals, including when breeding, keeping and handling dogs intended for military, police and customs services. Competencies in animal welfare require knowledge of the basic behavioural patterns and needs of the species concerned. Animal caretakers should have the competencies in animal welfare relevant to their tasks and the animals they handle, in order to avoid inflicting pain, distress and suffering on dogs and cats. Animal caretakers and relevant authorities, including government agencies should regularly update their competences through training programmes promoting training methods such as ‘operant conditioning’, prioritising positive reinforcement, instead of methods based on punishment. Amendment 21
    Proposal for a regulation
    Recital 25 (25)  Given the fact that animal welfare includes the health of animals, veterinarians are in the best position to provide advice to operators with a view to improving the animal welfare situation in establishments. Veterinarians should play an active role in raising awareness on the interrelationship between the health and welfare of those animals. Establishments keeping dogs and cats should therefore receive a regular animal welfare visit from a veterinarian. (25)  Given the fact that animal welfare includes the health of animals, veterinarians are in the best position to provide advice to operators with a view to improving the animal welfare situation in establishments. Veterinarians should play an active role in raising awareness on the interrelationship between the health and welfare of those animals. Establishments keeping a number of dogs and cats that exceeds a certain threshold dogs and cats should therefore receive an animal welfare visit from a veterinarian within the first year of application of this Regulation or within the first year of the notification of a new establishment, thereafter the visits from a veterinarian shall take place when appropriate, based on a risk analysis by the competent authorities. Amendment 22
    Proposal for a regulation
    Recital 25 a (new) (25a)  In order to ensure high level of animal welfare veterinarians maintain an appropriate degree of professional independence from the operator, as well as comprehensive education and ongoing training to stay abreast of scientific and professional advances. This training may, as appropriate, also encompass elements related to recognising instances of violence and animal abuse. Amendment 23
    Proposal for a regulation
    Recital 25 b (new) (25b)  Where veterinarians encounter circumstances during their animal health and welfare visits that could seriously affect the welfare of dogs or cats, they are encouraged, where appropriate, to notify the relevant authorities or to consider conducting a follow-up visit to assess the situation. Amendment 24
    Proposal for a regulation
    Recital 25 c (new) (25c)  Ending the life of dogs and cats should preferably be assisted by a veterinarian using methods that minimise pain and distress. In exceptional cases, such as when a hunting or livestock guardian dog is severely injured in a remote location where veterinary help is not accessible, other methods may be used, provided they minimise suffering to the greatest extent possible. Amendment 25
    Proposal for a regulation
    Recital 26 (26)  Certain breeding strategies may lead to welfare problems for dogs and cats. By selecting certain genetic traits for aesthetic or other marketing reasons, undesirable traits from an animal welfare perspective may also be created and passed on to future generations. Therefore, operators should take measures to ensure that their breeding strategies do not lead to such negative consequences for the welfare of the dogs and cats. (26)  Certain breeding strategies may lead to welfare problems for dogs and cats. By selecting certain genetic traits for aesthetic or other marketing reasons, undesirable traits from an animal welfare perspective may also be created and passed on to future generations. Therefore, operators should take measures to ensure that their breeding strategies do not lead to such negative consequences for the welfare of the dogs and cats. In particular, breeding strategies motivated by marketing objectives can result in certain types of dogs and cats developing ‘excessive conformational traits’. Since such excessive conformational traits can lead to significant health problems for the dogs and cats concerned, breeders should exclude them from breeding programmes. Amendment 26
    Proposal for a regulation
    Recital 26 a (new) (26a)  Aesthetic shows, exhibitions and competitions of dogs or cats have an impact on the market opportunities and price for selling dogs and cats. Mutilations and certain breeding strategies that result in dogs or cats with excessive conformational traits can be advantageous for breeders competing in aesthetic shows, exhibitions and competitions of dogs or cats. Organising and participating in such events can be driven by factors other than animal welfare, such as aesthetic standards, with the aim of advertising certain breeds and physical characteristics. In order to ensure that breeders prioritise the welfare of the dogs and cats they produce and in particular that dogs and cats do not develop excessive conformational traits and breeders do not perform mutilations to attain unhealthy aesthetic standards, operators of breeding and selling establishments and the organisers of such shows, exhibitions and competitions should not use or include dogs or cats with excessive conformational traits or those which have been mutilated for these shows, exhibitions or competitions. Amendment 27
    Proposal for a regulation
    Recital 27 (27)  Scientific evidence demonstrates that inbreeding has significant negative impacts on animal health and welfare. Therefore, inbreeding of dogs and cats including first-degree and second-degree matings should be prohibited, as this increases the incidence of inherited disorders and compromises immune system function, both of which adversely impact the health and welfare of dogs and cats. (27)  Scientific evidence demonstrates that inbreeding has significant negative impacts on animal health and welfare. Therefore, inbreeding of dogs and cats between parents and offspring, between siblings, between half siblings or between grandparents and grandchildren should be prohibited, as this increases the incidence of inherited disorders and compromises immune system function, both of which adversely impact the health and welfare of dogs and cats. Inbreeding should nevertheless be possible, when necessary to preserve local breeds with a limited genetic pool provided that it is authorised for that reason by the competent authority. Amendment 28
    Proposal for a regulation
    Recital 29 a (new) (29a)  Scientific evidence confirms that consistent access to adequate nutrition and hydration is fundamental for the welfare of dogs and cats. It is therefore appropriate to lay down minimum requirements for operators in this respect. Feeding and drinking facilities should be kept clean, and designed, constructed and installed in such a way as to ensure equal access for all animals, thus minimising competition and avoiding agonistic behaviour. Such facilities should also be designed to minimise spillage, prevent contamination of feed and water with harmful substances, and avoid any risk of harm to dogs and cats. Amendment 29
    Proposal for a regulation
    Recital 30 (30)  Scientific evidence is clear about the necessity for dogs and cats of having enough space to express their natural behaviour and having normal social interactions. This is not possible where animals are kept in confinement and in cages. The keeping of dogs and cats in cages should therefore be prohibited. (30)  Scientific evidence is clear about the necessity for dogs and cats of having enough space to express their natural behaviour and having normal social interactions. This is not possible where animals are kept in confinement and in containers for long periods. The keeping of dogs and cats in containers for long periods should therefore be prohibited, except if needed for the transport and temporary, short term isolation of individual dogs and or cats and during the participation in shows, exhibitions and competitions, for puppies or kittens with reduced thermoregulation capacity or puppies or kittens together with their mothers provided that stress is minimised and suffering due to extreme temperatures is avoided and the dogs and cats are able to stand and lie down in a natural position. Amendment 30
    Proposal for a regulation
    Recital 33 (33)  To prevent pregnancy complications and compromising their welfare, bitches and queens should only be bred after reaching skeletal as well as sexual maturity. To allow them to physically recuperate from pregnancy and lactation, bitches and queens should only be readmitted to reproduction after a sufficient period of time. However, to prevent certain pathological reproductive conditions in bitches and queens, such as pyometra, up to three consecutive pregnancies should be allowed, followed by an adequate recuperation period. Reproduction should gradually cease in bitches and queens coming into older age. (33)  To prevent pregnancy complications and compromising their welfare, bitches and queens should not be bred before reaching appropriate maturity. To allow them to physically recuperate from pregnancy and lactation, bitches and queens should only be readmitted to reproduction after a sufficient period of time. However, to prevent certain pathological reproductive conditions in bitches and queens, such as pyometra, up to three pregnancies litters within a period of 2 years should be allowed, followed by an adequate recuperation period, which should not be less of 1 year for bitches and queens that have delivered 3 litters, including stillborns, within a period of 2 years. Reproduction should cease in bitches and queens coming into older age and in bitches and queens that have had two cesarean sections, as it cannot be excluded that an additional pregnancy will have a negative effect on their welfare. All females used for reproduction should be regularly monitored by a veterinarian. Amendment 31
    Proposal for a regulation
    Recital 34 a (new) (34a)  Member States should lay down rules on effective, proportionate and dissuasive sanctions for non-compliance with this Regulation, including cases of abandonment of dogs and cats by operators. Breeding establishments that engage in abusive practices compromising animal welfare should, in particular, be subject to strong and dissuasive penalties. Such practices should be unequivocally condemned, and responsible persons should be prevented from continuing their activities in any Member State. Competent authorities should ensure that animals kept in such establishments are promptly removed and provided with appropriate care and protection. Amendment 32
    Proposal for a regulation
    Recital 36 (36)  Procedures with the purpose of altering the appearance of or preventing certain behaviours of cats and dogs, such as ear cropping, tail docking, removal of claws and resection of vocal cords, have a serious negative impact on the welfare of cats and dogs. These procedures cause pain and prevent cats and dogs from expressing innate behaviours. For this reason, they should only be allowed if performed by a veterinarian and only when necessary for medical reasons. (36)  Procedures with the purpose of altering the appearance of or preventing certain behaviours of cats and dogs, such as ear cropping, tail docking, removal of claws and resection of vocal cords, have a serious negative impact on the welfare of cats and dogs. These procedures cause pain and prevent cats and dogs from expressing innate behaviours. For this reason, they can only be allowed if performed by a veterinarian and only when necessary for medical reasons. However, for certain breeds, f.e. for hunting dogs, such procedures could be allowed for prophylactic, diagnostic and/or therapeutic reasons, and only if carried out by a veterinarian. In specific contexts and regions of Europe, tail docking may also be justified to prevent tail injuries, provided it is based on a full and thorough medical evaluation. Amendment 33
    Proposal for a regulation
    Recital 36 a (new) (36a)  Dogs used in the military, police and customs services normally undergo a very specific type of training to be prepared in the interest of national security. In order to have the possibility to attain the training deemed most appropriate, Member States should be able to grant derogations for dogs kept in breeding or selling establishments which are destined to be military, police or custom dogs. Amendment 34
    Proposal for a regulation
    Recital 37 (37)  The conditions in breeding establishments are particularly critical to ensure that dogs and cats are properly kept and treated before being placed on the market. It is therefore important that those establishments are approved by the competent authorities and are subject to onsite pre-inspection before their approval. It is also important that a list of those approved establishments is publicly available to allow potential buyers to verify the status of their suppliers. Since all establishments have an extended time for application of requirements on housing and health, it is necessary that the obligation of breeding establishments to obtain an approval should start to apply on the same date as the requirements for housing and health. (37)  Prior inspection of establishments by official veterinarians or other professionals, in case the official control task has been delegated, and consequent approval of establishments is an effective way to ensure that establishments comply with the requirements of this Regulation. However, given the limited availability of official veterinarians in Member States, it is not proportionate to require prior on-site inspection and approval for all establishments so that official veterinarians should focus on establishments representing a higher risk from the point of view of animal welfare. The conditions in breeding establishments are particularly critical to ensure that dogs and cats are properly bred, kept and treated before being placed on the market, in particular due to the consequences that poor animal welfare conditions at an early age can have for dogs and cats. It is therefore important that those establishments are approved by the competent authorities and are subject to onsite pre-inspection before their approval. It is also important that a list of those approved establishments is publicly available to allow potential buyers to verify the status of the breeding establishments and thus to strengthen public control and citizens’ awareness. Amendment 35
    Proposal for a regulation
    Recital 38 (38)  Some operators placing on the market dogs and cats, or shelters supplying dogs and cats, encourage potential customers to buy at any cost using emotional arguments, without mentioning to the potential owner the consequences of owning a pet animal. Other operators or shelters insist on the responsibility attached to pet ownership and this has the effect of limiting their ability to sell animals. This discrepancy of attitudes of operators tends to advantage less responsible operators, leading to distortions of competition despite the importance for animal welfare and public order of informing customers about their responsibility when buying a dog or a cat. It is therefore justified to require that all suppliers of dogs and cats in the Union market for use as pets inform future owners on their responsibility. In addition, where the supply of a dog or cat is facilitated by online means, an appropriate warning should accompany the online advertisement to efficiently convey the message of responsible ownership. (38)  Some operators placing on the market dogs and cats encourage potential customers to buy at any cost using emotional arguments, without mentioning to the potential owner the consequences of owning a pet animal. Other operators or shelters insist on the responsibility attached to pet ownership and this has the effect of limiting their ability to sell animals. This discrepancy of attitudes of operators tends to advantage less responsible operators, leading to distortions of competition despite the importance for animal welfare and public order of informing customers about their responsibility when buying a dog or a cat. It is therefore justified to require that all operators placing of dogs and cats in the Union market for use as pets inform future owners on their responsibility. In addition, where the placing on the market of a dog or cat is facilitated by online means, an appropriate warning should accompany the online advertisement to efficiently convey the message of responsible ownership. Amendment 36
    Proposal for a regulation
    Recital 39 (39)  Illegal trafficking and fraudulent practices in relation to the sale or transfer of dogs and cats for adoption is facilitated by the absence of traceability given the lack of identification and registration requirements for those animals. Furthermore, fraudulent practices may appear when the systems for the identification and registration of dogs and cats are not harmonised or cannot be easily operated because technical systems are not interoperable. It is therefore essential to harmonize the standards for the means of identification and registration and to ensure that the identification and registration of dogs and cats is completed before the animal is supplied in the Union for the first time. Suppliers of dogs and cats should provide evidence of identification and registration in one of the databases established by Member States for this purpose, before the first placing on the market of the animal in the Union. Subsequently, at every change of ownership or responsibility for the animal, the supplier must provide proof of identification and registration of the animal in one of the databases. For the sake of proportionality, natural persons supplying dogs and cats occasionally by other means than online platforms should not be subject to this obligation. (39)  Illegal trafficking and fraudulent practices in relation to the sale or transfer of dogs and cats for adoption is facilitated by the absence of traceability given the lack of identification and registration requirements for those animals. Furthermore, fraudulent practices may appear when the systems for the identification and registration of dogs and cats are not harmonised or cannot be easily operated because technical systems are not interoperable. It is therefore essential to harmonize the standards for the means of identification and registration and to ensure that the identification and registration of dogs and cats is completed before the animal placed on the Union market for the first time. Natural or legal persons placing of dogs and cats should provide evidence of identification and registration in one of the databases established by Member States for this purpose, before the first placing on the market of the animal in the Union. Subsequently, at every change of ownership or responsibility for the animal the change should be registered accordingly in one of the databases. For the sake of proportionality, natural persons supplying dogs and cats occasionally by other means than online platforms should not be subject to this obligation. Amendment 37
    Proposal for a regulation
    Recital 40 (40)  Suppliers of dogs and cats should not only provide evidence of identification, showing a document referring to the code of the transponder implanted in the animal but also evidence of the registration of that animal into an official database. This allows key information about the animal to be passed on to the new owner and ensures traceability. (40)  Natural or legal persons placing dogs and cats on the Union market should not only provide evidence of identification, showing a document referring to the code of the transponder implanted in the animal but also evidence of the registration of that animal into an official database. This allows key information about the animal to be passed on to the new owner and ensures traceability. Amendment 38
    Proposal for a regulation
    Recital 41 (41)  As most dogs and cats are currently offered for sale or donation by means of listings placed on online platforms, providers of online platforms should act diligently when intermediating access to dogs and cats. Therefore, without prejudice to Regulation (EU) 2022/2065, online platforms should be required to adapt the modalities of their listings for dogs and cats so that suppliers provide proofs of the identification and registration of the dogs and cats intended for sale or donation. In addition, the Commission should ensure the development of a system publicly available free of charge allowing to verify the authenticity of the identification and registration of a dog or a cat. This measure aims to better combat fraud by improving the traceability of dogs and cats supplied in the Union to their origin, allowing better controls by competent authorities and ultimately improving the welfare of these animals. This should not amount to an obligation for online platforms to generally monitor the listings offered through their platform, nor to a general fact-finding obligation aimed at assessing the accuracy of the identification and registration prior to the publication of the offer. (41)  As most dogs and cats are currently offered for sale or donation by means of advertisements placed on online platforms, providers of online platforms should act diligently when intermediating access to dogs and cats. Therefore, without prejudice to Regulation (EU) 2022/2065, online platforms should be required to adapt the modalities of their advertisements for dogs and cats so that natural or legal persons placing dogs or cats on the Union market provide proofs of the identification and registration of the dogs and cats intended for sale or donation. In addition, the Commission should ensure the development of a system publicly available free of charge allowing to verify the authenticity of the identification and registration of a dog or a cat. This measure aims to better combat fraud by improving the traceability of dogs and cats placed on the Union to their origin, allowing better controls by competent authorities and ultimately improving the welfare of these animals. This should not amount to an obligation for online platforms to generally monitor the listings offered through their platform, nor to a general fact-finding obligation aimed at assessing the accuracy of the identification and registration prior to the publication of the offer. Amendment 39
    Proposal for a regulation
    Recital 43 (43)  To ensure traceability of dogs and cats, animals should not only be marked with a unique identifier in the form of transponder, but their identification should also be registered in a database. Therefore, Member States that do not yet have national databases for dogs and cats should establish such databases so that identification can be reliable and verified. In addition, to ensure traceability within the Union, these national databases should be interoperable, allowing competent authorities and relevant stakeholders to verify the authenticity of the identification. (43)  To ensure traceability of dogs and cats, they should not only be individually identified with a unique identifier in the form of a transponder, but their identification should also be registered in a database. Therefore, Member States should be required to establish and maintain databases of dogs and cats placed on the Union market to ensure the traceability of these animals. It is also necessary to ensure the interoperability of these databases. This will make it easier for information on dogs and cats to be accessed across the Union, as well as enable competent authorities to carry out official checks to ensure compliance with animal welfare rules. In order to facilitate the interoperability between national databases, the Commission should establish an index database. Amendment 40
    Proposal for a regulation
    Recital 44 a (new) (44a)  In order to streamline cross-border movements of identified and registered dogs and cats, and to ensure timely access by veterinarians to relevant medical information, Member States are encouraged to establish a digital passport system. This digital document should include essential data on the animal’s identification and vaccination status, thereby enhancing both animal health management and administrative efficiency. Amendment 41
    Proposal for a regulation
    Recital 44 b (new) (44b)  The data protection in relation to the processing of personal data is a fundamental right. Regulation (EU) 2018/1725 of the European Parliament and of the Council lays down rules on the protection of natural persons with regard to the processing of personal data by the Union institutions, bodies, offices and agencies and on the free movement of such data. Regulation (EU) 2016/679 of the European Parliament and of the Council applies to the processing of personal data carried out by Member States in the course of the relevant procedures. Amendment 42
    Proposal for a regulation
    Recital 44 c (new) (44c)  The data protection in relation to the processing of personal data is a fundamental right. Regulation (EU) 2018/1725 of the European Parliament and of the Council lays down rules on the protection of natural persons with regard to the processing of personal data by the Union institutions, bodies, offices and agencies and on the free movement of such data. Regulation (EU) 2016/679 of the European Parliament and of the Council applies to the processing of personal data carried out by Member States in the course of the relevant procedures. The roles of the Commission and of the Member States in relation to the processing of personal data in cases under this Regulation need to be defined clearly in order to ensure a high level of data protection. Amendment 43
    Proposal for a regulation
    Recital 46 (46)  The provisions mentioned in the previous recital should be enforced through a listing of third countries approved to supply of dogs and cats to the Union based on a Commission assessment of the reliability of their official controls to enforce the animal welfare rules required under this Regulation, or equivalent rules, in establishments on their territory which supply or intend to supply dogs and cats to the Union. In addition, a list of establishments breeding and keeping dogs and cats in those third countries, and which are allowed to export those animals to the Union, should be established to ensure traceability and controls at Union Border Control Posts. The Commission should, following a risk-based approach, carry out audits of the reliability of official control system of third countries approved under this Regulation as well as those requesting to be approved under this Regulation. (46)  Enforcement of import rules should be ensured through a listing of third countries approved to place dogs and cats on the Union market based on a Commission assessment of the reliability of their official controls to enforce the animal welfare rules required under this Regulation, or recognised by the Union as equivalent rules, in establishments on their territory which export or intend to export dogs and cats to the Union market. In addition, a list of establishments breeding and keeping dogs and cats in those third countries, and which are allowed to export those animals to the Union, should be established to ensure traceability and controls at Union Border Control Posts. The Commission should, following a risk-based approach, carry out audits of the reliability of official control system of third countries approved under this Regulation as well as those requesting to be approved under this Regulation. Lastly, compliance with the relevant rules of this Regulation or with rules recognised by the Union as equivalent rules should be certified in the relevant health certificate used for such exports. For that purpose, the Commission should endeavour to amend the relevant model of official certificate, in order to include the related animal welfare attestation. Amendment 44
    Proposal for a regulation
    Recital 46 a (new) (46a)  To enhance consumer protection and to ensure the proper traceability of imports of dogs and cats into the Union, it is appropriate to require that they be identified before their entry and that the importers ensure their registration in one of the Member States’ databases. This will result in greater control on the movements of those animals. Furthermore, the EU Coordinated Action on the illegal trade of cats and dogs carried out in 2022 and 2023 demonstrated that one of the common fraudulent practices with the trade in dogs and cats consists in importing into the Union dogs and cats intended for trade claiming that those movements are non-commercial movements as defined by Union animal health rules, namely movements of dogs and cats accompanying their owners or a person authorised by the owner without the intention to transfer ownership. In order to provide tools for Member States to perform risk-based checks targeting this fraudulent practice, it is essential that the entry of dogs and cats as non-commercial be pre-notified through a dedicated Union pet travellers’ database. This database should collect notifications for all such entries into the Union regardless of the point of entry, for Member States to have the necessary overview and detect suspicious movements. For that reason it is appropriate that the Commission establish and maintain that database so that Member States have access to all available information for their checks. Amendment 45
    Proposal for a regulation
    Recital 47 (47)  Under Regulation (EU) 2016/429, a list of third countries authorised for the purpose of entry into the Union of dogs and cats is established for the purpose of managing the risk of introducing transmissible animal diseases into the Union. The list of third countries mentioned in the previous recital should therefore be limited to third countries authorised under Regulation (EU) 2016/429 and which provide appropriate guarantees of the capacity of their competent authority to control and ensure compliance of the establishments breeding and keeping dogs and cats for export to the Union with the animal welfare requirements set out in this Regulation. (47)  Under Regulation (EU) 2016/429, a list of third countries authorised for the purpose of entry into the Union of dogs and cats is established for the purpose of managing the risk of introducing transmissible animal diseases into the Union. The list of third countries mentioned in recital 46 should therefore be limited to third countries authorised under Regulation (EU) 2016/429 and which provide appropriate guarantees of the capacity of their competent authority to control and ensure compliance of the establishments breeding and keeping dogs and cats for export to the Union with the animal welfare requirements set out in this Regulation. Amendment 46
    Proposal for a regulation
    Recital 47 a (new) (47a)  In order to effectively trace the origin of the dog or a cat in the third country and to address illegal imports into the Union and fraudulent practices under the pretext of non-commercial movements as defined by Union Animal Health rules, it is important that dogs and cats are imported from third countries in compliance with this Regulation as regards their registration into a Member State database within 2 working days after their entry into the Union. Amendment 47
    Proposal for a regulation
    Recital 48 (48)  In order to take into account technical progress and scientific developments, and their social, economic and environmental impacts, the power to adopt acts in accordance with Article 290 TFEU should be delegated to the Commission for the purpose of amending Article 6 to this Regulation so that breeding strategies do not result in genotypes that have detrimental effects on the health or welfare of the dogs and cats. (48)  In order to take into account technical progress and scientific developments, especially the opinions of the European Food Safety Authority (EFSA), and their social, economic and environmental impacts, the power to adopt acts in accordance with Article 290 TFEU should be delegated to the Commission for the purpose of supplementing Article 6a of this Regulation to define the characteristics of genotypes, phenotypes, and excessive conformational traits that should be excluded from reproduction, so that breeding strategies do not result in genotypes that have detrimental effects on the health or welfare of the dogs and cats. In the context of aesthetic shows, exhibitions, and competitions, after considering both EFSA’s scientific opinion and the specific social and economic circumstances of the sector, the delegated acts should reflect a progressive and balanced approach, in order to ensure proportionate and practically achievable implementation.” Amendment 48
    Proposal for a regulation
    Recital 52 – indent 2 –  Article 17(5) to specify the information to be provided by suppliers as proof of identification and registration of dogs and cats, both in cases where they are offered through online platforms and by other means; deleted Amendment 49
    Proposal for a regulation
    Recital 52 – indent 6 –  Article 21(5) to establish a procedure for the recognition by the Union of equivalence of the conditions under which dogs and cats are bred and kept in establishments in a third country which intends to export animals to the Union, with the provisions of this Regulation regarding establishments. deleted Amendment 50
    Proposal for a regulation
    Recital 53 a (new) (53a)  The Member states may consider raising awareness about animal welfare and responsible animal care. Amendment 51
    Proposal for a regulation
    Recital 55 (55)  It is essential that Union legislation is subject to regular monitoring and evaluation so it can be adjusted in order to achieve the expected impacts. Therefore, this Regulation should contain an obligation for the Commission to perform monitoring on the welfare of dogs and cats in the Union and to carry out an evaluation to be presented to other Union institutions. (55)  It is essential that Union legislation is subject to regular monitoring and evaluation so it can be adjusted in order to achieve the expected impacts. Therefore, this Regulation should contain an obligation for the Commission to perform monitoring on the welfare of dogs and cats in the Union and to carry out an evaluation to be presented to other Union institutions. The evaluation should asses the technological and scientific developments that have occurred, including the means of identification of dogs or cats and the possibility of using alternative means which are less invasive than the implantation of a transponder. The evaluation should also guarantee the fraud-proof and robust character of the Union’s traceability system as well as the proportionality of the cost of identification for natural and legal persons subjected to the identification obligation under this Regulation. Amendments 282 and 311
    Proposal for a regulation
    Article 1 – paragraph 1 – point b (b)  the traceability of dogs and cats placed on the Union market or supplied in the Union. (b)  the traceability of dogs and cats bred or kept in the Union or placed on the Union market. Amendment 53
    Proposal for a regulation
    Article 2 – paragraph 1 1.  This Regulation shall apply to the breeding, keeping and placing on the market of dogs and cats, as well as their supplying in the Union. 1.  This Regulation shall apply to the breeding, keeping, placing on the market and entry into the Union of dogs and cats. Amendment 54
    Proposal for a regulation
    Article 2 – paragraph 2 2.  This Regulation shall not apply to the breeding, keeping, placing on the market or supplying of dogs or cats intended for scientific purposes. 2.  This Regulation shall not apply to the breeding, keeping, placing on the market or supplying of dogs or cats intended for scientific purposes or for clinical trials required for the marketing authorisation of veterinary medicinal products. Amendment 55
    Proposal for a regulation
    Article 2 – paragraph 2 a (new) 2a.  This Regulation shall not apply to: –  natural persons who keep dogs or cats for personal or familial enjoyment and companionship, and who allow such animals to reproduce, limited to a maximum of one litter per species per household, per 18 months, without placing them on the market; –  and to agricultural holdings, with the exception of the provisions laid down under Article 5. Amendment 284
    Proposal for a regulation
    Article 2 – paragraph 2 b (new) 2b.   Notwithstanding paragraph 2 of this Article, the requirements relating to identification and registration laid down in Article 17 shall apply to all dogs and cats held under the responsibility of natural persons. Amendment 56
    Proposal for a regulation
    Article 3 – paragraph 1 – point 1 a (new) 1a.  ‘Dogs that perform specific, working or professional activities’: means those animals which, having been selected for their physical, instinctive and temperamental qualities, are trained to assist people in a regulated activity or specific task, such as those used for hunting, working, herding, rescue, assistance or for sporting purposes or those used by law enforcement agencies, as well as guide animals, guide dogs or animals intended for zootherapy that have been trained in centres or by specialised professionals to support, guide and assist people with functional diversities; Amendment 57
    Proposal for a regulation
    Article 3 – paragraph 1 – point 3 a (new) 3a.  “breeding” means the activity of keeping dogs or cats in breeding establishments for the purpose of reproduction; Amendment 58
    Proposal for a regulation
    Article 3 – paragraph 1 – point 3 b (new) 3b.  “advertising” means any form of communication which has the direct or indirect effect of promoting a dog or cat in order to attract interest, engagement or sales, including the promotion of a breed or a physical characteristic; Amendment 59
    Proposal for a regulation
    Article 3 – paragraph 1 – point 4 4.  ‘keeping’ means any activity during which an animal is detained or handled in an establishment; 4.  ‘keeping’ means any activity during which dogs and cats are held, housed, detained or handled in an establishment or under the responsibility of an operator; Amendment 303
    Proposal for a regulation
    Article 3 – paragraph 1 – point 5 5.  ‘placing on the market’ means the keeping of dogs and cats for the purpose of sale, offering for sale, distribution or any other form of transfer of ownership or responsibility for the animal, that is against consideration or at least reimbursement of the costs incurred, including the advertising of animals for the above purposes; 5.  ‘placing on the market’ means the sale, offering for sale, distribution or any other form of transfer of ownership or responsibility, whether in return for payment or free of charge, excluding occasional and irregular donations of small numbers of dogs and cats by natural persons by means other than via the intermediation of an online platform, as well as the advertising of animals for the above purposes; Amendment 61
    Proposal for a regulation
    Article 3 – paragraph 1 – point 6 6.  ‘supplying’ means the transferring of ownership or responsibility for dogs or cats through any means or form, whether for a consideration or not, excluding occasional supplies by natural persons of dogs or cats by other means than via the intermediation of an online platform; deleted Amendment 62
    Proposal for a regulation
    Article 3 – paragraph 1 – point 7 7.  ‘online platforms’ means an online platform, as defined in Article 3, point (i), of Regulation (EU) 2022/2065, intermediating the placing on the market or the sypplying of dogs and cats; 7.  ‘online platforms’ means an online platform, as defined in Article 3, point (i), of Regulation (EU) 2022/2065, intermediating the placing on the market or of dogs or cats; Amendment 63
    Proposal for a regulation
    Article 3 – paragraph 1 – point 8 8.  ‘listing’ means the publication, on an online platform, of an advertisement for the supply of a dog or a cat; deleted Amendment 64
    Proposal for a regulation
    Article 3 – paragraph 1 – point 10 a (new) 10a.  ‘livestock guardian dog’ means a dog primarily, kept or trained to manage, move, or control livestock in agricultural or pastoral settings, including farms, grazing areas, or during transport; Amendment 65
    Proposal for a regulation
    Article 3 – paragraph 1 – point 11 11.  ‘establishments’ means breeding establishments, animal shelters and pet shops; 11.  ‘establishments’ means breeding establishments, selling establishments, shelters and foster homes; Amendment 66
    Proposal for a regulation
    Article 3 – paragraph 1 – point 12 12.  ‘breeding establishments’ means any premises or structure, where dogs and cats are kept for reproduction purposes with a view to placing their offspring on the market, including households; 12.  ‘breeding establishments’ means any premises or structure, where dogs or cats are kept for reproduction purposes with a view to placing their offspring on the market, including households; Amendment 67
    Proposal for a regulation
    Article 3 – paragraph 1 – point 12 a (new) 12a.  ‘agricultural holding means an agricultural holding within the meaning of Regulation (EU) 2018/1091 that is not a breeding establishment as defined in this Regulation; Amendment 68
    Proposal for a regulation
    Article 3 – paragraph 1 – point 13 13.  ‘pet shops’ means any premises or structure where dogs and cats are kept for sale as pet animals, without having been born there; 13.  ‘selling establishments’ means any premises or structure where dogs or cats are kept for sale without having been born there; Amendment 69
    Proposal for a regulation
    Article 3 – paragraph 1 – point 14 14.  ‘animal shelters’ means any premises or structure, excluding households, operated by a natural or legal person, where unwanted, abandoned, formal stray, lost or confiscated dogs and cats are kept for the purpose of supply, whether for consideration or at no cost; 14.  ‘shelters’ means any premises or structure, including households, operated by a natural or legal person, where unwanted, abandoned, formal stray, lost or confiscated dogs or cats are kept for the purpose of placing on the market; Amendment 70
    Proposal for a regulation
    Article 3 – paragraph 1 – point 14 a (new) 14a.  ‘foster home’ means a household that keeps dogs or cats on behalf of an operator responsible for unwanted, abandoned, stray, lost or confiscated dogs and cats; Amendment 71
    Proposal for a regulation
    Article 3 – paragraph 1 – point 15 15.  ‘operator’ means any natural or legal person, excluding those responsible for shelters, who breeds, keeps, trades or places on the market dogs and cats under his/her control, including for a limited period of time; 15.  ‘operator’ means any natural or legal person, that places dogs and cats on the market and that is responsible for a breeding establishment, a selling establishment or a shelter or that is responsible for dogs or cats kept therein, or that is responsible for unwanted, abandoned, stray, lost or confiscated and places them in foster homes; Amendment 72
    Proposal for a regulation
    Article 3 – paragraph 1 – point 16 16.  ‘supplier’ means any natural or legal person supplying a dog or a cat, including natural or legal persons responsible for shelters; deleted Amendment 73
    Proposal for a regulation
    Article 3 – paragraph 1 – point 18 a (new) 18a.  ‘euthanasia’ means the act of inducing death under anaesthesia and prolonged analgesia using medicinal products, using a method that causes a rapid and irreversible loss of consciousness with minimum pain and distress to an animal; Amendment 74
    Proposal for a regulation
    Article 3 – paragraph 1 – point 19 19.  ‘mutilation’ means an intervention, including a surgical intervention, carried out for reasons other than therapeutic or diagnostic purposes, which results in damage to or the loss of a sensitive part of the body or the alteration of bone structure; 19.  ‘mutilation’ means an intervention, including a surgical intervention, carried out for reasons other than therapeutic or diagnostic purposes, and other than neutering or implantation of a transponder, which results in damage to or the loss of a sensitive part of the body or the alteration of bone structure of a dog or a cat ; Amendment 75
    Proposal for a regulation
    Article 3 – paragraph 1 – point 19 a (new) 19a.  “Neutering” means the process whereby dogs or cats are surgically prevented from reproducing, including the surgical removal of gonads, namely the testicles in male cats and dogs and either the ovaries or the ovaries and the uterus in bitches and queens; Amendment 76
    Proposal for a regulation
    Article 3 – paragraph 1 – point 19 b (new) 19b.  “Non-surgical sterilisation” means alternatives to surgical sterilisation or neutering that preserve the integrity of the body of dog or cat and do not result in the removal or permanent alteration of any part of the dog or cat body; Amendment 77
    Proposal for a regulation
    Article 3 – paragraph 1 – point 20 20.  ‘suffering’ means an unpleasant, undesired physical or mental state of being, which is the result of an animal being exposed to noxious stimuli or the absence of important positive stimuli; 20.  ‘suffering’ means an unpleasant, undesired physical or mental state of being, which is the result of an animal being exposed to noxious stimuli or the continuous absence of important positive stimuli; Amendment 78
    Proposal for a regulation
    Article 3 – paragraph 1 – point 21 21.  ‘housing’ means buildings or delimited outdoor space in establishments where dogs and cats are kept; 21.  ‘housing’ means buildings or delimited outdoor space in establishments where dogs and cats are kept whether temporarily or permanently; Amendment 79
    Proposal for a regulation
    Article 3 – paragraph 1 – point 22 22.  ‘kennel’ means a physical structure containing one or more individual enclosures for housing dogs; 22.  ‘kennel’ means a physical structure containing one or more enclosures for housing dogs; Amendment 80
    Proposal for a regulation
    Article 3 – paragraph 1 – point 23 23.  ‘cattery’ means a physical structure containing one or more individual enclosures for housing cats; 23.  ‘cattery’ means a physical structure containing one or more enclosures for housing cats; Amendment 81
    Proposal for a regulation
    Article 3 – paragraph 1 – point 24 24.  ‘animal caretaker’ means a person taking care of the dogs and cats bred or kept in an establishment; 24.  ‘animal caretaker’ means a person taking care of the dogs and cats bred or kept in an establishment including volunteers, interns and part-time workers; Amendment 82
    Proposal for a regulation
    Article 3 – paragraph 1 – point 26 26.  ‘tethering’ means the tying of an animal to an anchor point to keep it in a desired area; 26.  ‘tethering’ means the tying of an animal to an anchor point or object to keep it in a desired area or to restrict its movement; Amendment 83
    Proposal for a regulation
    Article 3 – paragraph 1 – point 27 27.  ‘container’ means any crate, box, receptacle or other rigid structure used to confine dogs and cats; 27.  ‘container’ means any cage, crate, box, receptacle or movable structure used to confine dogs or cats; Amendment 84
    Proposal for a regulation
    Article 3 – paragraph 1 – point 28 28.  ‘pet animal’ means a dog or cat intended to be kept in a household for private enjoyment and companionship; deleted Amendment 85
    Proposal for a regulation
    Article 3 – paragraph 1 – point 29 29.  ‘responsible ownership’ means the commitment of a dog or cat owner or future dog or cat owner, to perform various duties focused on the satisfaction of the behavioural, environmental and physical needs of the dog or cat, and to prevent risks that the dog or cat may pose to the community, other animals or the environment. 29.  ‘responsible ownership’ means the commitment of a dog or cat owner or future dog or cat owner, to perform various duties focused on the satisfaction of the health, behavioural, environmental and physical needs of the dog or cat, and to minimize risks that the dog or cat may pose to the community, other animals or the environment. Amendment 86
    Proposal for a regulation
    Article 4 – paragraph 1 – introductory part This chapter shall not apply to: With the exception of the provisions laid down in Article 5 this chapter shall not apply to: Amendment 304
    Proposal for a regulation
    Article 4 – paragraph 1 – indent 1 –  breeding establishments keeping up to three bitches or queens and producing in total two litters or less per establishment and calendar year; –  breeding establishment where at most two litters per calendar year are produced for placing on the market shall only be subject to the obligations laid down in Article 5, Article 6(1), (1a) and (1b), Articles 6a, 7 and 8, Article 11(2), (3) and (4), Article 12(3), (4) and (7), Article 13(2), points (b), (c) and (d), Article 14(2), (3), (4) and (5a), Article 15 and Article 15a(1). Amendment 88
    Proposal for a regulation
    Article 4 – paragraph 1 – indent 2 –  pet shops keeping at any given time three dogs or less or six cats or less; deleted Amendment 89
    Proposal for a regulation
    Article 4 – paragraph 1 – indent 3 a (new) –  foster homes keeping at any given time five dogs or less or ten cats or less. Amendment 90
    Proposal for a regulation
    Article 5 – title General principles of welfare General welfare principles Amendment 91
    Proposal for a regulation
    Article 5 – paragraph 1 – introductory part Operators and natural or legal persons responsible for shelters shall apply the following principles with respect to dogs and cats bred or kept in their establishment: Operators and animal caretakers shall apply the following welfare principles with respect to dogs or cats bred or kept in their establishment: Amendment 92
    Proposal for a regulation
    Article 5 – paragraph 1 – point a (a)  dogs and cats are provided with water and feed of a quality and of a quantity that enables them to have good nutrition and hydration. (a)  dogs and cats are provided with water and feed of a quality and of a quantity that enables them to have good and appropriate nutrition and hydration. Amendment 93
    Proposal for a regulation
    Article 5 – paragraph 1 – point b (b)  dogs and cats are kept in a good physical environment which is comfortable, especially in terms of space, temperature, and ease of movement. (b)  dogs and cats are kept in an appropriate and clean physical environment which is secure and comfortable, especially in terms of space, air quality, temperature, light, protection against adverse climatic conditions and ease of movement, preventing overcrowding. Amendment 94
    Proposal for a regulation
    Article 5 – paragraph 1 – point c (c)  dogs and cats are kept safe, clean and in good health by preventing diseases, functional impairments, injuries, and pain, due in particular to management, handling practices, or mutilations. (c)  dogs and cats are kept safe, clean and in good health by preventing diseases, functional impairments, injuries, and pain, due in particular to management, handling practices, breeding practices or mutilations. Amendment 95
    Proposal for a regulation
    Article 5 – paragraph 1 – point e (e)  dogs and cats are kept in such a way as to optimise their mental state by preventing or reducing their negative experiences in time and intensity, as well as by maximizing opportunities for positive experiences in time and intensity in the different domains referred to in paragraphs (a) to (d). (e)  dogs and cats are kept in such a way as to optimise their mental state by preventing or reducing their negative experiences in duration and intensity, as well as by maximizing opportunities for positive experiences in duration and intensity, preventing the development of abnormal repetitive and other behaviours indicative of negative animal welfare, and taking into consideration the individual dog’s or cat’s needs in the different domains referred to in paragraphs (a) to (d). Amendment 96
    Proposal for a regulation
    Article 6 – title General welfare requirements for dogs and cats General welfare obligations Amendment 97
    Proposal for a regulation
    Article 6 – paragraph 1 1.  Operators and natural or legal persons responsible for shelters shall be responsible for the welfare of dogs and cats kept under their control and for minimising any risks to their welfare. 1.  Operators and animal caretakers shall be responsible for the welfare of dogs or cats kept in their establishments and under their control and to minimise any risks to their welfare. In the case of foster homes, the responsibility shall lie with the operator on whose behalf dogs or cats are kept. Such operators shall provide the foster family with adequate information on the animal welfare requirements and obligations as well as the individual needs of the dogs or cats, and shall ensure and verify that the relevant obligations set out by this Regulation are complied with in foster homes. Amendment 98
    Proposal for a regulation
    Article 6 – paragraph 1 a (new) 1a.  Operators shall not subject any dog or cat to cruelty, abuse or mistreatment, nor shall they breed, train or medicate them to participate in activities resulting in cruelty, abuse or mistreatment to themselves or to other dogs and cats, including dog fighting. Amendment 99
    Proposal for a regulation
    Article 6 – paragraph 1 b (new) 1b.  Operators and animal caretakers shall not abandon dogs or cats. Amendment 101
    Proposal for a regulation
    Article 6 – paragraph 3 3.  Operators of breeding establishments shall ensure that breeding strategies do not result in genotypes and phenotypes that have detrimental effects on the welfare of the dogs and cats, or of their descendants. deleted In the management of the reproduction of dogs and cats by operators, the mating between parents and offspring, or between grandparents and grandchildren, shall be prohibited. This paragraph shall not preclude the selection and breeding of brachycephalic dogs and cats provided that the selection or breeding programmes minimise the negative welfare consequences of brachycephalic traits. Amendment 102
    Proposal for a regulation
    Article 6 – paragraph 4 4.  The Commission is empowered to adopt delegated acts in accordance with Article 23 amending this article as regards the specific criteria that operators shall fulfil when designing breeding strategies to meet the requirements of paragraph 3, taking into account scientific opinions of the European Food Safety Authority as well as social, economic and environmental impacts. deleted Amendment 103
    Proposal for a regulation
    Article 6 a (new) Article 6a Breeding strategies obligations 1.  Operators of breeding establishments shall ensure that their breeding strategies prioritise the health and welfare of the animal, and minimise the risk of producing dogs or cats with genotypes or phenotypes associated with detrimental effects on their welfare 2.  Operators of breeding establishments shall not use for reproduction dogs or cats that have excessive conformational traits leading to a high risk of detrimental effects on the welfare of these dogs or cats, or of their offspring. 3.  The Commission is empowered to adopt delegated acts in accordance with Article 23 supplementing this Regulation by laying down the characteristics of the genotypes and phenotypes referred to in paragraph 1 of this Article, and the excessive conformational traits referred to in paragraph 2 of this Article, which shall be excluded from reproduction, taking into account scientific opinions of the European Food Safety Authority as well as social and economic impacts. The delegated acts concerning the excessive conformational traits shall be adopted by 1 July 2030. 4.  Unless approved by the competent authority based on a specific need to preserve local breeds with a limited genetic pool, the breeding between parents and offspring, between siblings, between halfsiblings or between grandparents and grandchildren shall be prohibited in the management of the reproduction of dogs and cats. Amendment 104
    Proposal for a regulation
    Article 7 – title Obligation to notify the breeding or keeping of dogs and cats in establishments Notification and registration of establishments Amendment 105
    Proposal for a regulation
    Article 7 – paragraph 1 – introductory part Operators and natural or legal persons responsible for shelters shall notify to the competent authorities of their activity, providing the following information: Operators shall notify to the competent authorities of their activity, providing at least the following information: Amendment 106
    Proposal for a regulation
    Article 7 – paragraph 1 – point c (c)  the type of establishment: breeding establishment, pet shop or shelter; (c)  the type of establishment: breeding establishment, selling establishment shelter or foster home; Amendment 107
    Proposal for a regulation
    Article 7 – paragraph 1 – point e (e)  the maximum number of animals which can be kept in the establishment; (e)  the capacity of the establishment expressed as the maximum number of dogs and cats which can be kept in the establishment. Amendment 108
    Proposal for a regulation
    Article 7 – paragraph 1 – subparagraph 1 a (new) Operators shall notify the competent authority of: (a)  any changes concerning the information referred to in paragraph 1; (b)  any cessation of activity and also specifying a deadline by which the activity must be closed, which should be no later than one month after the cessation, and also providing information on the fate of the animals; Without prejudice to any additional information required under this Article, operators are not required to notify again the information already submitted in accordance with point (b) of Article 84(1) of Regulation (EU) 2016/429. The competent authority shall maintain a register of establishments and may use for this purpose the register provided for in point (a) of Article 101(1) of Regulation (EU) 2016/429. Amendment 109
    Proposal for a regulation
    Article 7 a (new) Article 7a Approval of breeding establishments 1.  Operators of breeding establishments shall only place dogs or cats on the market after approval of their establishment by the competent authority. 2.  The competent authority shall perform on-site inspections to verify that the establishment meets the requirements of this Regulation. Member States may allow such inspections to be carried out remotely provided that the means of distance communication used provide sufficient evidence for the competent authority to perform reliable inspections. The competent authority shall only grant a certificate of approval to a breeding establishment that meets the requirements of this Regulation. 3.  The competent authorities shall maintain a list of the approved breeding establishments and make it publicly available. Amendment 110
    Proposal for a regulation
    Article 8 – paragraph 1 1.  When operators and natural or legal persons responsible for shelters place on the market or supply dogs or cats for purposes of keeping them as pet animals, they shall provide to the acquirer of pet the information necessary to enable him or her to ensure the welfare of the animal, including information on responsible ownership. 1.  Operators shall provide to the acquirer of a dog or cat written information necessary to enable him or her to ensure the welfare of the dog or cat including information on responsible ownership and on the specific needs of the dog or cat in terms of feeding, caring, health, housing and behavioural needs, as well as information on its health, including vaccination status. Amendment 111
    Proposal for a regulation
    Article 8 – paragraph 2 – subparagraph 1 2.  When the supplying of dogs and cats is advertised via online means, the listing shall display, in clearly visible and bold characters, the following warning: 2.  When operators and the natural or legal persons advertise the placing on the market of dogs and cats, via online platforms at least the following warning shall be displayed, in clearly visible and bold characters: Amendment 288
    Proposal for a regulation
    Article 8 – paragraph 2 2.  When the supplying of dogs and cats is advertised via online means, the listing shall display, in clearly visible and bold characters, the following warning: 2.  When the supplying of dogs and cats is advertised via online means, the listing shall display, in clearly visible and bold characters, the following warning: “An animal is not a toy. Buying or adopting an animal is a life-changing decision. As an animal owner, you are obliged to ensure that all the needs for its health and well-being are met at all times.” “An animal is not a toy. Buying or adopting an animal is a life-changing decision. As an animal owner, you are obliged to ensure its health and well-being needs are met at all times. Taking care of an animal requires financial resources. It is forbidden to abandon the animal once it is in your care.” Amendment 113
    Proposal for a regulation
    Article 9 – paragraph 1 – introductory part 1.  Animal caretakers shall have the following competences as regards the dogs and cats they are handling: 1.  Animal caretakers, with the exception of supervised volunteers and interns, shall have the following competences as regards the dogs and cats they are handling: Amendment 114
    Proposal for a regulation
    Article 9 – paragraph 1 – point b (b)  ability to recognise their expressions including any sign of suffering and to identify the appropriate mitigating measures to be taken in such cases; (b)  ability to recognise their expressions including any sign of suffering and to identify and take the appropriate mitigating measures to be taken in such cases; Amendment 115
    Proposal for a regulation
    Article 9 – paragraph 1 – point c (c)  ability to apply good animal management practices, to use and maintain the equipment used for the species under their care and to minimize any risks to the welfare of the animals; (c)  ability to apply good animal management practices, to use and maintain the equipment used for the species under their care and to minimize any risks to the welfare of the animals, preventing suffering; Amendment 116
    Proposal for a regulation
    Article 10 – title Animal welfare visits Advisory welfare visits Amendment 117
    Proposal for a regulation
    Article 10 – paragraph 1 – introductory part 1.  Operators and natural or legal persons responsible for shelters shall: 1.  Operators shall: Amendment 277
    Proposal for a regulation
    Article 10 – paragraph 1 – point a (a)  ensure that the establishments under their responsibility receive, at least once a year, a visit by a veterinarian, for the purpose of advising the operator or the natural or legal person responsible for the shelter on measures to address any risk factor for animal welfare; (a)  ensure that by … [1 year after the date of application of this Regulation] or within the first year from the date of the notification of a new establishment, the establishments under their responsibility receive, at least once a year, an unannounced visit by an official veterinarian, hired by the competent authority, for the purpose of identifying and assessing any risk factor for animal welfare, advising the operator or the natural or legal person responsible for the shelter on measures to address risks for animal welfare, health and the environment and, if the findings indicate severe risk factors, a report to the competent authority in accordance with Regulation (EU) 2017/625 and a follow-up visit within two months; Amendment 119
    Proposal for a regulation
    Article 10 – paragraph 1 – point b (b)  record the findings of the visit of the veterinarian referred to in point (a) and their follow up actions and keep those records for at least 6 years, making them available to the competent authorities upon request. (b)  keep the records of the findings of the visit of the veterinarian referred to in point (a) and of their follow up actions and keep those records for at least 5 years, from the day of the visit, and shall make them available to the competent authorities and visiting veterinarian upon request. Amendment 120
    Proposal for a regulation
    Article 10 – paragraph 2 2.  The Commission is empowered to adopt delegated acts in accordance with Article 23 supplementing this Article to lay down minimum criteria to be assessed during animal welfare visits. 2.  By [24 months from the date of entry into force of this Regulation] the Commission is empowered to adopt delegated acts in accordance with Article 23 supplementing this Article to lay down minimum criteria to identify and assess the risk factors by the veterinarian during the advisory welfare visits, including on follow-up actions. Amendment 121
    Proposal for a regulation
    Article 11 – paragraph 1 1.  Operators and natural or legal persons responsible for shelters shall ensure that dogs and cats are fed in accordance with the requirements laid down in point 1 of Annex I and may, based on the written advice of a veterinarian or an animal nutrition expert, adjust the feeding frequencies provided for in point 1 of Annex I. 1.  Operators shall ensure that dogs or cats are fed in accordance with the requirements laid down in point 1 of Annex I. Amendment 122
    Proposal for a regulation
    Article 11 – paragraph 2 – introductory part 2.  Operators and natural or legal persons responsible for shelters shall ensure that dogs and cats are adequately fed and hydrated by supplying: 2.  Operators shall ensure that dogs or cats are adequately fed and hydrated by supplying: Amendment 123
    Proposal for a regulation
    Article 11 – paragraph 2 – point a (a)  potable water, ad libitum; (a)  clean and fresh water, ad libitum; Amendment 124
    Proposal for a regulation
    Article 11 – paragraph 2 – point b (b)  feed in sufficient quantity and quality to meet the physiological, nutritional and metabolic needs and satiety of the dogs and cats, as part of a diet adapted to the age, breed, category, activity level, and health status of the dogs and cats; (b)  feed in sufficient quantity and quality to meet the physiological, nutritional and metabolic needs and satiety of the dogs and cats, as part of a diet adapted to the age, breed, category, activity level, and health status of the dogs and cats or cats, with the overall objective of achieving and maintaining good health; Amendment 125
    Proposal for a regulation
    Article 11 – paragraph 3 – introductory part 3.  Operators and natural or legal persons responsible for shelters shall ensure that feeding and drinking facilities are constructed and installed in such a way as to: 3.  Operators and caretakers shall ensure that feeding and drinking facilities are kept clean and constructed and installed in such a way as to: Amendment 126
    Proposal for a regulation
    Article 11 – paragraph 3 – point a (a)  provide equal access to all dogs and cats, thus minimizing competition between them, avoiding agonistic behaviour, in particular where dogs and cats do not have ad libitum access to feed; (a)  provide equal access to all dogs and cats; Amendment 127
    Proposal for a regulation
    Article 11 – paragraph 3 a (new) 3a.  Where advised in writing by a veterinarian to do so, the operators may adjust the feeding and watering frequencies. The operators shall keep a record of the advice for its entire duration as advised by the veterinarian. Amendment 128
    Proposal for a regulation
    Article 12 – paragraph 1 1.  Operators shall ensure that dogs and cats are provided with housing in accordance with point 2 of Annex I. 1.  Except of natural or legal person responsible for shelters, operators shall ensure that dogs and cats are provided with housing in accordance with point 2 of Annex I. Amendment 129
    Proposal for a regulation
    Article 12 – paragraph 2 – introductory part 2.  Operators and natural or legal persons responsible for shelters shall ensure that: 2.  Operators shall ensure that: Amendment 130
    Proposal for a regulation
    Article 12 – paragraph 2 – point c (c)  where animals are kept in breeding establishments or pet shops, air circulation, dust levels, temperature, relative air humidity and gas concentrations are kept within limits which are not harmful to dogs and cats and that ventilation is sufficient to avoid overheating and, where necessary, in combination with heating systems, to remove excessive moisture; (c)  in breeding establishments and selling establishments where dogs and cats are kept indoors, temperature, relative air humidity and gas concentrations are not harmful to dogs or cats and that ventilation is sufficient to avoid overheating; Amendment 131
    Proposal for a regulation
    Article 12 – paragraph 2 – point d (d)  dogs and cats have enough space to be able to move around freely and to express species-specific behaviour according to their needs, with sufficient space for enrichment material and structures, a possibility for animals to socialise and withdraw, and clean resting places; (d)  dogs and cats have enough space to be able to move around freely and to express species-specific behaviour according to their needs; Amendment 132
    Proposal for a regulation
    Article 12 – paragraph 3 – subparagraph 1 Keeping dogs or cats in containers shall be prohibited. Operators shall not keep dogs or cats in containers. Amendment 289
    Proposal for a regulation
    Article 12 – paragraph 3 – subparagraph 1 a (new) Keeping or selling dogs or cats in pet shops shall be prohibited. Amendment 133
    Proposal for a regulation
    Article 12 – paragraph 3 – subparagraph 2 Containers may only be used for the transport and temporary isolation of individual dogs and cats provided that stress due to extreme temperatures is avoided. By way of derogation, containers may only be used for the transport, short term isolation of individual dogs or cats and during the participation in shows, exhibitions and competitions, for puppies or kittens with reduced thermoregulation capacity or puppies or kittens together with their mothers, provided that stress is minimised and suffering is avoided and the dogs and cats are able to stand and lie down in a natural position. Amendment 134
    Proposal for a regulation
    Article 12 – paragraph 4 4.  Keeping dogs exclusively indoors shall be prohibited. Dogs kept indoors shall have daily access to an outdoor area that allows exercise and socialisation. In addition, when dogs are kept in kennels, operators shall design and construct individual enclosures to allow dogs to have free access to a confined outdoor space and an indoor space or an individual hut. 4.  Keeping dogs exclusively indoors shall be prohibited. Dogs kept indoors shall have daily access to an outdoor area that allows exercise, exploration and socialisation. In addition, when dogs are kept in kennels, operators shall design and construct individual enclosures to allow dogs to have free access to a confined outdoor space and an indoor space or an individual hut. Amendment 135
    Proposal for a regulation
    Article 12 – paragraph 6 a (new) 6a.  Operators of breeding and selling establishments shall use, where necessary, heating or cooling systems to maintain good air quality, an appropriate temperature in indoor enclosures at their establishments, and remove excessive moisture. Amendment 136
    Proposal for a regulation
    Article 12 – paragraph 7 7.  Operators shall ensure that dogs and cats have access to natural light at all times. Where needed, due to the climatic conditions and geographic position of a Member State, operators shall provide artificial lighting. 7.  Operators shall ensure that dogs or cats are exposed to light, and are able to stay in the dark for sufficient and uninterrupted periods in order to maintain a normal circadian rhythm. For the purposes of the first subparagraph, ‘light’ means natural light, complemented, where needed, due to the climatic conditions and geographic position of a Member State, by artificial light. Amendment 137
    Proposal for a regulation
    Article 12 – paragraph 8 8.  This Article applies from [5 years from the date of entry into force of this Regulation]. deleted Amendment 138
    Proposal for a regulation
    Article 12 – paragraph 8 a (new) 8a.  Paragraph 4 shall not apply to breeding establishments where livestock guardian dogs are kept during the periods when such dogs are being trained for herding purposes. Amendment 139
    Proposal for a regulation
    Article 13 – paragraph 1 1.  Operators shall ensure that measures are taken to safeguard the health of dogs and cats in accordance with point 3 of Annex 1. deleted Amendment 140
    Proposal for a regulation
    Article 13 – paragraph 2 – introductory part 2.  Operators and natural or legal persons responsible for shelters shall ensure that: 2.  Operators and caretakers shall ensure that: Amendment 141
    Proposal for a regulation
    Article 13 – paragraph 2 – point a (a)  dogs and cats under their responsibility are inspected by animal caretakers at least once a day; (a)  dogs or cats under their responsibility are inspected by animal caretakers at least once a day and vulnerable dogs and cats, such as newborns, ill or injured dogs and cats, and peri-partum bitches and queens, are inspected more frequently; Amendment 142
    Proposal for a regulation
    Article 13 – paragraph 2 – point b (b)  dogs or cats with signs of disease, sickness, injury or otherwise compromised welfare are transferred, where required, without undue delay to a separate area, are treated by a veterinarian, where appropriate, and kept there until they are fully recovered, or alternatively euthanised without undue delay; (b)  dogs or cats with signs of disease, sickness, injury or otherwise compromised welfare are transferred, where required, without undue delay to a separate area, are treated by a veterinarian, where appropriate, and kept there until they are fully recovered; Amendment 143
    Proposal for a regulation
    Article 13 – paragraph 2 – point c (c)  the euthanasia of a dog or a cat is only performed by a veterinarian. (c)  where, in cases referred to in point (b), recovery is not achievable and the dogs or cats experience severe pain or suffering that cannot be alleviated and keeping them alive is contrary to the rules of their well-being euthanasia may be only carried out by a veterinarian and with the prior consent of the operator Amendment 144
    Proposal for a regulation
    Article 13 – paragraph 2 – point d (d)  measures including veterinary medication are in place to prevent and control external and internal parasites, including preventive veterinary treatments to prevent common diseases to which dogs or cats are likely to be exposed with due regard to the epidemiological situation; (d)  measures are in place to prevent and control external and internal parasites, including preventive veterinary treatments such as vaccination, to prevent common diseases to which dogs or cats are likely to be exposed with due regard to the epidemiological situation; Amendment 145
    Proposal for a regulation
    Article 13 – paragraph 2 – point e (e)  enrichment materials do not present any risk of injury or biological or chemical contamination or any other health risk. (e)  enrichment materials do not present any risk of biological or chemical contamination. Amendment 146
    Proposal for a regulation
    Article 13 – paragraph 2 – point e a (new) (ea)  if available, relevant health related information shall be provided to the acquirer of a dog or a cat, including information on vaccination, allergies, health conditions and on responsible ownership in accordance with Article 8(1). Point (a) shall not apply to breeding establishments where livestock guardian dogs are kept during the periods when such dogs are used for herding or training purposes. Amendment 147
    Proposal for a regulation
    Article 13 – paragraph 2 a (new) 2a.   The euthanasia of a dog or a cat in animal shelters as a population management solution is prohibited. Amendment 148
    Proposal for a regulation
    Article 13 – paragraph 2 – point e b (new) (eb)   health care for animals is aligned with a ‘One Health’ approach, such as the prudent use of antibiotics to avoid anti-microbial resistance (AMR). Amendment 149
    Proposal for a regulation
    Article 13 – paragraph 3 – subparagraph 1 – introductory part Operators shall ensure that: Operators responsible for breeding establishments and their caretakers shall ensure that: Amendment 150
    Proposal for a regulation
    Article 13 – paragraph 3 – subparagraph 1 – point -a (new) (-a)  measures are taken to safeguard the health of dogs or cats in accordance with point 3 of Annex I; Amendment 151
    Proposal for a regulation
    Article 13 – paragraph 3 – subparagraph 1 – point a (a)  bitches and queens are only bred if they have a minimum age in accordance with Annex I points 3.1 and 3.2, their skeletal growth is completed, and they are free from disease or physical conditions which could negatively impact their pregnancy and welfare; (a)  bitches or queens are only bred if they have a minimum age in accordance with point 3 of Annex I, their skeletal growth is completed, and they have no diagnosed disease, clinical sign of diseases or physical conditions which could negatively impact their pregnancy and welfare; Amendment 152
    Proposal for a regulation
    Article 13 – paragraph 3 – subparagraph 1 – point b (b)  litter-giving pregnancies of bitches and queens follows a maximum frequency; (b)  litter-giving pregnancies of bitches or queens follows a maximum frequency in accordance with point 3 of Annex I; ; Amendment 153
    Proposal for a regulation
    Article 13 – paragraph 3 – subparagraph 1 – point d (d)  any bitch aged 8 years or more and any queen aged 6 years or more shall, before being used for breeding, undergo a physical examination by a veterinarian, to confirm in writing that her pregnancy will not pose any risk to her welfare, including her health. deleted Amendment 154
    Proposal for a regulation
    Article 13 – paragraph 3 – subparagraph 1 – point e (e)  adult female dogs and cats which are no longer used for reproduction, including as a result of the provisions of this Regulation, are not killed or abandoned. Operators shall continue to ensure the welfare of those animals in accordance with Regulation. (e)  dogs and cats which are no longer used for reproduction, including as a result of the provisions of this Regulation, are either kept or sold, donated or rehomed, not killed or abandoned. Amendment 155
    Proposal for a regulation
    Article 13 – paragraph 3 – subparagraph 2 The operator shall keep the written confirmation referred to in point (d) for a period of at least 3 years after the death of the bitch or the queen. deleted Amendment 156
    Proposal for a regulation
    Article 13 – paragraph 3 – subparagraph 2 a (new) When operators and natural or legal persons responsible for shelters possess results of health tests of a dog or a cat or genetic reports and diagnoses of sire or dam of the pet animal in question, they shall share this information with the animal´s acquirer. Amendment 157
    Proposal for a regulation
    Article 13 – paragraph 4 4.  This Article shall apply from [5 years from the date of entry into force of this Regulation]. deleted Amendment 158
    Proposal for a regulation
    Article 14 – paragraph 1 1.  Operators and natural or legal persons responsible for shelters shall ensure that measures are taken to meet the behavioural needs of cats and dogs in accordance with point 4 of Annex I. 1.  Operators shall ensure that measures are taken to meet the behavioural needs of cats or dogs in accordance with point 4 of Annex I. Amendment 159
    Proposal for a regulation
    Article 14 – paragraph 2 – introductory part 2.  Keeping dogs and cats in areas restraining their natural movements shall be prohibited, except for performing the following procedures or treatments: 2.  Keeping dogs and cats in areas restraining their natural movements shall be prohibited, except in case of Article 12(3), second subparagraph, and for performing the following procedures or treatments: Amendment 160
    Proposal for a regulation
    Article 14 – paragraph 2 – point a (a)  physical examinations, including identification of the animals; (a)  physical examinations; Amendment 161
    Proposal for a regulation
    Article 14 – paragraph 2 – point b (b)  marking animals for identification purposes; (b)  individual identification of dogs and cats and reading the identification information; Amendment 164
    Proposal for a regulation
    Article 14 – paragraph 3 3.  Tethering within the premises of the establishment for more than 1 hour shall be prohibited, except for the duration of a medical treatment. 3.  Tethering shall be prohibited, except for the duration of a medical treatment. Amendment 165
    Proposal for a regulation
    Article 14 – paragraph 5 a (new) 5a.  Operators shall ensure that enrichment is provided and accessible to all dogs or cats, creating a stimulating environment, enabling species-specific behaviour and reducing their frustration. Amendment 166
    Proposal for a regulation
    Article 14 – paragraph 5 b (new) 5b.  Member States may grant derogations from paragraph 3 for dogs intended for use in military, police and customs services that are kept in breeding or selling establishments. Amendment 167
    Proposal for a regulation
    Article 15 – paragraph 1 1.  Mutilations, including ear cropping, tail docking, partial or complete digit amputation, and resection of vocal cords or folds, shall be prohibited unless they are performed due to a medical indication with the sole purpose of improving the health of dogs and cats. In such case, the procedure shall only be performed by a veterinarian under anaesthesia and prolonged analgesia. 1.  Mutilations, including ear cropping, tail docking, claw removal or other partial or complete digit amputation, and resection of vocal cords or folds, shall be prohibited unless they are performed upon medical indication, which may include prophylactic, diagnostic, and/or treatment reasons, with the sole purpose of , preserving, improving the health of dogs or cats or preventing injury. In such case, the procedure shall only be performed by a veterinarian under anaesthesia and prolonged analgesia. Amendment 168
    Proposal for a regulation
    Article 15 – paragraph 1 a (new) 1a.  The medical indication for the mutilation and details of procedure to be carried out, shall be documented by a veterinarian. This document shall be retained by the operator until the dog or cat, along with this document, are transferred to another establishment or owner. The operator of the establishment responsible for the dog or cat when the mutilation was performed by the veterinarian shall retain a copy of the document for three years. By way of derogation, Member States may allow ear cropping by notching or tipping cat ears in the context of marking stray cats when neutered under trap-neuter programmes. Amendment 169
    Proposal for a regulation
    Article 15 – paragraph 2 2.  Male and female neutering shall be permitted only if performed by a veterinarian under anaesthesia and prolonged analgesia. 2.  Operators shall ensure that neutering is only performed under anesthesia and prolongued analgesia by a veterinarian. Veterinarians may consider non-surgical sterilisation to neutering, whenever appropriate. Amendment 170
    Proposal for a regulation
    Article 15 – paragraph 3 – introductory part 3.  The following handling practices shall be prohibited: 3.  The following handling practices that cause pain or suffering shall be prohibited: Amendment 171
    Proposal for a regulation
    Article 15 – paragraph 3 – point d (d)  prolonged use of muzzles, unless required for health or welfare reasons, in which case the duration shall be limited to the minimum period necessary. (d)  prolonged using of muzzles, unless required for health or welfare reasons, in which case the duration shall be limited to the minimum period necessary. Amendment 172
    Proposal for a regulation
    Article 15 – paragraph 3 – point e (e)  lifting dogs or cats by the limbs, the head, the tail and the hair. (e)  lifting dogs or cats by the limbs, the head, the tail, ears, skin or the hair. Amendment 173
    Proposal for a regulation
    Article 15 – paragraph 3 – point e a (new) (ea)  using prong collars; Amendment 174
    Proposal for a regulation
    Article 15 – paragraph 3 – point e b (new) (eb)  using choke collars without safety top; Amendment 175
    Proposal for a regulation
    Article 15 – paragraph 3 a (new) 3a.  Member States may grant derogations from paragraph 3 for dogs intended for use in military, police or customs services. Amendment 176
    Proposal for a regulation
    Article 15 a (new) Article 15a Aesthetic shows, exhibitions and competitions 1.  Operators of breeding or selling establishments shall not use in aesthetic shows, exhibitions and competitions of dogs and cats, dogs or cats with excessive conformational traits or dogs or cats which have been mutilated in such a way that results in an alteration of physical characteristics. 2.  Organisers of aesthetic shows, exhibitions and competitions of dogs and cats shall exclude from such shows, exhibitions and competitions dogs and cats which have excessive conformational traits or dogs or cats which have been mutilated in such a way that results in an alteration of physical characteristics. Amendment 177
    Proposal for a regulation
    Article 17 – paragraph 1 1.  From [3 years from the date of entry into force], all dogs and cats kept in establishments for supply in the Union, including adult dogs and cats kept in breeding establishments, dogs and cats kept in shelters, and dogs and cats supplied by natural persons, shall be marked for identification by means of a subcutaneous transponder containing a microchip, in accordance with Annex II. Operators of establishments shall ensure that dogs and cats born in their establishments are marked for identification by the date of their supply in the Union or at the latest within 3 months after the birth of the animal. The implantation of the transponder shall be performed by a veterinarian or under the responsibility of a veterinarian. 1.  All dogs and cats kept in establishments and all dogs and cats placed on the market shall be individually identified by means of a subcutaneous transponder containing a microchip, in accordance with Annex II. The implantation of the transponder shall be performed by a veterinarian or under the responsibility of a veterinarian. Where a veterinarian considers that the implantation of a microchip could significantly compromise the dog’s or cat’s health, he/she may delay the microchip implantation temporarily until the animal’s health concerns can be suitably addressed. In case a dog or a cat is experiencing significant adverse reactions after the implantation of the microchip, the veterinary shall take all the necessary actions to ensure the dog’s or cat’s health, including removal of the microchip. Amendment 178
    Proposal for a regulation
    Article 17 – paragraph 1 a (new) 1a.  Operators of establishments shall ensure that dogs and cats born in their establishments are individually identified within 3 months after their birth and in any event before the date of their placing on the market. Amendment 179
    Proposal for a regulation
    Article 17 – paragraph 1 b (new) 1b.  Operators of selling establishments, shelters, and those responsible for unwanted, abandoned, stray, lost or confiscated dogs and cats that enter their establishments or come under their responsibility shall ensure that dogs and cats are individually identified within 30 days after their arrival at the establishment and in any event before the date of their placing on the market. Amendment 180
    Proposal for a regulation
    Article 17 – paragraph 1 c (new) 1c.  Natural or legal persons, other than operators, placing dogs or cats on the market shall ensure that they are individually identified before the date of their placing on the market. Amendment 181
    Proposal for a regulation
    Article 17 – paragraph 1 d (new) 1d.  Dogs and cats which have been individually identified by means of an injectable transponder containing a microchip, in accordance with Union or national law before [the date of application of this Regulation], shall be considered compliant with the requirements in this paragraph, provided that the microchip is readable. Amendment 313
    Proposal for a regulation
    Article 17 – paragraph 1 e (new) 1e.   From … [5 years from the date of entry into force of this Regulation], all dogs kept shall be individually identified in accordance with paragraph 1. From … [10 years from the date of entry into force of this Regulation], all cats kept shall be individually identified in accordance with paragraph 1. Amendment 182
    Proposal for a regulation
    Article 17 – paragraph 2 2.  From [3 years from the date of entry into force], dogs and cats identified in accordance with paragraph 1 shall be registered by the veterinarian, or an assistant under the responsibility of the veterinarian, in a national database referred to in Article 19. For dogs and cats kept in breeding establishments, the registration shall be made in the name of the owner of the breeding establishment responsible for the dog or the cat. For dogs and cats kept in shelters , the registration shall be made in the name of the person responsible of the shelter. For natural persons intending to supply a dog or a cat in the Union, the registration shall be made in the name of that person. Any subsequent owner of, or responsible for, the dog or the cat, shall ensure that the change of ownership or responsibility is recorded in the database referred to in Article 19. 2.  Within two working days after their identification, in accordance with paragraph 1, the dogs and cats shall be registered by the veterinarian, in a national database referred to in Article 19. Member States may allow the registration by other persons than veterinarians, provided that they have measures in place to ensure the accuracy of information inserted in the database. For dogs and cats kept in establishments, the registration shall be made in the name of the operator of the establishment responsible for the dog or the cat. For natural persons placing a dog or a cat on the market, the registration shall be made in the name of that person. In case of transfer of ownership or responsibility, the natural or legal person placing, the dog or the cat on the market, shall ensure that any change of ownership or responsibility is recorded in the database referred to in Article 19, within two weeks from the date of change of ownership or responsibility, in accordance with the conditions laid down by the Member State responsible. Amendment 183
    Proposal for a regulation
    Article 17 – paragraph 2 a (new) 2a.  In the case of a death of a dog or a cat kept in an establishment, the operator shall ensure that the death is recorded in the database referred to in Article 19, in accordance with the conditions laid down by the Member State responsible for that database. Amendment 184
    Proposal for a regulation
    Article 17 – paragraph 2 b (new) 2b.  Member States may grant derogations from paragraph 2 and 2a for military, police and customs dogs that are kept in establishments. Amendment 185
    Proposal for a regulation
    Article 17 – paragraph 3 – subparagraph 1 – introductory part From [3 years from the date of entry into force], before supplying a dog or a cat in the Union, the supplier shall provide to the acquirer of the animal: Before placing a dog or a cat on the market the operators or natural or legal persons placing the dog or cat on the market shall provide to the acquirer of the animal: Amendment 186
    Proposal for a regulation
    Article 17 – paragraph 3 – subparagraph 1 – point a (a)  proof of the identification and registration of the animal in compliance with paragraphs 1 and 2; (a)  proof of the identification and registration of dog or cat in compliance with paragraphs 1 and 2 and a weblink to the system referred to in paragraph 6; Amendment 187
    Proposal for a regulation
    Article 17 – paragraph 3 – subparagraph 2 Acquirers shall be able to verify the authenticity of the identification and registration of animals supplied through the system referred to in paragraph 7. Acquirers shall be able to verify the authenticity of the identification and registration of dogs or cats placed on the market through the system referred to in paragraph 7. Amendment 188
    Proposal for a regulation
    Article 17 – paragraph 4 – subparagraph 1 From [5 years from the date of entry into force], providers of online platforms shall ensure that their online interface is designed and organised in such a way that allows the suppliers of dogs and cats to comply with their obligations under paragraph 3, in line with Article 31 of Regulation (EU) 2022/2065, and shall inform acquirers, in a visible manner, of the possibility to verify the identification and registration of the animal through a weblink to the system referred to in paragraph 6. Providers of online platforms shall ensure that their online interface is designed and organised in such a way that facilitates the operators or other natural or legal persons placing dogs or cats on the market to comply with their obligations under paragraph 3, and Article 8 paragraph 2 in line with Article 31 of Regulation (EU) 2022/2065, and shall inform acquirers, in a visible manner, of the possibility to verify the identification and registration of the dog or cat through a weblink to the system referred to in paragraph 6. Amendment 189
    Proposal for a regulation
    Article 17 – paragraph 4 – subparagraph 2 The supplier of dogs and cats shall be the sole responsible for the accuracy of the information provided through the interface of the online platform. Nothing in this paragraph shall be construed as imposing a general monitoring obligation on the provider of the online platform within the meaning of Article 8 of Regulation (EU) 2022/2065. The natural or legal person placing dogs or cats on the market shall be the solely responsible for the accuracy of the information provided through the interface of the online platform. Nothing in this paragraph shall be construed as imposing a general monitoring obligation on the provider of the online platform within the meaning of Article 8 of Regulation (EU) 2022/2065. Amendment 190
    Proposal for a regulation
    Article 17 – paragraph 5 5.  The Commission shall adopt implementing acts specifying the information to be provided by suppliers as proof of identification and registration of the animal in accordance with paragraph 3(a), both in cases where the dogs and cats are offered through online platforms and by other means. Those implementing acts shall be adopted in accordance with the examination procedure referred to in Article 24. deleted Amendment 191
    Proposal for a regulation
    Article 17 – paragraph 6 – introductory part 6.  From [3 years from the date of entry into force], the Commission shall ensure that a system performing automated checks of the authenticity of the identification and registration of dogs or cats supplied, using the database referred to in Article 19, is publicly available free of charge . The Commission may entrust the development, maintenance and operation of this system to an independent entity. The system shall meet the following criteria: 6.  The Commission shall ensure that an online system performing automated checks of the authenticity of the identification and registration of dogs or cats placed on the market, using the database referred to in Article 19, is publicly available free of charge . The Commission may entrust the development, maintenance and operation of this system to an independent entity following a public selection process, pursuant to the relevant provisions of Title VII of Regulation (EU, Euratom) 2018/1046. The system shall meet the following criteria: Amendment 192
    Proposal for a regulation
    Article 17 – paragraph 7 – subparagraph 1 – introductory part By the [3 years from the date of entry into force], the Commission shall adopt implementing acts specifying the following aspects of the system referred to in paragraph 6: The Commission shall adopt implementing acts laying down: Amendment 193
    Proposal for a regulation
    Article 17 – paragraph 7 – subparagraph 1 – point a (new) (a)  based on the content of the databases referred to in Article 19(3), point a, the exact information to be provided by natural and legal persons placing dogs or cats on the market, as proof of identification and registration of the dogs and cats in accordance with point (a) of paragraph 3, both in cases where the dogs and cats are offered through online platforms and by other means; Amendment 194
    Proposal for a regulation
    Article 17 – paragraph 7 – subparagraph 1 – point a – indent 2 a (new) –   the categories of personal data that are made available to the verifying person during the verification of the identification and registration, that shall be limited to those strictly needed to enable such verification. Amendment 195
    Proposal for a regulation
    Article 17 – paragraph 7 – – subparagraph 1 – point b (new) (b)  the following aspects of the system referred to in paragraph 6: —  the key functionalities of the system; Amendment 196
    Proposal for a regulation
    Article 17 – paragraph 7 – subparagraph 1 a(new) The implementing acts referred to in point (a) shall be adopted by [the date of application of this Regulation] and the implementing act referred to in point (b) shall be adopted by [3 years from date of entry into force of this Regulation] Amendment 197
    Proposal for a regulation
    Article 18 – paragraph 1 – point a a (new) (aa)   ensuring that veterinarians and other relevant professionals receive training on best practices in animal welfare, including on the detection and reporting of welfare violations including painful practices as set out in Article 15, in line with One Health principles. Amendment 198
    Proposal for a regulation
    Article 18 – paragraph 1 – point a b (new) (ab)   ensuring that operators, natural or legal persons responsible for shelters, foster homes and pounds, animal caretakers and veterinarians receive adequate and regular training and certificates for the completion of the training courses referred to in point (a); Amendment 199
    Proposal for a regulation
    Article 18 – paragraph 1 – point a c (new) (ac)  ensuring that shelter medicine courses, including those with a focus on herd health, are available for veterinarians; Amendment 200
    Proposal for a regulation
    Article 18 – paragraph 1 – point a d (new) (ad)   ensuring that trainers and handlers of dogs intended for military, police and customs services receive regular training within and preferably across Member States in order to improve their skills especially on operant conditioning and positive reinforcement, on behavioural science and welfare principles, and on stress management for both dogs and handlers; Amendment 201
    Proposal for a regulation
    Article 18 – paragraph 1 – point b a (new) (ba)   facilitating collaboration between competent authorities, veterinary associations, and educational institutions to develop and promote high-quality, long term science-based training programmes for animal caretakers and veterinary professionals, increasing the cooperation between relevant agencies and the synergies between the information campaigns. Amendment 202
    Proposal for a regulation
    Article 18 a (new) Article 18a National information campaigns on the protection of stray animals and legislation concerning the protection of stray animals 1.  Member States are encouraged to initiate and implement national information campaigns on current legislation concerning the protection and welfare of dogs and cats. These campaigns must be aimed both at animal owners and at the general public, in order to raise awareness about the legal obligations and best practices in caring for animals. 2.  Information campaigns may be conducted by the competent authorities in collaboration with animal protection organisations, veterinarians and other relevant entities. The information communicated shall include: (a)  the legal obligations of keepers of pet animals; (b)  the responsibilities and actions of local authorities in managing strays, as well as the actions that they are to take to prevent abandonment; (c)  the steps to be taken if a person finds a lost or abandoned animal, including contacting veterinary services, animal shelters or the local police; (d)  a statement of the importance of responsible adoption and neutering to reduce the stray animal population. 3.  Member States may provide national or regional funding for these campaigns and may encourage the participation of mass media and educational establishments with a view to disseminating the information further. 4.  The Commission shall encourage the exchange of best practices between Member States. Amendment 203
    Proposal for a regulation
    Article 18 b (new) Article 18b Measures to prevent abandonment and promote the neutering of dogs and cats 1.  Member States shall be encouraged to adopt concrete measures to prevent the abandonment of dogs and cats, including through public education, by raising awareness about responsible ownership and through the effective enforcement of existing legislation. 2.  To reduce the number of strays, Member States shall be encouraged to identify and use national and private sources of funding for: (a)  free or subsidised neutering campaigns for stray dogs and cats and for pet animals belonging to low-income people or animal protection organisations; (b)  programmes for the registration and identification of pet animals, including by means of microchipping, to facilitate adoption and the return of lost animals to their owners and prevent abandonment; (c)  actions to raise awareness among and educate the population about the responsibility of keeping a pet animal and the negative effects of abandonment on animal welfare and on communities. 3.  Member States may work with non-governmental organisations, veterinary clinics and local authorities to implement the measures referred to in paragraphs 1 and 2 and for the purpose of facilitating access to neutering and identification programmes. Amendment 204
    Proposal for a regulation
    Article 19 – paragraph 1 1.  From [3 years from the date of entry into force of this Regulation], competent authorities shall establish and maintain a database for the registration of microchipped dogs and cats. 1.  The competent authorities shall establish and maintain databases for dogs and cats identified and registered in accordance with Article 17 and Article 21(4) Amendment 205
    Proposal for a regulation
    Article 19 – paragraph 2 2.  From [5 years from date of entry into force of this Regulation], Member States shall ensure that their databases as referred to in paragraph 1 are interoperable with the same databases of other Member States so that the identification of a dog or a cat can be authenticated and traced across the Union. 2.  Member States shall ensure that their databases as referred to in paragraph 1 comply with the requirements laid down by the implementing act referred to in point (b) of paragraph 3 to ensure their interoperability so that the identification of a dog or a cat can be authenticated and traced across the Union. Amendment 206
    Proposal for a regulation
    Article 19 – paragraph 2 a (new) 2a.  The Commission shall establish and maintain an index database containing the identification numbers of the microchips of the dogs and cats and the national databases where the identification details are stored, without accessing personal data. The Commission may entrust the development, maintenance and operation of this index database to an independent entity, following a public selection process, pursuant to the relevant provisions of [ Title VII of the Regulation (EU, Euratom) 2024/2509. Amendment 316
    Proposal for a regulation
    Article 19 – paragraph 2 b (new) 2b.   The Commission and the competent authorities of Member States shall co-operate to establish and maintain a publicly accessible database of animal shelter establishments across the Union, ensuring transparency and accountability in the adherence to animal welfare law. Amendment 207
    Proposal for a regulation
    Article 19 – paragraph 3 – subparagraph 1 – point b (b)  their interoperability between Member States; (b)  the interoperability between Member States databases and the index database; Amendment 208
    Proposal for a regulation
    Article 19 – paragraph 3 – subparagraph 1 – point f a (new) (fa)  The interconnection between the Member States databases referred to in paragraph 1 and any other relevant database, including the Information Management System for Official Controls (IMSOC). Amendment 209
    Proposal for a regulation
    Article 20 a (new) Article 20a National information campaigns concerning stray animal legislation and protection 1.  The Member States are encouraged, in collaboration with the competent authorities, to initiate and implement national information campaigns concerning existing legislation on the protection and welfare of dogs and cats. These campaigns should be targeted at both animal owners and the general public in order to raise awareness of legal obligations and good practices in relation to animal care. 2.  Information campaigns can be run by the competent authorities in collaboration with animal protection organisations, veterinarians and other relevant entities. The information provided must include: (a)  The legal obligations of pet owners; (b)  The responsibilities and actions of local authorities in managing stray animals, and actions to prevent abandonment; (c)  Recommended steps if a person finds a lost or abandoned animal, including contacting veterinary services, animal shelters or the local police; (d)  The importance of responsible adoption and neutering to reduce the population of stray animals. 3.  The Member States can provide national or regional funding for these campaigns and can encourage the mass media and educational institutions to participate with a view to better dissemination of information. 4.  The European Commission shall encourage the sharing of good practices between the Member States. Amendment 210
    Proposal for a regulation
    Article 20 b (new) Article 20b Measures to prevent abandonment and promote the neutering of dogs and cats 1.  The Member States are encouraged, in collaboration with the competent authorities, to adopt concrete measures to prevent abandonment of dogs and cats, including by educating the public, making owners responsible and enforcing existing legislation effectively. 2.  To reduce the number of stray animals, the Member States are encouraged to identify and use national and private financing sources for: (a)  Free or subsidised neutering campaigns for stray dogs and cats and pets of persons on low incomes or animal protection organisations; (b)  Programmes to register and identify pets, including by microchipping, to facilitate adoption and the return of lost animals to owners and to prevent abandonment; (c)  Actions to raise awareness and educate the public with regard to the responsibility of owning a pet and the adverse effects of abandonment on animal welfare and the community. 3.  The Member States can work together with non-governmental organisations, veterinary clinics and local authorities to implement these measures and facilitate public access to neutering and identification programmes. Amendment 211
    Proposal for a regulation
    Article 20 c (new) Article 20c Data protection 1.  The competent authorities of the Member States shall be controllers within the meaning of Regulation (EU) 2016/679 in relation to the processing of personal data collected under Article 7, Article 7a and Article 19(1) of this Regulation. The Commission shall be a controller within the meaning of Regulation (EU) 2018/1725 in relation to the processing of personal data collected under Article 17(6) and the second subparagraph of Article 21(4) of this Regulation. It shall be prohibited for any person having access to the personal data referred to in the first and second sub-paragraphs to divulge any personal data, the knowledge of which was acquired in the exercise of their duties or otherwise incidentally to such exercise. Member States and the Commission shall take all appropriate measures to address infringements of that prohibition. The personal data collected under the first and second sub-paragraphs shall not be used for other purposes than official control of the compliance with the welfare and traceability requirements under this regulation and detection of fraudulent practices with a view to the adoption of control measures. 2.  That personal data referred to in paragraph 1 of this Article shall be retained for the following periods: (a)  in the case of Article 7 and Article 7a, 10 years after the date of cessation of the activity of the establishment; (b)  in the case of Article 19(1), 20 years after the first registration of the dog or cat in the database referred to in that Article or 5 years after the recording of the death of the dog or cat in that database; (c)  in the case of the second subparagraph of Article 21(4a), 5 years after the date of pre-notification. Amendment 212
    Proposal for a regulation
    Article 21 – paragraph 1 – introductory part 1.  From [5 years from the date of entry into force of this Regulation], dogs and cats may only be entered into the Union for placing on the Union market if they have been kept in compliance with any of the following: 1.  Dogs and cats may only be entered into the Union for placing on the market provided that the following conditions are met: Amendment 213
    Proposal for a regulation
    Article 21 – paragraph 1 – point a (a)  Chapters II of this Regulation; (a)  they have been breed and kept in compliance with any of the following: Amendment 214
    Proposal for a regulation
    Article 21 – paragraph 1 – point a – point i (new) (i)  Chapter II of this Regulation; Amendment 215
    Proposal for a regulation
    Article 21 – paragraph 1 – point b (b)   conditions recognised by the Union to be equivalent to those set out by this Regulation; or (ii)  conditions recognised by the Union in accordance with Article 129 of Regulation (EU) 2017/625 to be equivalent to those set out by Chapter II of this Regulation; or Amendment 216
    Proposal for a regulation
    Article 21 – paragraph 1 – point c (c)  where applicable, requirements contained in a specific agreement between the Union and the exporting country (iii)  where applicable, requirements contained in a specific agreement between the Union and the exporting country. Amendment 217
    Proposal for a regulation
    Article 21 – paragraph 2 2.   From [5 years from date of entry into force of this Regulation], dogs and cats may only be entered into the Union for placing on the market or supply provided that they come from a third country or territory and an establishment listed in accordance with Articles 126 and 127 of Regulation (EU) 2017/625. (b)   they come from a third country or territory and an establishment listed in accordance with Articles 126 and 127 of Regulation (EU) 2017/625. Amendment 218
    Proposal for a regulation
    Article 21 – paragraph 3 3.   From [date of entry into force of this Regulation + 5 years], the official certificate accompanying dogs and cats entering into the Union from third countries and territories shall contain an attestation certifying compliance with paragraphs 1 and confirming that the dogs and cats originate from an establishment listed in accordance with paragraph 2. 2.  The official certificate referred to in Article 126(2)(c) of Regulation (EU) 2017/625 accompanying dogs and cats entering into the Union from third countries and territories to be placed on the Union market, shall contain an attestation certifying compliance with paragraph 1 of this Article. Amendment 219
    Proposal for a regulation
    Article 21 – paragraph 4 – subparagraph 1 4.  Without prejudice to Article 10(1)(a) of Regulation (EU) No 576/2013 and Article 74(1) of Regulation (EU) 2020/69211 , dogs and cats entering into the Union shall be identified with a microchip as referred to in Article 17(1) and allowing for traceability. 3.  Without prejudice to Article 10(1)(a) of Regulation (EU) No 576/2013 and Article 74(1) of Regulation (EU) 2020/69211 , dogs and cats entering into the Union to be placed on the Union market, shall be identified before their entry by a veterinarian with a microchip. compliant with Annex II . The importer shall ensure the registration of dogs and cats by a veterinarian into a national database, referred to in Article 19 within two working days after their entry into the Union. Member States may allow the registration by other persons than veterinarians, provided that they have measures in place to ensure the accuracy of information inserted in the database. __________________ __________________ 11 Commission Delegated Regulation (EU) 2020/692 of 30 January 2020 supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council as regards rules for entry into the Union, and the movement and handling after entry of consignments of certain animals, germinal products and products of animal origin, OJ L 174, 3.6.2020, p. 379. 11 Commission Delegated Regulation (EU) 2020/692 of 30 January 2020 supplementing Regulation (EU) 2016/429 of the European Parliament and of the Council as regards rules for entry into the Union, and the movement and handling after entry of consignments of certain animals, germinal products and products of animal origin, OJ L 174, 3.6.2020, p. 379. Amendment 306
    Proposal for a regulation
    Article 21 – paragraph 4 – subparagraph 2 In case the dogs or cats entering into the Union are not yet registered in a Member State database as referred to in Article 19(1), once they arrive at their place of destination, the owner or person responsible for the animal shall ensure their registration into one of the Member States databases within 48 hours of arrival. In case the dogs or cats entering into the Union are not yet registered in a Member State database as referred to in Article 19(1), they shall be registered in the database of the Member State of entry by a veterinarian at the Union border. The registration shall be made in the name of the owner or person responsible for the animal and it shall record the establishment of origin listed in accordance with paragraph 2. Member States may allow the registration by persons other than veterinarians, provided that they have measures in place to ensure the accuracy of information inserted in the database. Amendment 221
    Proposal for a regulation
    Article 21 – paragraph 4 a (new) 4a.  The entry of dogs and cats into the Union under a non-commercial movement, as defined in point 14 of Article 4 of Regulation (EU) 2016/429, shall be pre-notified by their owners into an online Union pet travellers’ database at least five working days before the crossing of the Union border, except in the following cases: (a)  dogs or cats entering into the Union directly from third countries listed in accordance with Article 13(1) of Regulation (EU) No 576/2013; (b)  dogs or cats registered in a Member State database referred to in Article 19(1). The owner shall pre-notify the identity of the dog or cat and where relevant the identity of the authorised person travelling with that dog or cat, the identification number of the microchip of the dog or cat, its main destination in the Union, and where relevant the planned date and place of exit from the Union. Where the dog or cat stays more than four months in the Union, the owner shall ensure its registration in the database of the Member State of residence within five working days after the expiry of that fourth month. The Commission shall establish and maintain the Union pet travellers’ database referred to in the second subparagraph, and may entrust the development, maintenance and operation of this database to an independent entity, following a public selection process, pursuant to the relevant provisions of Title VII of the Regulation (EU, Euratom) 2018/1046. Access to this database shall be restricted to Member States’ competent authorities. Amendment 222
    Proposal for a regulation
    Article 21 – paragraph 5 5.  The Commission is empowered, by means of implementing acts, to establish a procedure for the recognition by the Union of equivalent conditions under point paragraph 1 point (b). Those implementing acts shall be adopted in accordance with the examination procedure referred to in Article 24. deleted Amendment 223
    Proposal for a regulation
    Article 22 – paragraph 1 – introductory part The Commission is empowered to adopt delegated acts in accordance with Article 23 amending the Annexes to this Regulation to take into account of scientific and technical progress, including, when relevant, scientific opinions of EFSA, and of social, economic and environmental impacts, as regards: The Commission is empowered to adopt delegated acts in accordance with Article 23 amending the Annexes to this Regulation to take into account of scientific and technical progress, including, when relevant, scientific opinions of the European Food Safety Authority, and of social, economic, and environmental impacts, as regards: Amendment 224
    Proposal for a regulation
    Article 22 – paragraph 1 – point a (a)  feeding frequencies and weaning process; (a)  watering and feeding requirements and weaning process; Amendment 225
    Proposal for a regulation
    Article 22 – paragraph 1 – point c (c)  lighting parameters; (c)  lighting requirements; Amendment 226
    Proposal for a regulation
    Article 22 – paragraph 1 – point h (h)  minimum age of bitches and queens for onset of breeding; (h)  minimum and maximum age of bitches and queens for breeding; Amendment 227
    Proposal for a regulation
    Article 22 – paragraph 1 – point j (j)  requirements for transponders used to mark dogs and cats; (j)  requirements for transponders used to individually identify dogs and cats; Amendment 228
    Proposal for a regulation
    Article 23 – paragraph 2 2.  The power to adopt delegated acts referred to in Article 6(4), Article 10(2) and Article 22 shall be conferred on the Commission for an indeterminate period of time from [the date of entry into force of this Regulation]. 2.  The power to adopt delegated acts referred to in Article 6(2b), Article 6a(3) and Article 22 shall be conferred on the Commission for an indeterminate period of time from [the date of entry into force of this Regulation]. Amendment 229
    Proposal for a regulation
    Article 23 – paragraph 3 3.  The delegation of power referred to in Article 6(4), Article 10(2) and Article 22 may be revoked at any time by the European Parliament or by the Council. A decision to revoke shall put an end to the delegation of the power specified in that decision. It shall take effect the day following the publication of the decision in the Official Journal of the European Union or at a later date specified therein. It shall not affect the validity of any delegated acts already in force. 3.  The delegation of power referred to in Article 6(2b), Article 6a(3) and Article 22 may be revoked at any time by the European Parliament or by the Council. A decision to revoke shall put an end to the delegation of the power specified in that decision. It shall take effect the day following the publication of the decision in the Official Journal of the European Union or at a later date specified therein. It shall not affect the validity of any delegated acts already in force. Amendment 230
    Proposal for a regulation
    Article 23 – paragraph 6 6.  A delegated act adopted pursuant to Article 6(4), Article 10(2) and Article 22 shall enter into force only if no objection has been expressed either by the European Parliament or by the Council within a period of two months of notification of that act to the European Parliament and the Council or if, before the expiry of that period, the European Parliament and the Council have both informed the Commission that they will not object. That period shall be extended by two months at the initiative of the European Parliament or of the Council. 6.  A delegated act adopted pursuant to Article 6(2b), Article 6a(3) and Article 22 shall enter into force only if no objection has been expressed either by the European Parliament or by the Council within a period of two months of notification of that act to the European Parliament and the Council or if, before the expiry of that period, the European Parliament and the Council have both informed the Commission that they will not object. That period shall be extended by two months at the initiative of the European Parliament or of the Council. Amendment 231
    Proposal for a regulation
    Article 25 – paragraph 1 1.  This Regulation shall not prevent Member States from maintaining any stricter national rules aimed at a more extensive protection of the welfare of dogs and cats and in force at the time of entry into force of this Regulation, provided that those rules are not inconsistent with this Regulation and do not interfere with the proper functioning of the internal market. Before [the date of application of this Regulation], Member States shall inform the Commission about such national rules. The Commission shall bring them to the attention of the other Member States. 1.  This Regulation shall not prevent Member States from maintaining or adopting any stricter national rules aimed at a more extensive protection of the welfare of dogs and cats, and to their traceability, provided that those rules are not inconsistent with this Regulation and do not interfere with the proper functioning of the internal market. Member States shall inform the Commission about such national rules. The Commission shall bring them to the attention of the other Member States. Amendment 232
    Proposal for a regulation
    Article 25 – paragraph 2 2.  This Regulation shall not prevent Member States from adopting stricter national measures aimed at ensuring more extensive protection of the welfare of dogs and cats kept in establishments within the territory of a Member State on the following animal welfare issues: deleted (a)  housing conditions; (b)  mutilations; (c)  enrichment; (d)  selection and breeding programmes, including minimum and maximum age for breeding. Member States shall inform the Commission about such national rules before their adoption. The Commission shall bring them to the attention of the other Member States. Amendment 233
    Proposal for a regulation
    Article 25 – paragraph 3 3.  The measures referred to in paragraph 2 shall only be allowed provided that they are not inconsistent with this Regulation and do not interfere with the proper functioning of the internal market. deleted Amendment 234
    Proposal for a regulation
    Article 25 – paragraph 4 4.  Member States shall not prohibit or impede the placing on the market within their territory of dogs and cats kept in another Member State on the grounds that the dogs and cats concerned have not been kept in accordance with its stricter national rules on animal welfare. 4.  Member States that have stricter national rules referred to in paragraph 1 shall not prohibit or impede the placing on the market within their territory of dogs and cats kept in another Member State on the grounds that the dogs and cats concerned have not been kept in accordance with its stricter national rules on animal welfare. Amendment 235
    Proposal for a regulation
    Article 26 – paragraph 1 1.  On the basis of the reports received in accordance with Article 20 and additional relevant information, the Commission shall publish, by [7 years after the date of entry into force of this Regulation] and thereafter every 5 years, a monitoring report on the welfare of dogs and cats placed on the market in the Union. 1.  On the basis of the reports received in accordance with Article 20 and additional relevant information, the Commission shall publish, by [7 years after the date of entry into force of this Regulation] and thereafter every 5 years, a monitoring report on the welfare of dogs and cats placed on the market in the Union. The monitoring report shall assess the effectiveness, efficiency, relevance, coherence, socio-economic impact and EU added value of this Regulation in achieving its objectives. In particular, the Commission shall assess: Amendment 236
    Proposal for a regulation
    Article 26 – paragraph 1 – point a (new) (a)  the extent to which this Regulation has contributed to ensuring a high level of welfare for dogs and cats, improving traceability, reducing illegal trade, and addressing the problems associated with inhumane breeding practices, including so-called puppy and kitten mills; Amendment 237
    Proposal for a regulation
    Article 26 – paragraph 1 – point b (new) (b)  whether the scope of this Regulation remains fit for purpose, taking into account market developments, scientific and technological progress, and animal welfare considerations; and whether the current exceptions remain appropriate and sufficient in light of these developments; Amendment 238
    Proposal for a regulation
    Article 26 – paragraph 1 – point c (new) (c)  whether scientific and technological progress has occurred, including development of new means of identification, taking into account their technical reliability, cost-effectiveness and invasiveness for the animal; Amendment 239
    Proposal for a regulation
    Article 26 – paragraph 1 – point d (new) (d)  the impact of this Regulation on breeders, shelters, foster homes, and other operators, including the administrative burden and compliance costs; Amendment 240
    Proposal for a regulation
    Article 26 – paragraph 1 – point e (new) (e)  the level of enforcement and compliance achieved by Member States, and the effectiveness of the cooperation between competent authorities, including data exchange and traceability mechanisms, Amendment 241
    Proposal for a regulation
    Article 26 – paragraph 1 – point f (new) (f)  the feasibility, costs and benefits of introducing a digital passport for dogs and cats which could contain information on the identification, vaccination status and medical history of the animal. Amendment 242
    Proposal for a regulation
    Article 26 – paragraph 1 – point g (new) (g)  the feasibility, impact and proportionality of extending mandatory identification and registration to all dogs and cats, including those kept by private owners, Amendment 243
    Proposal for a regulation
    Article 26 – paragraph 1 a (new) 1a.  By … [2 years from the date of entry into force of this Regulation], the Commission shall assess the possibility of registering dogs and cats, in accordance with Article 21(3), upon their entry into the Union, and shall present a report on its main findings to the European Parliament, the Council, the European Economic and Social Committee and the Committee of the Regions. Amendment 244
    Proposal for a regulation
    Article 26 – paragraph 2 2.  By [15 years from the date of entry into force of this Regulation], the Commission shall carry out an evaluation of this Regulation, including an assessment of a possible maximum age for breeding of dogs and cats, and present a report on the main findings to the European Parliament, the Council, the European Economic and Social Committee, and the Committee of the Regions. 2.  By [12 years from the date of entry into force of this Regulation], the Commission shall carry out an evaluation of this Regulation, including an assessment of a possible maximum age for breeding of dogs and cats, and present a report on the main findings to the European Parliament, the Council, the European Economic and Social Committee, and the Committee of the Regions. Amendment 301
    Proposal for a regulation
    Article 26 – paragraph 2 a (new) 2a.   By … [5 years after the date of entry into force of this Regulation], the Commission shall: (a)  carry out an evaluation and a review of this Regulation, including an assessment of a possible maximum age for the breeding of dogs and cats; (b)  carry out an assessment of the situation of stray animals; (c)  establish a list of animal species allowed to be kept and placed on the market, where a prior impact assessment has shown its added value and feasibility; (d)  assess the potential extension of the scope of this Regulation to include other animals by amending this Regulation; (e)  assess the possibility of using alternative means of identification which are less invasive than the implantation of a transponder; and (f)  present a report on the main findings of points (a) to (e) to the European Parliament, the Council, the European Economic and Social Committee, and the Committee of the Regions. Amendment 245
    Proposal for a regulation
    Article 27 – paragraph 1 Member States shall lay down the rules on penalties applicable to infringements of this Regulation and shall take all measures necessary to ensure that they are implemented. The penalties provided for shall be effective, proportionate and dissuasive. Member States shall lay down the rules on penalties applicable to infringements of this Regulation, as well as those resulting from the abandonment of pets, and shall take all measures necessary to ensure that they are implemented. The penalties provided for shall be effective, proportionate and dissuasive. Amendment 246
    Proposal for a regulation
    Article 27 – paragraph 1 a (new) Member States shall ensure that the level of the financial penalties imposed for violations of this Regulation and of the rules referred to in Article 2(1), involving fraud or deception, reflects, in accordance with national law, at least the economic advantage for the operator, or, where appropriate, a percentage of the operator´s turnover and is high enough to have a deterrent effect. In cases where the infringements of the requirements of this Regulation are serious and repeated, Member States shall ensure that the penalties include a prohibition on working with and owning animals. Amendment 279
    Proposal for a regulation
    Article 27 – paragraph 2 a (new) Considering the administrative burden of animal shelters and organisations responsible for the management of populations of stray dogs and cats in addition to the existing economic constraints, Member States may explore the capabilities of streamlining resources recovered from infringements of this Regulation to support and cover the administrative and operational costs of shelters and organisations responsible for the management of stray populations of dogs or cats. Amendment 247
    Proposal for a regulation
    Article 28 – paragraph 2 It shall apply from [2 years from the date of entry into force of this Regulation], unless otherwise provided for in this Regulation. It shall apply from [2 years from the date of entry into force of this Regulation], except: (i)  Article 13 from 5 years from the date of entry into force of this Regulation; (ii)  Article 9(2) and Article 19(1) from 3 years from the date of entry into force of this Regulation; (iii)  Article 12, Article 17(4) and (6), Article 19(2) and (2a), and Article 21(1) to (4a) from 5 years from the date of entry into force of this Regulation; (iv)  Article 7a from 6 years from the date of entry into force of this Regulation; and (v)  Article 17(1) to (3) – in relation to dogs from 3 years from the date of entry into force of this Regulation – in relation to cats 7 years from the date of entry into force of this Regulation.. Amendment 248
    Proposal for a regulation
    Annex I – point 1 – introductory part 1.  Feeding 1.  Feeding and watering Amendment 249
    Proposal for a regulation
    Annex I – point 1 – point 1.1 – introductory part 1.1.  The operator shall implement the following feeding frequencies: 1.1.  Dogs and cats shall be fed at least twice per day. Puppies and kittens shall be fed more frequently. These requirements shall not apply to breeding establishments where livestock guardian dogs are kept during the periods when such dogs are used for herding purposes. Amendment 250
    Proposal for a regulation
    Annex I – point 1 – point 1.1 – point a (a)  adult cats and dogs shall be fed twice a day; deleted Amendment 252
    Proposal for a regulation
    Annex I – point 1 – point 1.1 – point c (c)  puppies under 8 weeks of age shall be fed at least 5 times a day; deleted Amendment 253
    Proposal for a regulation
    Annex I – point 1 – point 1.1 – point d (d)  kittens under 12 weeks of age shall be fed at least 4 times a day. deleted Amendment 254
    Proposal for a regulation
    Annex I – point 1 – point 1.2 1.2.  Every new-born puppy or kitten shall be fed with colostrum from their bitch or queen in the first two days of their lives. 1.2.  Each puppy or kitten shall be fed with colostrum during at least the first two days of its life and thereafter with milk from its mother or a lactating bitch or queen. If this is not possible, because is ill or is otherwise unable to feed her offspring or not sufficient, the puppy or kitten shall be fed with a milk replacer designed for puppies and kittens with such feeding frequency as instructed by the producer of the replacer or by a veterinarian. Amendment 255
    Proposal for a regulation
    Annex I – point 1 – point 1.3 1.3.  If the bitch or the queen is ill or is otherwise unable to feed her offspring, the operator shall provide milk from other bitches and queens at the same holding and supplementary milk formulas designed for puppies and kittens with the feeding frequency as instructed by the formula producer or a veterinarian, until weaning is completed. deleted Amendment 256
    Proposal for a regulation
    Annex I – point 1 – point 1.4 1.4.  The operator shall ensure that all unweaned puppies and kittens are getting enough milk to steadily gain bodyweight. 1.4.  All unweaned puppies and kittens shall be fed enough milk, milk replacer or a combination thereof to steadily gain bodyweight. Amendment 257
    Proposal for a regulation
    Annex I – point 2 – point 2.1 – paragraph 1 – point a (a)  10 to 26°C in the indoor areas where adult dogs are kept; deleted Amendment 258
    Proposal for a regulation
    Annex I – point 2 – point 2.1 – paragraph 1 – point b (b)  15 to 26°C in the indoor areas where adult cats are kept; deleted Amendment 259
    Proposal for a regulation
    Annex I – point 2 – point 2.2 – point 2.2.1 2.2.1.  Where applicable, artificial lighting shall be provided for a period at least equivalent to the period of natural light normally available between 9 a.m. and 5 p.m. 2.2.1.  Dogs and cats shall be exposed to light for at least 7 hours per day. Amendment 260
    Proposal for a regulation
    Annex I – point 2 – point 2.2 – point 2.2.2 2.2.2.  Artificial light shall be broad spectrum or full spectrum. 2.2.2.  Artificial light shall be broad spectrum or full spectrum with a frequency of at least 80 Hertz. Amendment 261
    Proposal for a regulation
    Annex I – point 2 – point 2.2 – point 2.2.3 2.2.3.  The illuminance shall be at least 50 lux at the height of an animal’s head. deleted Amendment 262
    Proposal for a regulation
    Annex I – point 2 – point 2.2 – point 2.2.4 2.2.4.  Animals shall have the possibility to stay in the dark for at least 8 hours per day. 2.2.4.  Dogs and cats shall have the possibility to be without artificial lights for at least 8 hours per day. Amendment 263
    Proposal for a regulation
    Annex I – point 2 – point 2.2 a (new) 2.2a.  Dogs shall have access to an outdoor area or shall be walked daily for a minimum of 1 hour per day in total, to allow exercise, exploration and socialisation Amendment 264
    Proposal for a regulation
    Annex I – point 2 – point 2.3 – point 2.3.3 2.3.3.  If enclosures are occupied by more than one dog or cat, operators must ensure by taking specific measures (e.g., separation panels) that these animals do not pose threat to each other due to aggressive behaviour. 2.3.3.  If enclosures are occupied by more than one dog or cat, operators must ensure by taking specific measures (e.g., separation panels) that these animals do not pose threat to each other due to aggressive behaviour. Member States may grant derogations from the minimum space allowances requirements set out in paragraph 2.3.1 for hunting dogs used to living in packs. Amendment 265
    Proposal for a regulation
    Annex I – point 3 – point 3.2 3.2.  Bitches shall only be bred if their age is at least 18 months; 3.2.  Bitches shall only be bred from their second oestrus; Amendment 266
    Proposal for a regulation
    Annex I – point 3 – point 3.3 3.3.  Operators shall allow for up to 3 litters per bitch or queen within a period of 2 years. 3.3.  A bitch or queen shall not deliver more than 3 litters within a period of 2 years. Amendment 267
    Proposal for a regulation
    Annex I – point 3 – point 3.4 3.4.  After 3 consecutive litter-giving pregnancies of a bitch or a queen within a period of 2 years, operators shall ensure a recuperation period by preventing pregnancies of the bitch or queen for a period of at least 1 year. 3.4.  For bitches and queens that have delivered 3 litters, including stillborns within a period of 2 years, there shall be a recuperation period of at least 1 year. Amendment 268
    Proposal for a regulation
    Annex I – point 3 – point 3.4 a (new) 3.4a.  Any bitch or queen that has undergone two cesarean sections shall no longer be used for breeding Amendment 269
    Proposal for a regulation
    Annex I – point 3 – point 3.4 b (new) 3.4b.  Before any bitch aged 8 years or more and any queen aged 6 years or more, is used for breeding, it must have been physically examined by a veterinarian who confirms in writing that, at the time of the examination, there are no counter-indications to pregnancy. The operator shall keep the written confirmation referred for a period of at least 3 years Amendment 270
    Proposal for a regulation
    Annex I – point 4 – point 4.1 – point c (c)  areas where cats and dogs are kept are equipped with enrichment structures and items accessible to all animals, providing a stimulating environment, and reducing frustration of animals; (c)  areas where cats and dogs are kept are equipped with enrichment structures and items accessible to all animals, providing a stimulating environment, and if possible, structures for climbing and hiding, and reducing frustration of animals; Amendment 271
    Proposal for a regulation
    Annex II – introductory part Transponders used to mark cats and dogs as required in Article 16 shall meet the following requirements: Transponders used to individually identify dogs and cat as required in Article 17 and Article 21 shall meet the following requirements: Amendment 272
    Proposal for a regulation
    Annex III – point 1 1.  Number of dogs and cats microchipped per year as referred to in Article 17; 1.  Number of dogs and cats registered per year as referred to in Article 17 and Article 21(4); Amendment 273
    Proposal for a regulation
    Annex III – point 1 a (new) 1a.  Number of establishments registered per year in accordance with Article 7; Amendment 274
    Proposal for a regulation
    Annex III – point 2 2.  Number of breeding establishment approved per year as referred to in Article 16. 2.  Number of breeding establishments approved per year as referred to in Article 7a. Amendment 275
    Proposal for a regulation
    Annex III – point 2 a (new) 2a.   Number of breeding and selling establishments whose approval has been suspended or withdrawn per year.

    MIL OSI Europe News

  • MIL-OSI Video: President Cyril Ramaphosa conducts oversight visit to Steve Biko Hospital

    Source: Republic of South Africa (video statements)

    President Cyril Ramaphosa conducts oversight visit to Steve Biko Hospital

    https://www.youtube.com/watch?v=I5Zk6xaJOI0

    MIL OSI Video

  • MIL-OSI United Kingdom: Home testing kits for lifesaving checks against cervical cancer

    Source: United Kingdom – Executive Government & Departments 2

    Press release

    Home testing kits for lifesaving checks against cervical cancer

    Government to offer home-testing kits as part of the cervical screening programme under its upcoming 10 Year Health Plan.

    • Under screened women to be offered convenient HPV self-sampling kits under new 10 Year Health Plan 
    • Home kits offered to those who have missed their invite, making care more convenient and supporting our shift from treatment to prevention
    • New initiative builds on NHS’ personalised approach to cervical screening

    Women and people with a cervix* across England who haven’t come forward for vital health checks will be offered home-testing kits as part of the cervical screening programme under the upcoming 10 Year Health Plan.

    The ground-breaking initiative aims to revolutionise cervical cancer prevention rates by tackling deeply entrenched barriers that keep some women away from potentially life-saving screenings, including a fear of discomfort, embarrassment, cultural sensitivities and the struggle to find time for medical appointments.  

    Women who have rarely or have never attended their cervical screening will be offered a self-sample kit to complete at home. They are then sent out in discreet packaging and returned via pre-paid mail in the local post box.  

    Participation in cervical cancer screening currently sits at just 68.8% – well below the NHS England target of 80%. This means over 5 million women in England are not up to date with their routine check-up**. But experts believe this targeted approach could increase participation in the screening programme that saves approximately 5000 lives a year across England.   

    The initiative is part of the government’s upcoming 10 Year Health Plan – due to be published in the coming weeks – which sets out how government plans to tackle the challenges facing the health service and build an NHS that is fit for the future by doing more to prevent ill health in the first place.

    Health and Social Care Secretary Wes Streeting said:   

    These self-sampling kits represent healthcare that works around people’s lives, not the other way around. They put women firmly in control of their own health, ensuring we catch more cancers at their earliest, most treatable stages.

    Our 10 Year Health Plan will fundamentally reform the NHS, shifting focus from treating illness to preventing it before it starts.

    We know the earlier cancer is diagnosed the better the chances are of survival. By making screening more convenient, we’re tackling the barriers that keep millions of women from potentially life-saving tests.

    The self-testing kits, which detect human papillomavirus (HPV), a group of viruses that can lead to cervical cancer, allow women to carry out this testing in the privacy and convenience of their own homes.  

    Michelle Kane, NHS Director of Screening, said:

    There are a number of reasons that stop some women taking up the offer of screening and we hope the introduction of self-testing will encourage more women to take up this life-saving test in a way that works for them.

    I’d encourage anyone who gets an invite for a cervical screening, either from their local GP practice or the NHS App, to attend and if you have any worrying symptoms, please contact your GP. It could save your life.

    The programme specifically targets those groups consistently missing vital appointments, with younger women, ethnic minority communities facing cultural hurdles, people with a disability and LGBT+ people all set to benefit. 

    Anyone testing positive for HPV through self-sampling will be encouraged to attend a clinician-taken follow-up cervical screening test to check for cervical cell changes. 

    Athena Lamnisos, Chief Executive, Eve Appeal, said:

    There are so many different reasons why those who are eligible aren’t responding to their cervical screening invitation letter.

    HPV self-testing will be a step change for some. Being able to do the test in their own time and following simple instructions is what many people want and need. Ensuring that the under-screened and never screened know about this new test is vital for Eve.

    As the leading gynae cancer prevention charity, we know how vital it is to address health inequalities and make sure that everyone knows that this test is available to them and why it’s important.

    Michelle Mitchell, Chief Executive of Cancer Research UK, said: 

    Screening is a powerful tool to prevent cervical cancer and save lives, but we know it isn’t always easy for everyone to take part. For some, the test may seem uncomfortable, embarrassing, or simply hard to fit into their lives. That’s why we welcome the UK government’s decision to roll out cervical cancer home screening kits in England – to help remove barriers and make cervical screening more accessible.

    The gold standard way to test for HPV is still a sample taken by a clinician and this will be suitable for most people. But beating cervical cancer means beating it for everyone, and this move helps to bring us closer to that goal.  It’s important to remember that cervical screening is for people without symptoms so, if you notice any unusual changes for you, do not wait for a screening invitation – speak to your doctor.

    This approach builds on the NHS’ recent announcement to make cervical cancer screening more personalised. From July, women aged 25-49 who test negative for HPV in a clinician-taken test will be invited for their next test in five years, rather than three, following a recommendation by the UK National Screening Committee. The programme is in line with major clinical evidence that shows if a person tests negative for HPV they are extremely unlikely to go on to develop cervical cancer within the next decade. Anyone whose sample indicates the presence of HPV will continue to be invited to more frequent screenings.  

    Digital invitations and reminders for cervical screening were also recently rolled out as part of the NHS App’s ‘ping and book’ service to make screenings even more convenient, boost uptake and save lives.  

    Through our Plan for Change, the government is cutting waiting times for cancer patients with 99,000 extra patients having had cancer diagnosed or ruled out since July than in the previous year. In February, the highest ever proportion of patients had a diagnosis or an all clear within four weeks.

    Dr Anita Lim, Chief Investigator of the YouScreen trial and Visiting Senior Research Fellow, King’s College London:

    This is a significant step forward for cervical cancer prevention and brings us closer to the NHS goal of eliminating the disease by 2040. The YouScreen trial, which provided self-sampling HPV kits to under-screen women in London, demonstrated that self-sampling could reach people who find it difficult to attend traditional screening – including those from diverse and underserved populations.

    It’s hugely positive to see this now reflected in national policy, helping more people get protected from this highly preventable cancer.

    Gem, who was diagnosed with cervical cancer in 2015, said:

    My cervical cancer was picked up during a routine screening by my GP. I was referred for surgery to remove the cancer cells, as well as lymph nodes from my abdomen and pelvis.

    It took me about six weeks to recover, and because it was caught early and hadn’t spread, I was told at my follow-up appointment that I was cancer-free and didn’t require further treatment.

    I’ve been cancer-free for years now, but I still live with the aftermath of my diagnosis. I hope that one day we live in a world where cervical cancer is eliminated. With advances in vaccines and screening, I believe that day is getting ever closer.

    For many, though, there are barriers to attending screening. Our everyday lives are busy juggling jobs, family life, and more, which can make attending appointments difficult. But feelings of embarrassment, fear, or unease can also prevent people from going.

    Making it easier for people to access screening they can do at home removes some of those barriers and will, I’m sure, save lives.

    If I hadn’t attended screening when I did, I’m certain I would have been facing a very different outcome. I will always be thankful that I went when I did and now try to use my experience to help others.

    ENDS  

    Updates to this page

    Published 24 June 2025

    MIL OSI United Kingdom

  • MIL-OSI Russia: Moscow is a city of youth: how student brigades help to realize oneself

    Translation. Region: Russian Federal

    Source: Moscow Government – Government of Moscow –

    This year, from April to August, members of Moscow student brigades work at various sites across the country. Over 500 people remained to work in the capital. During the academic year, students and schoolchildren were selected for all-Russian and interregional work projects of Russian student brigades (RSB) – they completed tasks and participated in interviews.

    “Thanks to the opportunities in the capital, young residents of the capital can realize themselves in various areas from volunteering to creativity. Moscow student brigades are an active community that works for the benefit of the entire country. More than 3.5 thousand participants of student brigades work at sites throughout Russia, master professions, gain experience and contribute to the development of the most important sectors – from education to industry,” said

    Ekaterina Dragunova, Chairman of the Committee for Public Relations and Youth Policy of the City of Moscow.

    They receive a working specialty and begin their journey into the profession

    Currently, the Moscow regional branch of the RSO has over 150 teams in eight areas. They unite over 3.5 thousand students from 80 capital universities, 30 colleges and 80 schools. In the spring, the children received free training in working specialties in order to begin their path to the profession in the summer, gain their first work experience and contribute to the development of key industries in the country.

    “Moscow student brigades are professional growth and acquisition of flexible skills, experience, a team and, of course, youthful romance. Now students and schoolchildren begin their working summer at construction sites, the railway, in hospitals, hotels, children’s camps, agricultural complexes, on the fishing season and archaeological excavations. The guys work both in the capital and throughout Russia,” said Yulia Drozhzhina, chairperson of the board of Moscow student brigades, State Duma deputy.

    More than a thousand participants in the pedagogical direction work as counselors, shift leaders and program organizers in children’s camps in the Central Federal District, Krasnodar Krai, the Republic of Crimea and Primorye.

    Over 70 people represent Moscow in major RSO work projects as part of all-Russian student teaching teams. These are Gagarin in Anapa, Okean in Vladivostok, Delfin.ru in Krasnodar Krai, Orlyonok, Krasnaya Nit and Sputnik in Rostov Oblast. Muscovites also work at the International Children’s Center Artek in Yalta. In addition, the children will become counselors as part of the district student teaching team Solnechny. Their functions include holding leisure and developmental events and creating a comfortable environment for communication and socialization of children.

    Making Reality More Interesting Than a Smartphone: Moscow Camp Counselors Talk About Children, Games, and Teaching Techniques

    In student construction teams, the guys work at city, federal and international sites. They participate in ensuring the stable functioning of city systems – in servicing the heating stations of PJSC MOEK, the electric grid complexes of PJSC Rosseti and the Moscow Metro facilities. In addition, with the assistance of the administration of the capital’s universities, the guys build dormitories of the Peoples’ Friendship University of Russia named after Patrice Lumumba and the innovative scientific and technological center of Moscow State University “Vorobyovy Gory”.

    They work on all-Russian student construction sites and international projects

    13 capital teams have been selected for five all-Russian labor projects of the RSO, including “Peaceful Atom — Leningrad NPP” in the city of Sosnovy Bor in the Leningrad Region, where they are taking part in the construction of the Leningrad NPP-2.

    In addition, student team members perform general construction work at the all-Russian student construction sites “Peaceful Atom” in Ozersk, Chelyabinsk Region, “Peaceful Atom – Skif” in Novosibirsk, “Peaceful Atom – Breakthrough” in Seversk, Tomsk Region, “Alabuga Stroy” in Yelabuga (Republic of Tatarstan), “Siberia”, as well as in the work projects of Aeroterminal LLC in Krasnodar and “Kovykta” at the Kovykta gas condensate field in the Irkutsk Region.

    25 students represent Moscow in international projects, ensuring the operation of power plants in the Arab Republic of Egypt, including the El Dabaa Nuclear Power Plant (NPP), as well as in the Republic of Bangladesh at the Rooppur NPP.

    Moscow student teams completed internships in more than 40 cities in RussiaSergei Sobyanin spoke about the work of Moscow student brigades

    They look after patients, work as orderlies and nurses

    The number of participants in medical teams is growing every year. Students from the capital’s famous medical universities provide support to the country’s healthcare system during the summer – they look after patients, work as orderlies and nurses in institutions throughout Russia.

    This year, in Moscow, they are working at the N.V. Sklifosovsky Research Institute of Emergency Care, the private healthcare institution “RZhD-Medicine Clinical Hospital named after N.A. Semashko”. Nine medical teams have been selected for all-Russian projects. From July, they will work in healthcare institutions on Sakhalin Island, Novosibirsk, Novokuznetsk, Chelyabinsk, Barnaul, Perm, Irkutsk and Tomsk, as well as in the Valeo district project in the Voronezh Region.

    Provide comfortable passenger transportation and service

    More than 200 participants in the conductor program ensure safe and comfortable passenger transportation on long-distance trains in the structural divisions of JSC Federal Passenger Company (Moscow-Kyiv and Nikolaevka). During trips, students control the placement of passengers according to tickets and serve them along the way, supervise safe boarding and disembarking on platforms, and monitor the technical condition of the carriage.

    This year, three student conductors became leaders of the all-Russian labor projects “Moscow” and “Adler”. Miron Ganichev from the student conductor team “Sinoger” based at the Russian State Agrarian University – Moscow Agricultural Academy named after K.A. Timiryazev took the position of instructor at the passenger car depot “Moscow-Kyiv”. Before each trip, he instructs students on labor protection and fire safety while working on the train.

    Participants in the service direction work as waiters, maids, lifeguards, bartenders, administrators and animators in hotels and sanatoriums on the Black Sea coast as part of the All-Russian student service teams “Sochi Park Hotel” in the city of Sochi, “Gelendzhik” in the city of the same name, “More” in Crimea.

    The “Runway” project in St. Petersburg allowed the children to become escorts for passengers with limited mobility, call center operators, inform passengers about airport services, clean aircraft cabins – raise seat backs, armrests and lay out blankets.

    For the first time this year, students began working at passenger check-in desks and became baggage handlers at Vnukovo Airport. On the Sapsan and Lastochka trains on the Moscow-St. Petersburg route, they hold the positions of waiter-stewards and serve passengers on high-speed trains. In addition, the guys work as waiters in the business lounges of Paveletsky and Kazansky railway stations in the center of the capital.

    They get jobs in admissions offices of universities and work in agriculture

    Another area of activity of service teams is administrative work at Moscow universities. Thus, students work in admissions committees of universities. They receive documents from applicants, form lists of applicants, draw up schedules for conducting entrance examinations and participate in summing up the results of the admissions campaign.

    Agricultural sector participants are involved in harvesting crops, working with cattle and poultry as veterinarians, livestock technicians, laboratory technicians, and much more.

    For example, this year students are participating in a large all-Russian project to harvest apples on the territory of OOO Agronom-Sad in Lipetsk Oblast and are being employed as winegrowers at AO Divnomorye in Krasnodar Krai.

    Students majoring in animal husbandry — veterinarians, zootechnicians, technologists and biologists — will try themselves at subsidiaries of the EkoNiva group of companies in the Voronezh region, at enterprises of the Damate group of companies in the Rostov region and at branches of Stavropolsky Broiler LLC.

    From July 1, members of the fishing teams will go to student fishing seasons in the Kamchatka and Khabarovsk regions as fish processors, caviar fishermen and short-distance fishing sailors.

    Moscow to open 65th summer work season of student teams

    They are on duty at MCC, MCD stations and railway stations

    This year, schoolchildren aged 14 to 17 years old, as part of the adolescent work teams, will work as hall attendants at the stations of the Moscow Central Circle, Moscow Central Diameters, and as attendants at the capital’s railway stations.

    For the first time this year, Moscow teenagers’ work teams were selected for the all-Russian work project “Alabuga TOP” in Yelabuga (Republic of Tatarstan). There they will become office managers for receiving and processing incoming calls in the office, and will clean residential premises and public places.

    More detailed information about the activities of Moscow student teams can be found in the community VKontakte or intelegram channel. You can learn more about the opportunities for young residents of the capital on the portal “Youth of Moscow” and in social networks project.

    Moscow is a city of youth. The capital offers wide opportunities for its development, creative self-expression, comfortable life and interesting leisure. It has a developed infrastructure, thousands of events of different scale and focus are held here.

    In honor of Youth Day, themed events will be held at more than 250 city venues. The flagship event will be the festival, which will take place on June 28 and 29 at Bolotnaya Square.

    You can find more detailed information and a map with all city events on the portal “Youth of Moscow”.

    Moscow student teams took part in the action “Snow landing of the RSO. Victory landing”From a conductor to a counselor: who can work in Moscow student groups

    Get the latest news quicklyofficial telegram channel the city of Moscow.

    Please note: This information is raw content directly from the source of the information. It is exactly what the source states and does not reflect the position of MIL-OSI or its clients.

    Please Note; This Information is Raw Content Directly from the Information Source. It is access to What the Source Is Stating and Does Not Reflect

    https: //vv.mos.ru/nevs/ite/155748073/

    MIL OSI Russia News

  • MIL-OSI Australia: 2025–26 ACT Budget – what’s in it for Canberrans

    Source: Northern Territory Police and Fire Services

    The Budget includes support for the revitalisation of Telstra Tower.

    In Brief

    • The 2025–26 ACT Budget has been handed down.
    • This article provides an overview of the key initiatives supported through this year’s Budget.

    The 2025–26 ACT Budget is investing in the services and infrastructure our growing city needs.

    This year’s Budget makes a record investment in the ACT’s public health system. This will ensure Canberrans have access to the health care they need, when they need it.

    The Budget will enable the delivery of more homes for Canberra. Practical initiatives will boost supply, increase affordability and deliver diverse housing options to suit all stages of life.

    There is continued cost of living support for those who need it most, as well as new and upgraded suburban infrastructure.

    This year’s ACT Budget also invests in a new pool and convention centre for Canberra, and the revitalisation of Telstra Tower.

    Health

    The 2025–26 ACT Budget will deliver more affordable GP services for families.

    A new pilot program to support general practices that commit to bulk billing children will reduce out-of-pocket costs for families.

    Junior doctors will start training rotations in general practices, allowing them to begin practising in primary care in the community sooner in their training.

    There will be more professional development and wellbeing support for the general practice workforce, ensuring they can keep delivering the best care possible.

    The Budget includes support to enable the ACT Government’s commitment of 70,000 elective surgeries over four years.

    The ACT Government will also continue to invest in health infrastructure across Canberra, including:

    • planning and detailed design work for the new northside hospital in Bruce
    • planning and design work for a new pathology and clinical services building at Canberra Hospital
    • a new public medical imaging outpatient service at Belconnen Community Health Centre.

    Housing

    The ACT Government is committed to enabling 30,000 homes by 2030.

    The Budget supports a range of practical initiatives to deliver more homes for Canberrans – now and in the future.

    Key Budget initiatives include:

    • an increase of the stamp duty concession threshold to $1.02 million for eligible buyers
    • 85 new public housing dwellings delivered through community housing providers under the Housing Australia Future Fund Facility (HAFFF)
    • additional funding for the Affordable Housing Project Fund
    • 300 affordable Build-to-Rent homes
    • 17 new social housing townhouses acquired in Coombs under the Social Housing Accelerator
    • ongoing investment in the Growing and Renewing Public Housing Program to maintain and expand Canberra’s public housing portfolio.

    Cost of living

    The ACT Government will deliver new and continuing cost of living measures through the 2025–26 ACT Budget. The measures focus support where it’s needed most.

    These include:

    The 2025–26 ACT Budget also includes investment in:

    For all your ACT Budget news in one place, visit the Our CBR website.

    To read the 2025-26 ACT Budget papers visit the Budget website.

    What’s in it for your region?

    The Budget invests in new and improved suburban infrastructure across Canberra – from playgrounds to paths, shops and sporting facilities.

    Click on the map below to find out what’s been funded in the 2025–26 ACT Budget for your region.


    Get ACT news and events delivered straight to your inbox, sign up to our email newsletter:


    MIL OSI News

  • MIL-OSI Banking: Panasonic’s nanoe(TM) inhibits dust mite allergens hidden within bedding fibers, a common cause of sleep disturbances during the rainy season

    Source: Panasonic

    Headline: Panasonic’s nanoe(TM) inhibits dust mite allergens hidden within bedding fibers, a common cause of sleep disturbances during the rainy season

    Osaka, Japan, June 24, 2025 – Panasonic Corporation (https://holdings.panasonic/global/) (Panasonic) today announced that it has demonstrated that nanoe (hydroxyl radicals contained in water) technology can inhibit dust mite allergens*1 located 1 cm beneath the surface of bedding, which are considered one of the causes of sleep disturbances. The demonstration was conducted under the supervision of Dr. Shuichiro Shirakawa, Ph.D., Director of Sleep Assessment & Research Institute, Inc. In addition, joint research with Associate Professor Tomoki Fukuyama of the School of Veterinary Medicine at Azabu University verified at the cellular level that the immune response involved in the itching and inflammation caused by dust mite allergens was also inhibited.
    According to the Ministry of Health, Labour and Welfare, approximately one in two Japanese people has an allergic disease,*2 with dust mite allergies being the second most common allergy in terms of the number of patients.*3 Many dust mite allergens are hidden in bedding such as futons and pillows. It is said that there are more than 140,000 dust mites per 2 m2 (equivalent to one futon).*4 Dr. Shirakawa points out that dust mite-derived allergens within 1 cm of the bedding surface are stirred into the air by turning over in bed, becoming one of the factors that can trigger allergic symptoms and disrupt sleep.*1 In particular, from the rainy season in June to the height of summer in August, the humid environment favored by dust mites promotes their peak proliferation.*5
    The verification test was conducted based on the hypothesis that nanoe (hydroxyl radicals contained in water), consisting of nano-sized particles one hundred-thousandth the size of a hair, could inhibit dust mite allergens hidden within the fibers. As a result of the verification, two new findings were obtained: nanoe (hydroxyl radicals contained in water) inhibited both dust mite allergens hidden within bedding and the cellular reactions that lead to itching and inflammation caused by them. The verification found that nanoe (hydroxyl radicals contained in water) technology holds new potential to surpass spatial purification and enhance the quality of the sleep environment. Note that this verification was conducted based on the test conditions described below and did not assess effectiveness in an actual usage environment.
    Panasonic aims to contribute to society by providing safe and secure spaces and will continue to evolve nanoe (hydroxyl radicals contained in water) technology while exploring its future potential.

    ■Comments from Dr. Shuichiro Shirakawa, Director, Sleep Assessment & Research Institute, Inc.

    There are more dust mites hidden in futons and pillows than you might imagine. We believe that this is an unavoidable issue when seeking high-quality sleep. We know that bedding care can be provided through methods such as sun drying, cleaning, or washing, but these are time-consuming, and frequent care can be burdensome. On the other hand, this verification test demonstrated that nanoe (hydroxyl radicals contained in water) can inhibit dust mite allergens without the need for human intervention. We believe this technology has the potential to contribute to creating a comfortable bedroom environment.
    * Panasonic requested comments from Dr. Shirakawa, which were subsequently edited and published here.

    ■Comments from Associate Professor Tomoki Fukuyama, School of Veterinary Medicine, Azabu University

    It is no exaggeration to say that dust mite allergies, like hay fever, are a widespread condition affecting many people and are one of the causes of sleep disturbances. This test verified that nanoe (hydroxyl radicals contained in water) technology can inhibit the immune response that leads to itching and inflammation by inhibiting dust mite allergens. Based on these results, we believe that nanoe (hydroxyl radicals contained in water) technology has the potential to alleviate the symptoms of dust mite allergies and reduce their sleep-disrupting effects.
    * Panasonic requested comments from Associate Professor Tomoki Fukuyama, which were subsequently edited and published here.

    ■Key points of this verification

    Dust mite allergens typically reside within 1 cm of the surface of bedding and are considered one of the factors that disrupt sleep. This verification demonstrated that nanoe (hydroxyl radicals contained in water) can inhibit them.
    Exposing cells to dust mite allergens inhibited by nanoe (hydroxyl radicals contained in water) technology demonstrated that nanoe inhibited the activity of the cells leading to inflammation and itching.

    ■Principle of nanoe (hydroxyl radicals contained in water) generation

    Figure 5. nanoe (hydroxyl radicals contained in water) generator

    nanoe (hydroxyl radicals contained in water), approximately 5 to 20 nanometers in size and containing hydroxyl radicals, is generated by cooling the atomizing electrode with a Peltier element, condensing moisture from the air into water, and applying a high voltage between the atomizing electrode and the counter electrode.

    ◆Click here for a summary of this press release.https://www.panasonic.com/global/consumer/nanoe/ja/topics/2506XX.html
    ◆Click here for the research results of nanoe (hydroxyl radicals contained in water) technologyhttps://www.panasonic.com/global/consumer/clean/hydroxyl.html

    Notes:
    *1: Reference: Shuichiro Shirakawa, “Interview on factors that disrupt sleep”
    *2: Reference: Ministry of Health, Labour and Welfare, “Rheumatism and Allergy Countermeasures Committee Report”
    *3: Reference: Takechika Ohmori, “Trends in Outpatient Therapy for Allergies”
    *4: Reference: Hiroki Kamezaki, “Fauna and spatial distribution of house-dust mites in Japanese mattress”
    *5: Reference: Junko Miyamoto, “Ecological studies of house dust mites—Seasonal changes in mite populations in house dust in Japan”

    Media Contact:

    Living Appliances and Solutions Company, Panasonic CorporationPublic Relations, Corporate Policy Department, Corporate Planning CenterEmail: las-pr@gg.jp.panasonic.com

    Customer Contact:

    Living Appliances and Solutions Company, Panasonic CorporationDevices Products Business Unit, Beauty and Personal Care Business DivisionTelephone: +81-(0)749-27-0485 (available 9:30 a.m. to 5:00 p.m. excluding Saturdays, Sundays, and public holidays)

    MIL OSI Global Banks

  • MIL-OSI Asia-Pac: Public invited to Hospital Authority Board Meeting

    Source: Hong Kong Government special administrative region

    Public invited to Hospital Authority Board Meeting 
         The HA Board Meeting has been open to members of the public since 1998 to demonstrate the continuous effort of the Authority to enhance its transparency and public accountability. The HA Board holds meetings at regular intervals to discuss major health policy issues that have impacts on the public. Through these open meetings, the community is able to understand more about the role and functions of the HA Board as well as the operation and services of the HA and its hospitals.
     
         The HA Board will discuss the following agenda items in the coming meeting:
          The meeting agenda and papers will be made available to the public at the meeting. Members of the public are reminded that they can attend the Board Meeting only as observers and will not be participating in the meeting discussions.
     
         Members of the public who are interested in attending the coming Board Meeting have to make an advance booking by contacting the Secretariat of the HA Board at 2300 6797 before noon on June 26. To facilitate booking arrangements, members of the public are advised to provide their names and contact telephone numbers. In view of the limited seating available in the public gallery of the meeting venue, seating will be reserved on a first-come, first-served basis.
    Issued at HKT 12:00

    NNNN

    MIL OSI Asia Pacific News

  • MIL-OSI Russia: NSU students won six medals at the “I am a professional” Olympiad

    Translation. Region: Russian Federal

    Source: Novosibirsk State University – Novosibirsk State University –

    The results of the All-Russian Student Olympiad “I am a Professional” – one of the largest educational projects in the country – have been summed up. NSU students won six medals: three gold and three bronze.

    Master’s student Faculty of Information Technology Ivan Baksheev won the gold medal and became the winner of the Olympiad for the fourth time. This year, he immediately went to the final as last year’s medalist. The Olympiad included two rounds: theoretical and practical, both under strict online proctoring.

    — I have been participating in the Olympiad for several years now. This year was my last chance, as the Olympiad is not held for postgraduates. The most difficult tasks were those on the physical protection of critical facilities, but in the end I solved them best. And in the practical round, I had to urgently deal with memory dumps — quickly find the necessary software, install and use it. The results were expected: judging by the scores, it was already clear in April that the gold was in my pocket, — Ivan shares.

    The student is currently continuing his research work, with his interests focused on various aspects of information theory, including issues related to data protection:

    “I am studying various aspects of information theory and plan to enroll in graduate school at NSU or one of the institutes of the Siberian Branch of the Russian Academy of Sciences, continuing to work in this field,” he says.

    The gold medal in the Psychology track was won by Lyubov Pecherina, a student at the Institute of Medicine and Medical Technologies of NSU. The Olympiad was held in two stages – an online qualifying round and an in-person final, which Lyubov wrote at the TSU site.

    — During my school years, I actively participated in Olympiads — I won and took prizes. In my fourth year, I wanted to test my knowledge again, but in the direction of my studies at the university, that is, psychology. The result was the status of a gold medalist, that is, first place. The Olympiad tasks were really interesting, and completing them brought me considerable pleasure. I think the most difficult task was the one in which I had to read an English-language article from a scientific journal on cognitive sciences and write an abstract for it, also in English. But what I liked most was the task about the problems of the modern urban environment and the psychological consequences of living in the city, which required multidisciplinary knowledge. I was once again convinced that the main thing when solving problems in the Olympiad is not to be afraid to think and always go beyond the curriculum, to act creatively. I was amazed at such a high result. When I saw my gold medal diploma, tears came to my eyes, and I realized that all the effort I put into my studies was not wasted, says Lyubov.

    Lyubov is currently studying the characteristics of self-perception in people with autism spectrum disorders and is preparing to enter the NSU Master’s program in counseling and clinical psychology.

    — I study autism spectrum disorder, namely, what characterizes and distinguishes the perception of the surrounding world, oneself, one’s body and emotions in people with ASD from neurotypical people. In the future, I plan to enroll in a master’s program at NSU, finish and publish an article dedicated to the peculiarities of self-perception in autistic people, and, of course, take part in the Olympiad again, — Lyubov shares.

    Another gold medal winner is Alexander Tomilov, a student Faculty of Natural SciencesHe became the winner in the track “Chemistry”.

    — I have been participating in this Olympiad for the second year, because it gives an opportunity to demonstrate my knowledge and receive a reward in the form of an increased scholarship or cash prizes for medalists. This year I managed to become a gold medalist in Chemistry and a prize winner in Physics, which I am very happy about. The selection was held online, the semi-final included theoretical problems, and the final at Moscow State University was a practical course. There, it was necessary to work in a chemical laboratory: prepare solutions, carry out synthesis and analyze products. This year, the problems were closer to those we solve at the department, so I coped with them more confidently. The medal is both recognition and financial support, — says Alexander.

    Nazim Mustafin, a student of the Faculty of Natural Sciences, became a two-time bronze medalist of the Olympiad in two tracks at once: Chemistry and Biotechnology.

    — There is a qualifying round for both Olympiads, but I only wrote the chemistry qualifying round, since my diploma in biotechnology was accepted last year. The chemistry qualifying round was quite difficult, so I didn’t think I would make it to the final. However, I was lucky, — says Nazim.

    The final of the chemical track took place at Moscow State University. Nazim managed to meet friends in Moscow, visit various museums and become a prize winner.

    — Last year I won a silver medal in biotechnology and fourth place in chemistry — this year the results have shifted a little. The student track for the master’s degree is more difficult: I had to compete with graduates of the master’s degree. The final in chemistry itself was easier this year — I scored 99 points out of 100 for the practical. But in biotechnology they added a choice of problems, and it became more difficult to calculate the time correctly, — Nazim admits.

    Nazim calls participation in the Olympiad a challenge and an opportunity to earn money – there is a solid cash prize for medals. Next year, he plans to try his hand at mathematics and quantum computing.

    — I am very happy with this victory. Now the period of active study is over, so I plan to delve into the theoretical foundations of what I do in the laboratory, at the same time I am working there on a project to assemble an experimental setup, — the prize winner concludes.

    Also, a bronze medal in biotechnology was won by a student of the Faculty of Natural Sciences Anna Skotareva. This is her first participation in this track, and immediately – a prize place.

    — I have been participating in Olympiads since the first grade. At university I decided to continue — this year I tried myself in biotechnology for the first time and unexpectedly received bronze. The tasks were classic, without surprises. The topics about industrial ecology and synthetic structures turned out especially well — they are close to what I do, — Anna shares.

    In addition, Anna became the winner in the track “Ecology”. Now she studies genes associated with antibiotic resistance in prokaryotes, is interested in systems biology and bioinformatics.

    “These days it’s difficult to be a specialist in one field; you need to be able to adapt quickly,” says Anna.

    The All-Russian Olympiad “I am a Professional” is the flagship project of the presidential platform “Russia – the Land of Opportunities”. It is held with the support of the Ministry of Education and Science of the Russian Federation, more than 35 leading universities in the country and over 500 companies, including Yandex, Sber, VTB, Rosatom, Russian Railways and others.

    Congratulations to the winners and prize winners!

    Please note: This information is raw content directly from the source of the information. It is exactly what the source states and does not reflect the position of MIL-OSI or its clients.

    MIL OSI Russia News

  • MIL-OSI China: China maps new healthcare blueprint for world

    Source: People’s Republic of China – State Council News

    How can people in remote and underdeveloped areas access advanced healthcare services? Can tailored medical solutions meet their unique needs? China, with such questions in mind, is boosting technological advancements to map a healthcare blueprint that benefits the world.

    Jotham Kimondo, a 35-year-old doctoral student from Tanzania, is currently studying at the University of Electronic Science and Technology of China in Chengdu, capital of southwest China’s Sichuan Province.

    Under the supervision of Wu Zhe, a professor at the university and director of the Chengdu Tianfu Jincheng Frontier Medical Equipment Research Institute, Kimondo is focusing on the design of ultrasonic medical devices.

    As a faculty member in Tanzania, Kimondo aims to learn ultrasonic instrument design and manufacturing in China to benefit his home country.

    “My research involves innovative design of ultrasonic medical instruments to monitor the pathological changes of human tissues, which is an important indication of disease. Women in Tanzania still rely on traditional methods like physician’s palpation to check for lumps in the mammary examination. This approach greatly depends on physicians’ individual experience and is not always accurate. And some women are not willing to do breast examinations,” said Kimondo.

    Kimondo added that many diseases still plague the people of Tanzania. “I want to improve healthcare in Tanzania, helping people to maintain health. If we develop more innovative ultrasonic medical equipment together in the future, it would be highly beneficial for early screening of breast diseases and other illnesses in Tanzania, especially after those devices become more convenient and cheaper, and can be better promoted across African countries.”

    At the Tianfu Jincheng Lab City of Future Medicine, over 53 registered companies related to frontier medicine have been attracted to explore the cutting edge of future medical innovation and integrated medicine.

    Recently, at the Remote Ultrasound Center of the Tianfu Jincheng institute, a doctor was talking online with another doctor at the Ultrasound Department of Chengdu Eastern New Area Second People’s Hospital, guiding the use of a portable ultrasound device on a patient’s carotid artery.

    Real-time imaging and relevant data of the ultrasound inspection were displayed on a shared screen, allowing the two doctors to communicate directly, discuss pathological conditions and give professional diagnostic results.

    “Traditional high-end ultrasound machines are expensive, costing millions. Rural residents in China’s western regions often need to seek ultrasound examinations in higher-level county hospitals,” Wu explained.

    “Our research efforts aim to enable portable ultrasound devices to be widely used in rural areas of western China for early disease screening and chronic disease management. Compared to high-end ultrasound machines, our portable device significantly lowers costs. Additionally, it is simpler and more convenient to use in grassroots hospitals,” Wu added.

    Use of this portable ultrasound device, which is the size of a smartphone, has already been implemented in over 10 health centers in eastern Chengdu — providing free carotid and thyroid screenings to more than 2,000 residents.

    With the continuous improvement of China’s industrial design and manufacturing capabilities and medical research levels, innovation in the development of medical devices is soaring. The growing recognition of Chinese medical devices in overseas markets is resulting in increasing international orders, encouraging more Chinese medical companies to go global.

    In the City of Future Medicine, an industrial park, workers at Chengdu Seamaty Technology Co., Ltd. are packing biochemical analysis reagents. This batch of goods is set to be shipped globally from Chengdu.

    This “Little Giant” firm, which refers to novel and elite small and medium-sized enterprises that specialize in a niche market, boast cutting-edge technologies and show great potential, focuses on the research and production of point-of-care testing (POCT) medical devices, and has already sold its medical products to more than 150 countries and regions worldwide.

    In its quality inspection center, hundreds of fully automated biochemical analyzers undergo pre-shipment quality checks.

    “This shipment of instruments will be sent to Europe. Last year, our company’s total sales reached 320 million yuan (about 44.6 million U.S. dollars), and in the first five months of this year, our international business has increased by 59 percent compared to the same period last year,” said Wang Bin, deputy general manager of the company, highlighting that the growth in overseas orders reflects an increasing acceptance of Chinese medical device manufacturing products in international markets.

    Innovative technologies such as 3D printing, organ-on-chip systems, nanorobots and brain-computer interfaces are advancing the scientific research applications of medical devices in China, presenting a future-oriented medical landscape.

    At Chengdu Tianqi Additive Intelligent Manufacturing Co., Ltd., personalized patient-matched medical solutions are being precisely created with 3D printing technology. It uses computer-aided design and manufacturing (CAD/CAM) modeling, and a layer-by-layer printing process, to turn virtual designs into physical products, making the envisioned design a tangible reality.

    In a modern manufacturing workshop, dozens of industrial printers operate in an orderly manner, with a laser engraver precisely etching patterns in titanium alloy powder to an accuracy of 0.01 millimeters.

    Within just a few hours, products such as patient-matched maxillofacial bone plates are printed. This seemingly ordinary industrial scene reflects significant advancements that China has made in the realm of precision medical manufacturing.

    Compared to the handmade bending of bone plates in the past, 3D printing offers a more precise, convenient, safe and stable way to create customized products.

    “We are currently conducting custom production for a case in Singapore. Engineers input patient data transmitted from the hospital into the system, and the AI algorithms aid designers in creating personalized data models for patient facial reconstruction, which are then integrally formed via metal 3D printers,” Gao Bangkui, marketing director of Chengdu Tianqi Additive lntelligent Manufacturing Co., Ltd said.

    Gao added that in the future, the company will prioritize serving the Middle East, Africa and Southeast Asia to meet the customized medical needs of countries and regions participating in the Belt and Road Initiative. 

    MIL OSI China News

  • MIL-OSI USA: Gov. Pillen Celebrates Elimination of the Developmental Disabilities Waitlist

    Source: US State of Nebraska

    .Powell@nebraska.gov”>Jeff.Powell@nebraska.gov

    Gov. Pillen Celebrates Elimination of the Developmental Disabilities Waitlist

    LINCOLN, NE – Today, Governor Jim Pillen joined leaders from the Nebraska Department of Health and Human Services (DHHS), Vital Services, Inc., program participants and families in celebrating the elimination of the developmental disabilities (DD) waitlist and improving support for Nebraskans with intellectual and developmental disabilities (IDD).

    The elimination of the waitlist is the result of an unprecedented investment of over $18 million, plus matching federal funds, to better enable the delivery of support services to children with disabilities and their families.

    “Eliminating the DD waitlist is a great accomplishment for the state of Nebraska,” said Gov.  Pillen. “Now, children and adults with IDD can access support at the time they need it. The new approach ensures a full continuum of care for individuals and their families, creating better opportunities and outcomes. Our kids are our future, and it is our responsibility to give each one the best future possible.”

    Historically, the DHHS Division of Developmental Disabilities (DDD) has maintained a waitlist for developmental disability waivers. In March of 2024, there were 2,706 individuals on the waitlist. At that time, Gov. Pillen joined representatives from DHHS in announcing that the state would eliminate the waitlist and establish a new approach to DDD services.

    During that 15-month process, more than 3,000 individuals were eliminated from the waitlist, including those who came on after March 2024. The new program provides the following:

    • Medicaid for DD eligible children that meet the required level of care

    • Additional access to family support and day services waivers that allow families to live together

    • Case management services for individuals who do not require waiver services

    • Employment services

    • Comprehensive DD waivers based on a nationally validated needs assessment adopted by DHHS with the support of stakeholders

    • New models of staffing including remote support and Legally Responsible Individuals (LRI) as paid providers for personal care

    • Expansion of independent providers

    “Today we celebrate with everyone who made the elimination of the DD Waitlist possible – Governor Pillen, leadership in the DD community, participants, family members, providers, our partners, front line staff, and many more,” said Tony Green, Director of DDD.   “As of this week, all individuals on the DD waitlist will have received an offer letter. Waivers, natural supports, and Medicaid assistance allow those individuals to remain in their communities, seek employment, and explore a future that meets the needs of each participant at each stage of life.”

    Today’s news conference was hosted by Vital Services, Inc., a local organization supporting individuals with IDD by offering residential support, supported employment, and day support in the Lincoln area. Prior to the announcement, Gov. Pillen, First Lady Suzanne, and Dir. Green received a tour of the facility and greeted program participants and staff.

    “Vital Services, Inc. teaches life skills to people with developmental disabilities and cares for each person’s unique needs with a variety of assistance programs. Our programs provide individuals with the tools to achieve independence, advocate for themselves, and integrate into their community. We are excited and grateful to celebrate with Governor Pillen the transformation in access to developmental disabilities services in Nebraskans,” said Joshua Bumgardner, Development Director of Vital Services, Inc.

    Andi Aschoff and her daughter, Kira Amos also spoke to the benefits they have experienced personally since DHHS changed its service delivery model. Kira currently receives a family support waiver, one of three waiver types, provided through the DDD program and she is a participant at Vital Services, Inc.

    “Having the support has changed our daily lives,” said Aschoff. “We do feel supported, and that really does make a big difference.”

    For more information on programs for individuals with IDD, or to apply for services, please visit the DDD website: https://dhhs.ne.gov/Pages/Developmental-Disabilities.aspx

    MIL OSI USA News

  • MIL-OSI USA: Case Opposes Proposed Funding Bill That Cuts Food Assistance To Hawaii Residents

    Source: United States House of Representatives – Congressman Ed Case (Hawai‘i – District 1)

    (Washington, DC) – U.S. Congressman Ed Case (HI-01), a member of the House Appropriations Committee, tonight voted against the proposed Fiscal Year (FY) 2026 Agriculture, Rural Development, Food and Drug Administration (FDA) and Related Agencies funding measure.  

    The measure would provide $25.5 billion, a $1 billion decrease from the current year, for U.S. Department of Agriculture (USDA) agriculture and rural development programs, the Farm Credit Administration, Commodity Futures Trading Commission and the FDA.

    It is the third of twelve separate bills developed and approved by the Appropriations Committee that would fund the federal government at some $1.6 trillion for FY 2026 commencing October 1st of this year. 

    “While the measure funds many critical Hawai‘i priorities, I regrettably had to vote against it because it would cut food assistance for vulnerable families and make it even harder for Hawai‘i farmers to make ends meet,” said Case, who is in his seventh year on Appropriations and previously served on the House Committee on Agriculture.  

    “At a time when families around the country and our state are struggling with the high cost of living and rising food costs, and when Hawai‘i agriculture is struggling with high production costs and the consequences of the administration’s rash and chaotic tariff war, we should be maintaining our time-tested federal programs, not reducing or even eliminating them.” 

    The bill:  

    ·        Cuts $100 from the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) and fails to support the cash benefit for fruits and vegetables that ensures women, infants and children get the nutrients they need.  

    ·        Reduces staffing for the Farm Service Agency (FSA), which operates offices across the country that assist farmers in getting needed federal assistance. The bill provides $110 million less for FSA staffing than what was provided in FY 2025.  

    ·        Cuts funding for the Natural Resources Conservation Service Conservation Operations by 5 percent below FY 2025 funding levels.

    ·        Cuts rural housing and water and waste-water grants.

    In addition, the bill eliminates key programs for Hawai‘i, like the Reimbursement Transportation Cost Payment Program for Geographically Disadvantaged Farmers and Ranchers. This program helps our local farmers with the cost of getting their produce to the mainland markets. Additionally, the Micro-Grants for Food Security Program, which increases the quantity and quality of locally grown food through small-scale gardening, herding and livestock and apiary operations, was eliminated.  

    Case especially objected to large cuts in critical foreign food assistance programs, including $900 million for Food for Peace, almost 50% down to its lowest level since 2002, and $220 million for the McGovern-Dole International Food for Education and Child Nutrition program, $20 million below the FY 2025 level. 

    “Cutting our international food assistance programs is contrary to our values and harms our national security. Global food insecurity leads to political instability, making countries more vulnerable to conflict and extremism, and helping other countries and peoples with their food needs knits together alliances and partnerships which are critical to our national defense,” said Case, a member of the Defense Appropriations Subcommittee.  

    Despite these and other significant problems with the bill, Case highlighted positive provisions he requested including important victories for Hawai‘i, including $216 million for the Specialty Crop Pests Program, which helps to protect our topical crops from invasive species. In addition, $15 million was included for Minor Crop Pest Management, which provides expert assistance for effective minor/specialty crop protection. The bill also provides research and education funds for Alaska Native and Native Hawaiian-Serving institutions, in addition to funding for our land-grant universities like the University of Hawai‘i.  

    “Invasive species pose a significant ecological and economic threat to our Hawai‘i, with specially damaging impacts on local agriculture,” said Case.  

    “This agriculture funding bill provides support for our local farmers, farmers markets and food promotion programs, which combined will help our Hawai‘i deal with the soaring cost of food, much of which is imported to our islands,” said Case.  

      Provisions in the bill of interest to Hawai‘i that Case worked to secure include:  

    ·        $5 million for Education Grants for Alaska Native and Native Hawaiian-Serving Institutions. This program addresses the educational needs of food and agricultural sciences-related disciplines and prepares low-income students for careers related to food, agricultural and natural resources.  

    ·        $123 million for the USDA Wildlife Damage Management Program, which helps to prevent the spread of the Brown Tree Snake to Hawai‘i.  

    ·        $3 million for Agricultural Canine Detection and Surveillance of invasive species and diseases, an increase of $500,000.  

    ·        $1.1 billion for the Animal and Plant Health Inspection Service, including $216 million for combating specialty crop pests.  

    ·        $36 million for Agriculture Quarantine Inspections to prevent infestations of pests and diseases.  

    ·        $15 million for the Minor Crop Pest Management Program to provide expert assistance to minor and specialty crop producers.  

    ·        $8 million for the Grassroots Source Water Protection Program that is designed to prevent water source pollution.  

    ·        $5 million for Aquaculture Centers and $2 million for aquaculture research programs.  

    ·        $1 million for Tropical and Subtropical Agricultural Research Grants for Insular Areas.  

       The measure also:  

    ·        Directs the Agricultural Research Service to continue research on tropical and subtropical crops, emphasizing the need to combat invasive pests.

    ·        Directs the Animal and Plant Health Inspection Service to report on existing protocols protecting Hawai‘i from invasive species and evaluate options for enhancing this protocol.  

      A summary of the agriculture funding bill is available here.  

      ###

     

     

    MIL OSI USA News

  • MIL-OSI Security: Pacific Partnership 2025 Conducts Mission Stop in Nuku’Alofa, Tonga, June 23, 2025 [Image 10 of 11]

    Source: United States Navy (Logistics Group Western Pacific)

    Issued by: on


    NUKU’ALOFA, Tonga (June 23, 2025) U.S. Navy Capt. Sharlene Gee, optometrist deployed in support of Pacific Partnership 2025 (PP-25), examines a patient for a glasses fitting during a PP-25 community health engagement at Vaiola Hospital in Nuku’Alofa, Tonga, June 23, 2025. Now in its 21st iteration, the Pacific Partnership series is the largest annual multinational humanitarian assistance and disaster management preparedness mission conducted in the Indo-Pacific. Pacific Partnership works collaboratively with host and partner nations to enhance regional interoperability and disaster response capabilities, increase security and stability in the region, and foster new and enduring friendships in the Indo-Pacific. (U.S. Navy photo by Mass Communication Specialist 2nd Class Moises Sandoval/Released)

    Date Taken: 06.23.2025
    Date Posted: 06.23.2025 23:29
    Photo ID: 9128318
    VIRIN: 250623-N-ED646-7446
    Resolution: 8002×5345
    Size: 7.43 MB
    Location: NUKU’ALOFA, TO

    Web Views: 0
    Downloads: 0

    PUBLIC DOMAIN  

    MIL Security OSI

  • MIL-OSI Security: Pacific Partnership 2025 Conducts Mission Stop in Nuku’Alofa, Tonga, June 21, 2025 [Image 1 of 10]

    Source: United States Navy (Logistics Group Western Pacific)

    Issued by: on


    NUKU’ALOFA, Tonga (June 21, 2025) Builder 3rd Class Tanapat Insamrong, left, and Builder 2nd Class Graham Kuckuk, both assigned to Naval Mobile Construction Battalion 4, transport a storage shelf into the pharmacy clinic at Vaiola Hospital as part of Pacific Partnership 2025 in Nuku’Alofa, Tonga, June 21, 2025. Now in its 21st iteration, the Pacific Partnership series is the largest annual multinational humanitarian assistance and disaster management preparedness mission conducted in the Indo-Pacific. Pacific Partnership works collaboratively with host and partner nations to enhance regional interoperability and disaster response capabilities, increase security and stability in the region, and foster new and enduring friendships in the Indo-Pacific. (U.S. Navy photo by Mass Communication Specialist 2nd Class Moises Sandoval/Released)

    Date Taken: 06.21.2025
    Date Posted: 06.23.2025 23:07
    Photo ID: 9128267
    VIRIN: 250621-N-ED646-4291
    Resolution: 8640×5760
    Size: 6.57 MB
    Location: NUKU’ALOFA, TO

    Web Views: 0
    Downloads: 0

    PUBLIC DOMAIN  

    MIL Security OSI